EurekaMag PDF full texts Chapter 71,851

Gomard, E.; Duprez, V.; Henin, Y.; Levy, J.P. 1976: H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes. Nature 260(5553): 707-709

Stutman, O.; Shen, F.W. 1978: H-2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets. Nature 276(5684): 181-182

Curtis, A.S.; Rooney, P. 1979: H-2 restriction of contact inhibition of epithelial cells. Nature 281(5728): 222-223

Ertl, H.C. 1981: H-2 restriction pattern of secondary influenza virus-immune cytolytic T cells. Australian Journal of Experimental Biology and Medical Science 59(Pt 5): 585-597

Margulies, D.H.; Evans, G.A.; Flaherty, L.; Seidman, J.G. 1982: H-2-like genes in the Tla region of mouse chromosome 17. Nature 295(5845): 168-170

Garrido, F.; Schirrmacher, V.; Festenstein, H. 1976: H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature 259(5540): 228-230

Monaco, J.J.; McDevitt, H.O. 1984: H-2-linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex. Nature 309(5971): 797-799

Maryanski, J.L.; Pala, P.; Corradin, G.; Jordan, B.R.; Cerottini, J.C. 1986: H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 324(6097): 578-579

Martin, W.J.; Gipson, T.G.; Rice, J.M. 1977: H-2a-associated alloantigen expressed by several transplacentally-induced lung tumours of C3Hf mice. Nature 265(5596): 738-739

Vojtísková, M. 1969: H-2d antigens on mouse spermatozoa. Nature 222(5200): 1293-1294

Pearman, C.; Kent, W.; Bracken, N.; Hussain, M. 2006: H-89 inhibits transient outward and inward rectifier potassium currents in isolated rat ventricular myocytes. British Journal of Pharmacology 148(8): 1091-1098

Campagner, A.; Sconfienza, L.; Cabitza, F. 2020: H-Accuracy, an Alternative Metric to Assess Classification Models in Medicine. Studies in Health Technology and Informatics 270: 242-246

Gu, J.-Z.; Wan, S.-M.; Kirillova, M.V.; Kirillov, A.M. 2020: H-Bonded and metal(ii)-organic architectures assembled from an unexplored aromatic tricarboxylic acid: structural variety and functional properties. Dalton Transactions 49(21): 7197-7209

Yang, Y.; Zhao, X.; Yu, J.; Chen, X.; Chen, X.; Cui, C.; Zhang, J.; Zhang, Q.; Zhang, Y.; Wang, S.; Cheng, Y. 2020: H-Bonding Supramolecular Hydrogels with Promising Mechanical Strength and Shape Memory Properties for Postoperative Antiadhesion Application. Acs Applied Materials and Interfaces 12(30): 34161-34169

Ramesh, P.; Chauhan, A.; Goyal, P.; Singh, A. 2020: H-FABP: a beacon of hope for prediabetic heart disease. Journal of Family Medicine and Primary Care 9(7): 3421-3428

Mesquita, Gçalo.; Silva, Tânia.; Gomes, A.C.; Oliveira, P.F.; Alves, M.G.; Fernandes, R.; Almeida, A.A.; Moreira, A.C.; Gomes, M.Salomé. 2020: H-Ferritin is essential for macrophages' capacity to store or detoxify exogenously added iron. Scientific Reports 10(1): 3061

Mazzucchelli, S.; Truffi, M.; Baccarini, F.; Beretta, M.; Sorrentino, L.; Bellini, M.; Rizzuto, M.A.; Ottria, R.; Ravelli, A.; Ciuffreda, P.; Prosperi, D.; Corsi, F. 2017: H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer. Scientific Reports 7(1): 7505

Wingo, C.S.; Madsen, K.M.; Smolka, A.; Tisher, C.C. 1990: H-K-ATPase immunoreactivity in cortical and outer medullary collecting duct. Kidney International 38(5): 985-990

Nakamura, T.; Suzuki-Minakuchi, C.; Kawano, H.; Kanesaki, Y.; Kawasaki, S.; Okada, K.; Nojiri, H. 2020: H-NS Family Proteins Drastically Change their Targets in Response to the Horizontal Transfer of the Catabolic Plasmid pCAR1. Frontiers in Microbiology 11: 1099

Stone, J.B.; Withey, J.H. 2021: H-NS and ToxT inversely control cholera toxin production by binding to overlapping DNA sequences. Journal of Bacteriology 2021: Jb0018721

Bouffartigues, E.; Buckle, M.; Badaut, C.; Travers, A.; Rimsky, S. 2007: H-NS cooperative binding to high-affinity sites in a regulatory element results in transcriptional silencing. Nature Structural and Molecular Biology 14(5): 441-448

Fang, Y.-L.; Cui, Y.; Zhou, L.; Thawai, C.; Naqvi, T.A.; Zhang, H.-Y.; He, Y.-W. 2021: H-NS family protein MvaU downregulates phenazine-1-carboxylic acid (PCA) biosynthesis via binding to an AT-rich region within the promoter of the phz2 gene cluster in the rhizobacterium Pseudomonas strain PA1201. Synthetic and Systems Biotechnology 6(4): 262-271

Pflum, M.Kay.H. 2006: H-NS gives invading DNA the silent treatment. Nature Chemical Biology 2(8): 400-401

Dorman, C.J. 2007: H-NS, the genome sentinel. Nature Reviews. Microbiology 5(2): 157-161

Dorman, C.J. 2004: H-NS: a universal regulator for a dynamic genome. Nature Reviews. Microbiology 2(5): 391-400

Kraszewski, A.; Sobkowski, M.; Stawinski, J. 2020: H-Phosphonate Chemistry in the Synthesis of Electrically Neutral and Charged Antiviral and Anticancer Pronucleotides. Frontiers in Chemistry 8: 595738

Yan, X.; Yang, Y.; Chen, Z.; Yin, Z.; Deng, Z.; Qiu, T.; Tang, K.; Cao, Z. 2020: H-RACS: a handy tool to rank anti-cancer synergistic drugs. Aging 12(21): 21504-21517

Castro, P.; Soares, P.; Gusmão, L.; Seruca, R.; Sobrinho-Simões, M. 2006: H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid. Oncogene 25(33): 4620-4627

Sciacchitano, S.; Sacconi, A.; De Vitis, C.; Blandino, G.; Piaggio, G.; Salvati, V.; Napoli, C.; Marchetti, P.; Taurelli, B.Salimbeni.; Coluzzi, F.; Rocco, M.; Vecchione, A.; Anibaldi, P.; Marcolongo, A.; Ciliberto, G.; Mancini, R.; Capalbo, C. 2021: H-Ras gene takes part to the host immune response to COVID-19. Cell Death Discovery 7(1): 158

Saeidi, S.; Kim, S-Jung.; Han, H-Jun.; Kim, S.Hoon.; Zheng, J.; Lee, H-Byoel.; Han, W.; Noh, D-Young.; Na, H-Kyung.; Surh, Y-Joon. 2020: H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression. Toxicology and Applied Pharmacology 402: 115121

Sathyan, K.M.; Nalinakumari, K.R.; Kannan, S. 2007: H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 20(11): 1141-1148

Li, C.; Teng, R-H.; Tsai, Y-C.; Ke, H-S.; Huang, J-Y.; Chen, C-C.; Kao, Y-L.; Kuo, C-C.; Bell, W.R.; Shieh, B. 2005: H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells. British Journal of Cancer 92(1): 80-88

Rainy, N.; Chetrit, D.; Rouger, V.; Vernitsky, H.; Rechavi, O.; Marguet, D.; Goldstein, I.; Ehrlich, M.; Kloog, Y. 2013: H-Ras transfers from B to T cells via tunneling nanotubes. Cell Death and Disease 4: E726

Rimessi, A.; Marchi, S.; Patergnani, S.; Pinton, P. 2014: H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene 33(18): 2329-2340

Millán, O.; Ballester, A.; Castrillo, A.; Oliva, Jé.Luis.de.la.; Través, P.G.; Rojas, Jé.María.; Boscá, L. 2003: H-Ras-specific activation of NF-kappaB protects NIH 3T3 cells against stimulus-dependent apoptosis. Oncogene 22(4): 477-483

Hofving, T.; Karlsson, J.; Nilsson, O.; Nilsson, J.A. 2019: H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines. Nature Genetics 51(10): 1426-1427

Wachtel, S.S.; Koo, G.C.; Ohno, S.; Gropp, A.; Dev, V.G.; Tantravahi, R.; Miller, D.A.; Miller, O.J. 1976: H-Y antigen and the origin of XY female wood lemmings (Myopus schisticolor). Nature 264(5587): 638-639

Ehrenreich, P.; Birkhold, S.T.; Zimmermann, E.; Hu, H.; Kim, K-Dae.; Weickert, J.; Pfadler, T.; Schmidt-Mende, L. 2016: H-aggregate analysis of P3HT thin films-Capability and limitation of photoluminescence and UV/Vis spectroscopy. Scientific Reports 6: 32434

Kumagai, T.; Shiotari, A.; Okuyama, H.; Hatta, S.; Aruga, T.; Hamada, I.; Frederiksen, T.; Ueba, H. 2011: H-atom relay reactions in real space. Nature Materials 11(2): 167-172

Ding, P.-G.; Zhou, F.; Wang, X.; Zhao, Q.-H.; Yu, J.-S.; Zhou, J. 2020: H-bond donor-directed switching of diastereoselectivity in the Michael addition of α-azido ketones to nitroolefins. Chemical Science 11(15): 3852-3861

Maji, A.; Dahiya, A.; Lu, G.; Bhattacharya, T.; Brochetta, M.; Zanoni, G.; Liu, P.; Maiti, D. 2018: H-bonded reusable template assisted para-selective ketonisation using soft electrophilic vinyl ethers. Nature Communications 9(1): 3582

Lee, S.W. 1996: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Medicine 2(7): 776-782

Christophe, D. 1988: H-form DNA and the hairpin-triplex model. Nature 333(6170): 214

Kelly, C.D.; Jennions, M.D. 2007: H-index: age and sex make it unreliable. Nature 449(7161): 403

Esposito, M. 2010: H-index: an index to quantifiy the impact of scientific research. European Journal of Oral Implantology 3(1): 3-4

Eskandari, H.; Albadalejo-Lijarcio, J.Luis.; Zetterstrom, O.; Tyc, Táš.; Quevedo-Teruel, O. 2021: H-plane horn antenna with enhanced directivity using conformal transformation optics. Scientific Reports 11(1): 14322

Sakamoto, A.; Oda, Y.; Adachi, T.; Oshiro, Y.; Tamiya, S.; Tanaka, K.; Matsuda, S.; Iwamoto, Y.; Tsuneyoshi, M. 2001: H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 14(4): 343-349

Luo, S.; Haller, C.; Deng, M.X.; Honjo, O. 2021: H-repair in supravalvular aortic stenosis. Jtcvs Techniques 6: 114-117

Baek, J.; Ahmed, R.; Ye, J.; Gerber, S.A.; Parker, K.J.; Doyley, M.M. 2020: H-scan, Shear Wave and Bioluminescent Assessment of the Progression of Pancreatic Cancer Metastases in the Liver. Ultrasound in Medicine and Biology 46(12): 3369-3378

Lesovik, G.B.; Lebedev, A.V.; Sadovskyy, I.A.; Suslov, M.V.; Vinokur, V.M. 2016: H-theorem in quantum physics. Scientific Reports 6: 32815

Bank, J.; Voaklander, R.; Sossenheimer, M. 2020: H-type Tracheoesophageal Fistula: a Rare Cause of Cough and Dysphagia in Adults. Acg Case Reports Journal 7(12): E00492

Gunlemez, A.; Anik, Y.; Elemen, L.; Tugay, M.; Gökalp, A.S. 2009: H-type tracheoesophageal fistula in an extremely low birth weight premature neonate: appearance on magnetic resonance imaging. Journal of Perinatology: Official Journal of the California Perinatal Association 29(5): 393-395

Beck, D.E. 2011: H. David vargas, m.d. Clinics in Colon and Rectal Surgery 24(4): 201-202

McKay, D.; Rubenstein, L. 2021: H. Jack Geiger: a Pioneer Physician for Human Rights. American Journal of Public Health 111(5): 789-791

Martín-Núñez, G.M.; Cornejo-Pareja, I.; Roca-Rodríguez, M.D.M.; Clemente-Postigo, M.; Cardona, F.; Fernández-García, J.é C.; Moreno-Indias, I.; Tinahones, F.J. 2020: H. pylori Eradication Treatment Causes Alterations in the Gut Microbiota and Blood Lipid Levels. Frontiers in Medicine 7: 417

Howden, C.W. 2018: H. pylori and Barrett's Esophagus: Implications for Populations and Practice. American Journal of Gastroenterology 113(8): 1119-1120

Takeda, T.; Nagahara, A. 2021: H. pylori and image enhanced endoscopy. Nihon Shokakibyo Gakkai Zasshi 118(10): 927-942

Bahar, A.; MirmohammadKhani, M.; Dabiri, R.; Semnani, V.; Pakdel, A. 2021: H. pylori effects on ghrelin axis: Preliminary change in gastric pathogenesis. Microbial Pathogenesis 161(Part A): 105262

Dickson, I. 2020: H. pylori elimination reduces gastric cancer risk. Nature Reviews. Gastroenterology and Hepatology 17(4): 194

Yuan, J.; Li, P.; Tao, J.; Shi, X.; Hu, B.; Chen, H.; Guo, X. 2009: H. pylori escape host immunoreaction through inhibiting ILK expression by VacA. Cellular and Molecular Immunology 6(3): 191-197

Han, T.; Jing, X.; Bao, J.; Zhao, L.; Zhang, A.; Miao, R.; Guo, H.; Zhou, B.; Zhang, S.; Sun, J.; Shi, J. 2020: H. pylori infection alters repair of DNA double-strand breaks via SNHG17. Journal of Clinical Investigation 130(7): 3901-3918

Kamada, T.; Haruma, K. 2021: H. pylori infection and gastric cancer up-to-date. Nihon Shokakibyo Gakkai Zasshi 118(10): 911-919

Chen, Y.; Sheppard, D.; Dong, X.; Hu, X.; Chen, M.; Chen, R.; Chakrabarti, J.; Zavros, Y.; Peek, R.M.; Chen, L-Feng. 2020: H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis. Cell Death and Disease 11(8): 667

Sarajlic, M.; Neuper, T.; Vetter, J.; Schaller, S.; Klicznik, M.M.; Gratz, I.K.; Wessler, S.; Posselt, G.; Horejs-Hoeck, J. 2020: H. pylori modulates DC functions via T4SS/TNFα/p38-dependent SOCS3 expression. Cell Communication and Signaling: Ccs 18(1): 160

Chu, A.; Yu, X.; Guo, Q.; Li, Q.; Sun, M.; Yuan, Y.; Gong, Y. 2020: H. pylori slyD, a novel virulence factor, is associated with Wnt pathway protein expression during gastric disease progression. Microbial Pathogenesis 148: 104428

Vakil, N. 2009: H. pylori treatment: new wine in old bottles?. American Journal of Gastroenterology 104(1): 26-30

Bionda, M.; Kapoglou, I.; Wiest, R. 2020: H. pylori-associated gastritis: diagnostic, treatment and surveillance. Therapeutische Umschau. Revue Therapeutique 77(4): 127-131

Lu, L.; Zhu, H.; Wang, H.; Liang, H.; Hou, Y.; Dou, H. 2021: H. sinensis mycelium inhibits epithelial-mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis. Frontiers of Medicine 15(2): 313-329

Barbey-Gampert 1945: H.C.B. Denber on the innervation of adrenal capsules. Bulletin d'Histologie Appliquee a la Physiologie et a la Pathologie et de Technique Microscopique 22: 30-32

Bourg, R.; Vanden Driessche, R. 1947: H.G.K. hemorrhagic syndrome caused by the implantation of 100 mgr. folliculin. Bruxelles Medical 27(16): 879-888

Ventura, H.O.; Swan, H.J.C. 2006: H.J.C. "Jeremy" Swan, MD: in memory of his contributions to cardiovascular medicine. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 67(2): 171-174

Czekay, D.P.; Kothe, U. 2021: H/ACA Small Ribonucleoproteins: Structural and Functional Comparison Between Archaea and Eukaryotes. Frontiers in Microbiology 12: 654370

McCann, K.L.; Kavari, S.L.; Burkholder, A.B.; Phillips, B.T.; Hall, T.M.T. 2020: H/ACA snoRNA levels are regulated during stem cell differentiation. Nucleic Acids Research 48(15): 8686-8703

Zhang, M.; Zhao, W.; Liu, S.; Liu, H.; Liu, L.; Peng, Q.; Du, C.; Jiang, N. 2021: H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 14: 1331-1345

Xiao, X.; Chen, Z.; Chen, B. 2016: H/C atomic ratio as a smart linkage between pyrolytic temperatures, aromatic clusters and sorption properties of biochars derived from diverse precursory materials. Scientific Reports 6: 22644

Prasannan, C.B.; Gmyrek, A.; Martin, T.A.; Villar, M.T.; Artigues, A.; Lee, J.C.; Fenton, A.W. 2020: H/D Exchange Characterization of Silent Coupling: Entropy-Enthalpy Compensation in Allostery. Biophysical Journal 118(12): 2966-2978

Smith, J.D.; Durrant, G.; Ess, D.H.; Gelfand, B.S.; Piers, W.E. 2020: H/D exchange under mild conditions in arenes and unactivated alkanes with C6D6 and D2O using rigid, electron-rich iridium PCP pincer complexes. Chemical Science 11(39): 10705-10717

Kopinke, F.-D.; Georgi, A. 2020: H/D-isotope fractionation due to aqueous phase diffusion - Deuterated hydrocarbons revisited. Chemosphere 258: 127357

Becker, Börn.; Blum, A.; Gießelmann, E.; Dausend, J.; Rammo, D.; Müller, N.C.; Tschacksch, E.; Steimer, M.; Spindler, J.; Becherer, U.; Rettig, J.; Breinig, F.; Schmitt, M.J. 2016: H/KDEL receptors mediate host cell intoxication by a viral A/B toxin in yeast. Scientific Reports 6: 31105

Baudry, M.; Martres, M.P.; Schwartz, J.C. 1975: H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature 253(5490): 362-364

Zaitsev, S.V.; Haberland, A.; Otto, A.; Vorob'ev, V.I.; Haller, H.; Böttger, M. 1997: H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer. Gene Therapy 4(6): 586-592

Healton, S.E.; Pinto, H.D.; Mishra, L.N.; Hamilton, G.A.; Wheat, J.C.; Swist-Rosowska, K.; Shukeir, N.; Dou, Y.; Steidl, U.; Jenuwein, T.; Gamble, M.J.; Skoultchi, A.I. 2020: H1 linker histones silence repetitive elements by promoting both histone H3K9 methylation and chromatin compaction. Proceedings of the National Academy of Sciences of the United States of America 117(25): 14251-14258

Huen, M.S.Y.; Chen, J. 2016: H1 provides the missing link. Cell Research 26(1): 5-6

Almos, P.Z.; Horváth, S.; Czibula, A.; Raskó, I.; Sipos, B.; Bihari, P.; Béres, J.; Juhász, A.; Janka, Z.; Kálmán, J. 2008: H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population. Heredity 101(5): 416-419

Li, F.; Wang, J.; Wu, N.; Zhang, H.; Li, Z.; Wei, N. 2019: H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA. Biochemical and Biophysical Research Communications 520(1): 93-98

Zhang, L.; Han, D. 2013: H1-antihistamines. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 27(2): 104-109

Xavier, R.ér.P.; Mengarda, A.C.; Silva, M.P.; Roquini, D.B.; Salvadori, M.C.; Teixeira, F.S.; Pinto, P.L.; Morais, T.R.; Ferreira, L.L.G.; Andricopulo, A.D.; de Moraes, J.é 2020: H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies. Parasites and Vectors 13(1): 278

Kroeze, W.K.; Hufeisen, S.J.; Popadak, B.A.; Renock, S.M.; Steinberg, S.; Ernsberger, P.; Jayathilake, K.; Meltzer, H.Y.; Roth, B.L. 2003: H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28(3): 519-526

Salvi, V.; Mencacci, C.; Barone-Adesi, F. 2016: H1-histamine receptor affinity predicts weight gain with antidepressants. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 26(10): 1673-1677

Chakrabarty, A.; Rexer, B.N.; Wang, S.E.; Cook, R.S.; Engelman, J.A.; Arteaga, C.L. 2010: H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3. Oncogene 29(37): 5193-5203

Zhao, C-Xiang.; Niu, C-Yao.; Qin, Z-Jie.; Ren, X.Yan.; Wang, J-Tao.; Cho, J-Hyung.; Jia, Y. 2016: H18 Carbon: A New Metallic Phase with sp2-sp3 Hybridized Bonding Network. Scientific Reports 6: 21879

Yu, J.; Fang, C.; Zhang, Z.; Zhang, G.; Shi, L.; Qian, J.; Xiong, J. 2020: H19 Rises in Gastric Cancer and Exerts a Tumor-Promoting Function via miR-138/E2F2 Axis. Cancer Management and Research 12: 13033-13042

Liang, W-Cheng.; Fu, W-Ming.; Wang, Y-Bing.; Sun, Y-Xin.; Xu, L-Liang.; Wong, C-Wa.; Chan, K-Ming.; Li, G.; Waye, M.Miu-Yee.; Zhang, J-Fang. 2016: H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA. Scientific Reports 6: 20121

Milligan, L.; Antoine, E.; Bisbal, C.; Weber, M.; Brunel, C.; Forné, T.; Cathala, G. 2000: H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation. Oncogene 19(50): 5810-5816

Li, W.; Hua, R.-X.; Wang, M.; Zhang, D.; Zhu, J.; Zhang, S.; Yang, Y.; Cheng, J.; Zhou, H.; Zhang, J.; He, J. 2021: H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Molecular Genetics and Genomic Medicine 9(2): E1584

Rolla, M.Łg.; Jawiarczyk-PrzybyŁowska, A.; KolaČkov, K.; Bolanowski, M. 2021: H19 in Endocrine System Tumours. Anticancer Research 41(2): 557-565

Fernández-Ruiz, I. 2020: H19 in cardiac hypertrophy. Nature Reviews. Cardiology 17(10): 612

Bartolomei, M.S.; Vigneau, S.; O'Neill, M.J. 2008: H19 in the pouch. Nature Genetics 40(8): 932-933

Zhou, J.; Yang, L.; Zhong, T.; Mueller, M.; Men, Y.; Zhang, N.; Xie, J.; Giang, K.; Chung, H.; Sun, X.; Lu, L.; Carmichael, G.G.; Taylor, H.S.; Huang, Y. 2015: H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nature Communications 6: 10221

Deng, J.; Mueller, M.; Geng, T.; Shen, Y.; Liu, Y.; Hou, P.; Mamillapalli, R.; Taylor, H.S.; Paidas, M.; Huang, Y. 2017: H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses. Cell Death and Disease 8(12): E3175

Cao, T.; Jiang, Y.; Wang, Z.; Zhang, N.; Al-Hendy, A.; Mamillapalli, R.; Kallen, A.N.; Kodaman, P.; Taylor, H.S.; Li, D.; Huang, Y. 2019: H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas. Oncogene 38(27): 5356-5366

Li, C-Xiao.; Li, H-Guo.; Huang, L-Ting.; Kong, Y-Wei.; Chen, F-Ying.; Liang, J-Yin.; Yu, H.; Yao, Z-Rong. 2017: H19 lncRNA regulates keratinocyte differentiation by targeting miR-130b-3p. Cell Death and Disease 8(11): E3174

Ritso, M.; Rudnicki, M.A. 2020: H19 lncRNA to dystrophin's rescue. Nature Cell Biology 22(11): 1289-1290

Zhang, L.; Yang, Z.; Huang, W.; Wu, J. 2019: H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis. Cell Death and Disease 10(3): 168

Li, J.; Wang, X.; Wang, Y.; Yang, Q. 2020: H19 promotes the gastric carcinogenesis by sponging miR-29a-3p: evidence from lncRNA-miRNA-mRNA network analysis. Epigenomics 12(12): 989-1002

Li, A.; Mallik, S.; Luo, H.; Jia, P.; Lee, D.-F.; Zhao, Z. 2020: H19, a Long Non-coding RNA, Mediates Transcription Factors and Target Genes through Interference of MicroRNAs in Pan-Cancer. Molecular Therapy. Nucleic Acids 21: 180-191

Pan, F.-F.; Zheng, Y.-B.; Shi, C.-J.; Zhang, F.-W.; Zhang, J.-F.; Fu, W.-M. 2021: H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma. European Journal of Pharmacology 893: 173810

Salimi, M.; Shirazi, A.; Norouzian, M.; Jafari, A.; Edalatkhah, H.; Mehravar, M.; Majidi, M.; Mehrazar, M.M. 2020: H19/Igf2 Expression and Methylation of Histone 3 in Mice Chimeric Blastocysts. Reports of Biochemistry and Molecular Biology 9(3): 357-365

He, Z.; Zhang, J.; Chen, G.; Cao, J.; Chen, Y.; Ai, C.; Wang, H. 2021: H19/let-7 axis mediates caffeine exposure during pregnancy induced adrenal dysfunction and its multi-generation inheritance. Science of the Total Environment 792: 148440

Peng, F.; Li, T-Ting.; Wang, K-Li.; Xiao, G-Qing.; Wang, J-Hong.; Zhao, H-Dong.; Kang, Z-Jie.; Fan, W-Jun.; Zhu, L-Li.; Li, M.; Cui, B.; Zheng, F-Meng.; Wang, H-Jiang.; Lam, E.W-F.; Wang, B.; Xu, J.; Liu, Q. 2017: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death and Disease 8(1): E2569

Ruan, T.; Sun, J.; Liu, W.; Prinz, R.A.; Peng, D.; Liu, X.; Xu, X. 2020: H1N1 Influenza Virus Cross-Activates Gli1 to Disrupt the Intercellular Junctions of Alveolar Epithelial Cells. Cell Reports 31(13): 107801

Zhao, B.; Shan, J.; Xiong, R.; Xu, K.; Li, B. 2018: H1N1 Virus Production and Infection. Bio-Protocol 8(20):E3062

Akins, P.Taylor.; Belko, J.; Uyeki, T.M.; Axelrod, Y.; Lee, K.K.; Silverthorn, J. 2010: H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocritical Care 13(3): 396-406

Li, H.; Zhao, X.; Zhao, Y.; Li, J.; Zheng, H.; Xue, M.; Guo, L.; Zhou, J.; Yang, J.; Zuo, Y.; Chen, Y.; Yang, Z.; Fan, Q.; Qin, L.; Shi, H.; Liu, L. 2021: H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice. Emerging Microbes and Infections 2021: 1-38

Maguire, P.A.; Reay, R.E.; Looi, J.C.L. 2021: H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care. Schizophrenia Research 237: 101-102

Esposito, D.V.; Levin, I.; Moffat, T.P.; Talin, A.Alec. 2013: H2 evolution at Si-based metal-insulator-semiconductor photoelectrodes enhanced by inversion channel charge collection and H spillover. Nature Materials 12(6): 562-568

Atzori, M.; Lau, D.; Tansey, E.P.; Chow, A.; Ozaita, A.; Rudy, B.; McBain, C.J. 2000: H2 histamine receptor-phosphorylation of Kv3.2 modulates interneuron fast spiking. Nature Neuroscience 3(8): 791-798

Driver, P.S. 1990: H2 receptor antagonists. Archives of Internal Medicine 150(11): 2408

Chassany, O.; Bergmann, J.F. 1998: H2 receptor antagonists and proton pump inhibitors: principles and rules of use. La Revue du Praticien 48(8): 893-898

Zimmerman, J.; Millard, J. 1989: H2-antagonist inhibition of human neutrophil superoxide anion synthesis. Clinical Pharmacology and Therapeutics 45(5): 487-494

Maudsley, D.V.; Kobayashi, Y.; Williamson, E.; Bovaird, L. 1973: H2-receptor blockade and stimulation of histidine decarboxylase. Nature: new Biology 245(144): 148-149

Klotz, U. 1987: H2-receptor blocking agents and hepatic drug elimination. Clinical Pharmacology and Therapeutics 42(5): 595-596

Grennan, D.M.; Rooney, P.J.; Gilbertson, E.; Dick, W.C. 1974: H2-receptors in peripheral blood vessels. Nature 249(455): 368-370

Barcelo-Ordinas, J.M.; Ferrer-Cid, P.; Garcia-Vidal, J.; Viana, M.; Ripoll, A. 2021: H2020 project CAPTOR dataset: Raw data collected by low-cost MOX ozone sensors in a real air pollution monitoring network. Data in Brief 36: 107127

Ding, J.; Miao, Q.-F.; Zhang, J.-W.; Guo, Y.-X.; Zhang, Y.-X.; Zhai, Q.-X.; Chen, Z.-H. 2020: H258R mutation in KCNAB3 gene in a family with genetic epilepsy and febrile seizures plus. Brain and Behavior 10(12): E01859

Lei, B.; Berger, F.éd.ér. 2020: H2A Variants in Arabidopsis: Versatile Regulators of Genome Activity. Plant Communications 1(1): 100015

Derkacheva, M.; Liu, S.; Figueiredo, D.D.; Gentry, M.; Mozgova, I.; Nanni, P.; Tang, M.; Mannervik, M.; Köhler, C.; Hennig, L. 2016: H2A deubiquitinases UBP12/13 are part of the Arabidopsis polycomb group protein system. Nature Plants 2: 16126

Jiang, X.; Wen, J.; Paver, E.; Wu, Y.-H.; Sun, G.; Bullman, A.; Dahlstrom, J.E.; Tremethick, D.J.; Soboleva, T.A. 2021: H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma. Embo Reports 22(8): E52462

Yuan, Y.; Cao, W.; Zhou, H.; Qian, H.; Wang, H. 2021: H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma. Cell Death and Disease 12(6): 609

Chen, Z.; Ponts, N. 2020: H2A.Z and chromatin remodelling complexes: a focus on fungi. Critical Reviews in Microbiology 46(3): 321-337

Rudnizky, S.; Bavly, A.; Malik, O.; Pnueli, L.; Melamed, P.; Kaplan, A. 2016: H2A.Z controls the stability and mobility of nucleosomes to regulate expression of the LH genes. Nature Communications 7: 12958

Long, H.; Zhang, L.; Lv, M.; Wen, Z.; Zhang, W.; Chen, X.; Zhang, P.; Li, T.; Chang, L.; Jin, C.; Wu, G.; Wang, X.; Yang, F.; Pei, J.; Chen, P.; Margueron, R.; Deng, H.; Zhu, M.; Li, G. 2020: H2A.Z facilitates licensing and activation of early replication origins. Nature 577(7791): 576-581

Weber, C.M.; Henikoff, J.G.; Henikoff, S. 2010: H2A.Z nucleosomes enriched over active genes are homotypic. Nature Structural and Molecular Biology 17(12): 1500-1507

Dalvai, M.; Bellucci, L.; Fleury, L.; Lavigne, A-C.; Moutahir, F.; Bystricky, K. 2013: H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression. Oncogene 32(36): 4243-4251

Bongiovanni, L.; Andriessen, A.; Silvestri, S.; Porcellato, I.; Brachelente, C.; de Bruin, A. 2021: H2AFZ: a Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment. Frontiers in Veterinary Science 8: 705359

Yin, X.; Romero-Campero, F.J.; de Los Reyes, P.; Yan, P.; Yang, J.; Tian, G.; Yang, X.; Mo, X.; Zhao, S.; Calonje, M.; Zhou, Y. 2021: H2AK121ub in Arabidopsis associates with a less accessible chromatin state at transcriptional regulation hotspots. Nature Communications 12(1): 315

Havusha-Laufer, S.; Kosenko, A.; Kisliouk, T.; Barash, I. 2020: H2AX Promoter Demethylation at Specific Sites Plays a Role in STAT5-Induced Tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 25(3): 205-218

Zhao, B.; Tan, T.L.; Mei, Y.; Yang, J.; Yu, Y.; Verma, A.; Liang, Y.; Gao, J.; Ji, P. 2016: H2AX deficiency is associated with erythroid dysplasia and compromised haematopoietic stem cell function. Scientific Reports 6: 19589

Vasireddy, R.S.; Sprung, C.N.; Cempaka, N.L.; Chao, M.; McKay, M.J. 2010: H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype. British Journal of Cancer 102(10): 1511-1518

Mahajan, K.; Fang, B.; Koomen, J.M.; Mahajan, N.P. 2012: H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes. Nature Structural and Molecular Biology 19(9): 930-937

Brünken, S.; Sipilä, O.; Chambers, E.T.; Harju, J.; Caselli, P.; Asvany, O.; Honingh, C.E.; Kamiński, T.; Menten, K.M.; Stutzki, Jürgen.; Schlemmer, S. 2014: H2D(+) observations give an age of at least one million years for a cloud core forming Sun-like stars. Nature 516(7530): 219-221

Chen, C.; Huang, X.; Zhu, W.; Ding, C.; Huang, P.; Li, R. 2021: H2O2 gel bleaching induces cytotoxicity and pain conduction in dental pulp stem cells via intracellular reactive oxygen species on enamel/dentin disc. Plos one 16(9): E0257221

Hao, Y.; Wang, H.; Fang, L.; Bian, J.; Gao, Y.; Li, C. 2021: H2S Donor and Bone Metabolism. Frontiers in Pharmacology 12: 661601

Eberhardt, M.; Dux, M.; Namer, B.; Miljkovic, J.; Cordasic, N.; Will, C.; Kichko, T.I.; de la Roche, J.; Fischer, M.; Suárez, Sán.A.; Bikiel, D.; Dorsch, K.; Leffler, A.; Babes, A.; Lampert, A.; Lennerz, J.K.; Jacobi, J.; Martí, M.A.; Doctorovich, F.; Högestätt, E.D.; Zygmunt, P.M.; Ivanovic-Burmazovic, I.; Messlinger, K.; Reeh, P.; Filipovic, M.R. 2014: H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. Nature Communications 5: 4381

Sercu, B.; Boon, N.; Verstraete, W.; Van Langenhove, H. 2006: H2S degradation is reflected by both the activity and composition of the microbial community in a compost biofilter. Applied Microbiology and Biotechnology 72(5): 1090-1098

Li, Y.; Chandra, T.P.; Song, X.; Nie, L.; Liu, M.; Yi, J.; Zheng, X.; Chu, C.; Yang, J. 2021: H2S improves doxorubicin-induced myocardial fibrosis by inhibiting oxidative stress and apoptosis via Keap1-Nrf2. Technology and Health Care: Official Journal of the European Society for Engineering and Medicine 29(S1): 195-209

Xiao, A.; Wang, H.; Lu, X.; Zhu, J.; Huang, D.; Xu, T.; Guo, J.; Liu, C.; Li, J. 2015: H2S, a novel gasotransmitter, involves in gastric accommodation. Scientific Reports 5: 16086

Muzaffar, S.; Jeremy, J.Y.; Sparatore, A.; Del Soldato, P.; Angelini, G.D.; Shukla, N. 2008: H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. British Journal of Pharmacology 155(7): 984-994

Zhou, N.; Bao, J.; Ning, Y. 2021: H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection. Bmc Bioinformatics 22(1): 18

Yang, K.; Liu, J.; Zhang, X.; Ren, Z.; Gao, L.; Wang, Y.; Lin, W.; Ma, X.; Hao, M.; Kuang, H. 2020: H3 Relaxin Alleviates Migration, Apoptosis and Pyroptosis Through P2X7R-Mediated Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation in Retinopathy Induced by Hyperglycemia. Frontiers in Pharmacology 11: 603689

Kerimoglu, C.; Pham, L.; Tonchev, A.B.; Sakib, M.S.; Xie, Y.; Sokpor, G.; Ulmke, P.A.; Kaurani, L.; Abbas, E.; Nguyen, H.; Rosenbusch, J.; Michurina, A.; Capece, V.; Angelova, M.; Maricic, N.; Brand-Saberi, B.; Esgleas, M.; Albert, M.; Minkov, R.; Kovachev, E.; Teichmann, U.; Seong, R.H.; Huttner, W.B.; Nguyen, H.P.; Stoykova, A.; Staiger, J.F.; Fischer, A.; Tuoc, T. 2021: H3 acetylation selectively promotes basal progenitor proliferation and neocortex expansion. Science Advances 7(38): Eabc 6792

Francis, H.; Franchitto, A.; Ueno, Y.; Glaser, S.; DeMorrow, S.; Venter, J.; Gaudio, E.; Alvaro, D.; Fava, G.; Marzioni, M.; Vaculin, B.; Alpini, G. 2007: H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Laboratory Investigation; a Journal of Technical Methods and Pathology 87(5): 473-487

Pinskaya, M.; Gourvennec, Séphanie.; Morillon, A. 2009: H3 lysine 4 di- and tri-methylation deposited by cryptic transcription attenuates promoter activation. EMBO Journal 28(12): 1697-1707

Foley, A.G.; Prendergast, A.; Barry, C.; Scully, D.; Upton, N.; Medhurst, A.D.; Regan, C.M. 2009: H3 receptor antagonism enhances NCAM PSA-mediated plasticity and improves memory consolidation in odor discrimination and delayed match-to-position paradigms. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34(12): 2585-2600

Liu, J.; Yang, K.; Jin, Y.; Liu, Y.; Chen, Y.; Zhang, X.; Yu, S.; Song, E.; Chen, S.; Zhang, J.; Jing, G.; An, R. 2020: H3 relaxin protects against calcium oxalate crystal-induced renal inflammatory pyroptosis. Cell Proliferation 53(10): E12902

Zhang, X.; Li, B.; Rezaeian, A.Hossein.; Xu, X.; Chou, P-Chieh.; Jin, G.; Han, F.; Pan, B-Syong.; Wang, C-Yun.; Long, J.; Zhang, A.; Huang, C-Yang.; Tsai, F-Jen.; Tsai, C-Hai.; Logothetis, C.; Lin, H-Kuan. 2017: H3 ubiquitination by NEDD4 regulates H3 acetylation and tumorigenesis. Nature Communications 8: 14799

Khazaei, S.; De Jay, N.; Deshmukh, S.; Hendrikse, L.D.; Jawhar, W.; Chen, C.C.L.; Mikael, L.G.; Faury, D.; Marchione, D.M.; Lanoix, J.; Bonneil, Ér.; Ishii, T.; Jain, S.U.; Rossokhata, K.; Sihota, T.S.; Eveleigh, R.; Lisi, V.ér.; Harutyunyan, A.S.; Jung, S.; Karamchandani, J.; Dickson, B.C.; Turcotte, R.; Wunder, J.S.; Thibault, P.; Lewis, P.W.; Garcia, B.A.; Mack, S.C.; Taylor, M.D.; Garzia, L.; Kleinman, C.L.; Jabado, N. 2020: H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone. Cancer Discovery 10(12): 1968-1987

Burkhart, K.B.; Sando, S.R.; Corrionero, A.; Horvitz, H.R. 2020: H3.3 Nucleosome Assembly Mutants Display a Late-Onset Maternal Effect. Current Biology: Cb 30(12): 2343-2352.E3

Fraschka, S.Anne-Kristin.; Henderson, R.Wilhelmus.Maria.; Bártfai, Rárd. 2016: H3.3 demarcates GC-rich coding and subtelomeric regions and serves as potential memory mark for virulence gene expression in Plasmodium falciparum. Scientific Reports 6: 31965

Guo, S.-M.; Liu, X.-P.; Zhou, L.-Q. 2021: H3.3 kinetics predicts chromatin compaction status of parental genomes in early embryos. Reproductive Biology and Endocrinology: Rb&e 19(1): 87

Jin, C.; Zang, C.; Wei, G.; Cui, K.; Peng, W.; Zhao, K.; Felsenfeld, G. 2009: H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nature Genetics 41(8): 941-945

Delaney, K.; Strobino, M.; Wenda, J.M.; Pankowski, A.; Steiner, F.A. 2019: H3.3K27M-induced chromatin changes drive ectopic replication through misregulation of the JNK pathway in C. elegans. Nature Communications 10(1): 2529

Wen, H.; Shi, X. 2020: H3.3S31 phosphorylation: linking transcription elongation to stimulation responses. Signal Transduction and Targeted Therapy 5(1): 176

Seiler, M.; Yoshimi, A.; Darman, R.; Chan, B.; Keaney, G.; Thomas, M.; Agrawal, A.A.; Caleb, B.; Csibi, A.; Sean, E.; Fekkes, P.; Karr, C.; Klimek, V.; Lai, G.; Lee, L.; Kumar, P.; Lee, S.Chun-Wei.; Liu, X.; Mackenzie, C.; Meeske, C.; Mizui, Y.; Padron, E.; Park, E.; Pazolli, E.; Peng, S.; Prajapati, S.; Taylor, J.; Teng, T.; Wang, J.; Warmuth, M.; Yao, H.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P.G.; Buonamici, S. 2018: H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nature Medicine 24(4): 497-504

Kervarrec, T.; Collin, C.; Larousserie, Fédérique.; Bouvier, C.; Aubert, Sébastien.; Gomez-Brouchet, A.; Marie, Béatrice.; Miquelestorena-Standley, E.; Le Nail, L.Romée.; Avril, P.; Christophe Pagès, J.; de Pinieux, G. 2017: H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 30(3): 393-406

Gong, L.; Bui, M.M.; Zhang, W.; Sun, X.; Zhang, M.; Yi, D. 2021: H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Histology and Histopathology 36(1): 61-68

Jurkowska, R.Z.; Qin, S.; Kungulovski, G.; Tempel, W.; Liu, Y.; Bashtrykov, P.; Stiefelmaier, J.; Jurkowski, T.P.; Kudithipudi, S.; Weirich, S.; Tamas, R.; Wu, H.; Dombrovski, L.; Loppnau, P.; Reinhardt, R.; Min, J.; Jeltsch, A. 2017: H3K14ac is linked to methylation of H3K9 by the triple Tudor domain of SETDB1. Nature Communications 8(1): 2057

Zhao, B.; Xu, W.; Rong, B.; Chen, G.; Ye, X.; Dai, R.; Li, W.; Chen, J.; Cai, J.; Song, L.; Luo, Z-Qing.; Zeng, R.; Shi, Y.; Han, J-Dong.J.; Lan, F. 2018: H3K14me3 genomic distributions and its regulation by KDM4 family demethylases. Cell Research 28(11): 1118-1120

Chen, Y-Che.; Hsu, P-Yuan.; Chin, C-Hung.; Hsiao, C-Chun.; Liou, C-Wei.; Wang, T-Ya.; Lin, Y-Yong.; Lee, C-Ping.; Lin, H-Ching.; Lin, M-Chih.; Su, M-Chang. 2021: H3K23/H3K36 hypoacetylation and HDAC1 up-regulation are associated with adverse consequences in obstructive sleep apnea patients. Scientific Reports 11(1): 20697

Zhang, Y.; Liu, Z.; Yang, X.; Lu, W.; Chen, Y.; Lin, Y.; Wang, J.; Lin, S.; Yun, J.-P. 2021: H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics 11(3): 1473-1492

Chang, L.; An, Z.; Zhang, J.; Zhou, F.; Wang, D.; Liu, J.; Zhang, Y. 2021: H3K27 demethylase KDM6B aggravates ischemic brain injury through demethylation of IRF4 and Notch2-dependent SOX9 activation. Molecular Therapy. Nucleic Acids 24: 622-633

Duong, P.; Ma, K.H.; Ramesh, R.; Moran, J.J.; Won, S.; Svaren, J. 2021: H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve. Journal of Biological Chemistry 297(1): 100852

Svotelis, A.; Bianco, Séphanie.; Madore, J.; Huppé, G.; Nordell-Markovits, A.; Mes-Masson, A-Marie.; Gévry, N. 2011: H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency. EMBO Journal 30(19): 3947-3961

Guillermo, A.R.R.; Chocian, K.; Gavriilidis, G.; Vandamme, J.; Salcini, A.E.; Mellor, J.; Woollard, A. 2021: H3K27 modifiers regulate lifespan in C. elegans in a context-dependent manner. Bmc Biology 19(1): 59

Osada, Y.; Saito, R.; Shibahara, I.; Sasaki, K.; Shoji, T.; Kanamori, M.; Sonoda, Y.; Kumabe, T.; Watanabe, M.; Tominaga, T. 2021: H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade glioma. Neuro-OncologyAdvances 3(1):Vdab 038

Harutyunyan, A.S.; Chen, H.; Lu, T.; Horth, C.; Nikbakht, H.; Krug, B.; Russo, C.; Bareke, E.; Marchione, D.M.; Coradin, M.; Garcia, B.A.; Jabado, N.; Majewski, J. 2020: H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation. Cell Reports 33(7): 108390

Harutyunyan, A.S.; Krug, B.; Chen, H.; Papillon-Cavanagh, S.; Zeinieh, M.; De Jay, N.; Deshmukh, S.; Chen, C.C.L.; Belle, J.; Mikael, L.G.; Marchione, D.M.; Li, R.; Nikbakht, H.; Hu, B.; Cagnone, G.; Cheung, W.A.; Mohammadnia, A.; Bechet, D.; Faury, D.; McConechy, M.K.; Pathania, M.; Jain, S.U.; Ellezam, B.; Weil, A.G.; Montpetit, A.; Salomoni, P.; Pastinen, T.; Lu, C.; Lewis, P.W.; Garcia, B.A.; Kleinman, C.L.; Jabado, N.; Majewski, J. 2019: H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis. Nature Communications 10(1): 1262

Pun, M.; Haggerty-Skeans, J.; Pratt, D.; Fudym, Y.; Al-Holou, W.N.; Camelo-Piragua, S.; Venneti, S. 2020: H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy. Acta Neuropathologica 140(2): 227-229

Chia, N.; Wong, A.; Teo, K.; Tan, A.Peng.; Vellayappan, B.A.; Yeo, T.Tsai.; Oh, S.Yi.; Tan, C.Loo. 2021: H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival. Neuro-OncologyAdvances 3(1):Vdab 135

Pei, J.; Harakalova, M.; Treibel, T.A.; Lumbers, R.T.; Boukens, B.J.; Efimov, I.R.; van Dinter, J.T.; González, A.; López, B.ña.; El Azzouzi, H.; van den Dungen, N.; van Dijk, C.G.M.; Krebber, M.M.; den Ruijter, H.M.; Pasterkamp, G.; Duncker, D.J.; Nieuwenhuis, E.E.S.; de Weger, R.; Huibers, M.M.; Vink, A.; Moore, J.H.; Moon, J.C.; Verhaar, M.C.; Kararigas, G.; Mokry, M.; Asselbergs, F.W.; Cheng, C. 2020: H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts. Clinical Epigenetics 12(1): 106

Chen, C.; Chen, Q.; Wu, J.; Zou, H. 2021: H3K27ac-induced FOXC2-AS1 accelerates tongue squamous cell carcinoma by upregulating E2F3. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 50(10): 1018-1030

Ma, Y.; Zheng, W. 2021: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis. Journal of Ovarian Research 14(1): 76

Makise, N.; Sekimizu, M.; Konishi, E.; Motoi, T.; Kubo, T.; Ikoma, H.; Watanabe, S-Ichi.; Okuma, T.; Hiraoka, N.; Fukayama, M.; Kawai, A.; Ichikawa, H.; Yoshida, A. 2019: H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 32(3): 435-445

Yamaguchi, N.; Matsubara, S.; Yoshimizu, K.; Seki, M.; Hamada, K.; Kamitani, M.; Kurita, Y.; Nomura, Y.; Nagashima, K.; Inagaki, S.; Suzuki, T.; Gan, E-Seng.; To, T.; Kakutani, T.; Nagano, A.J.; Satake, A.; Ito, T. 2021: H3K27me3 demethylases alter HSP22 and HSP17.6C expression in response to recurring heat in Arabidopsis. Nature Communications 12(1): 3480

Lyskjaer, I.; Lindsay, D.; Tirabosco, R.; Steele, C.D.; Lombard, P.; Strobl, A.-C.; Rocha, A.M.; Davies, C.; Ye, H.; Bekers, E.; Ingruber, J.; Lechner, M.; Amary, F.; Pillay, N.; Flanagan, A.M. 2020: H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours. Journal of Pathology 252(2): 151-164

Ammendola, S.; Caldonazzi, N.ò; Simbolo, M.; Piredda, M.L.; Brunelli, M.; Poliani, P.L.; Pinna, G.; Sala, F.; Ghimenton, C.; Scarpa, A.; Barresi, V. 2021: H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology. Virchows Archiv: An International Journal of Pathology 479(5): 987-996

Cai, Y.; Zhang, Y.; Loh, Y.Ping.; Tng, J.Qi.; Lim, M.Chee.; Cao, Z.; Raju, A.; Lieberman Aiden, E.; Li, S.; Manikandan, L.; Tergaonkar, V.; Tucker-Kellogg, G.; Fullwood, M.Jane. 2021: H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. Nature Communications 12(1): 719

de Krijger, I.; van der Torre, J.; Peuscher, M.H.; Eder, M.; Jacobs, J.J.L. 2020: H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres. Oncogene 39(25): 4814-4827

Shao, R.; Zhang, Z.; Xu, Z.; Ouyang, H.; Wang, L.; Ouyang, H.; Greenblatt, M.; Chen, X.; Zou, W. 2021: H3K36 methyltransferase NSD1 regulates chondrocyte differentiation for skeletal development and fracture repair. Bone Research 9(1): 30

Abed, J.AlHaj.; Jones, R.S. 2012: H3K36me3 key to Polycomb-mediated gene silencing in lineage specification. Nature Structural and Molecular Biology 19(12): 1214-1215

Yang, D.; Su, Z.; Wei, G.; Long, F.; Zhu, Y.-C.; Ni, T.; Liu, X.; Zhu, Y.Z. 2021: H3K4 Methyltransferase Smyd3 Mediates Vascular Smooth Muscle Cell Proliferation, Migration, and Neointima Formation. Arteriosclerosis Thrombosis and Vascular Biology 41(6): 1901-1914

Chong, S.Yen.; Cutler, S.; Lin, J-Jer.; Tsai, C-Hung.; Tsai, H-Kuang.; Biggins, S.; Tsukiyama, T.; Lo, Y-Chen.; Kao, C-Fu. 2020: H3K4 methylation at active genes mitigates transcription-replication conflicts during replication stress. Nature Communications 11(1): 809

Pekowska, A.; Benoukraf, T.; Zacarias-Cabeza, J.; Belhocine, M.; Koch, F.; Holota, Hélène.; Imbert, J.; Andrau, J-Christophe.; Ferrier, P.; Spicuglia, S. 2011: H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO Journal 30(20): 4198-4210

Foroozani, M.; Vandal, M.P.; Smith, A.P. 2021: H3K4 trimethylation dynamics impact diverse developmental and environmental responses in plants. Planta 253(1): 4

Bae, S.; Lesch, B.J. 2020: H3K4me1 Distribution Predicts Transcription State and Poising at Promoters. Frontiers in Cell and Developmental Biology 8: 289

Vonk, P.Jan.; Ohm, R.A. 2021: H3K4me2 ChIP-Seq reveals the epigenetic landscape during mushroom formation and novel developmental regulators of Schizophyllum commune. Scientific Reports 11(1): 8178

Piatek, P.ł; Tarkowski, M.; Namiecinska, M.; Riva, A.; Wieczorek, M.; Michlewska, S.; Dulska, J.; Domowicz, M.łg.; Kulińska-Michalska, M.łg.; Lewkowicz, N.; Lewkowicz, P.ła. 2021: H3K4me3 Histone ChIP-Seq Analysis Reveals Molecular Mechanisms Responsible for Neutrophil Dysfunction in HIV-Infected Individuals. Frontiers in Immunology 12: 682094

Shen, J.; Jiang, D.; Fu, Y.; Wu, X.; Guo, H.; Feng, B.; Pang, Y.; Streets, A.M.; Tang, F.; Huang, Y. 2015: H3K4me3 epigenomic landscape derived from ChIP-Seq of 1,000 mouse early embryonic cells. Cell Research 25(1): 143-147

Sun, N.; Chen, H.; Ma, Y.; Pang, W.; Wang, X.; Zhang, Q.; Gao, L.; Li, W. 2020: H3K4me3-Mediated Upregulation of LncRNA-HEIPP in Preeclampsia Placenta Affects Invasion of Trophoblast Cells. Frontiers in Genetics 11: 559478

Kuroki, S.; Maeda, R.; Yano, M.; Kitano, S.; Miyachi, H.; Fukuda, M.; Shinkai, Y.; Tachibana, M. 2020: H3K9 Demethylases JMJD1A and JMJD1B Control Prospermatogonia to Spermatogonia Transition in Mouse Germline. Stem Cell Reports 15(2): 424-438

Peng, J.C.; Karpen, G.H. 2007: H3K9 methylation and RNA interference regulate nucleolar organization and repeated DNA stability. Nature Cell Biology 9(1): 25-35

Rowbotham, S.P.; Li, F.; Dost, A.F.M.; Louie, S.M.; Marsh, B.P.; Pessina, P.; Anbarasu, C.R.; Brainson, C.F.; Tuminello, S.J.; Lieberman, A.; Ryeom, S.; Schlaeger, T.M.; Aronow, B.J.; Watanabe, H.; Wong, K.K.; Kim, C.F. 2018: H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression. Nature Communications 9(1): 4559

Yang, L.; Yu, Y.; Tian, G.; Deng, H.; Yu, B. 2021: H3K9ac modification was involved in doxorubicin induced apoptosis by regulating Pik3ca transcription in H9C2 cells. Life Sciences 284: 119107

Qi, Y.; Li, B.; Wen, Y.; Yang, X.; Chen, B.; He, Z.; Zhao, Z.; Magdalou, J.; Wang, H.; Chen, L. 2021: H3K9ac of TGFβRi in human umbilical cord: a potential biomarker for evaluating cartilage differentiation and susceptibility to osteoarthritis via a two-step strategy. Stem Cell Research and Therapy 12(1): 163

Olcina, M.M.; Leszczynska, K.B.; Senra, J.M.; Isa, N.F.; Harada, H.; Hammond, E.M. 2016: H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene 35(6): 793-799

Schleich, K.; Kase, J.; Dörr, J.R.; Trescher, S.; Bhattacharya, A.; Yu, Y.; Wailes, E.M.; Fan, D.N.Y.; Lohneis, P.; Milanovic, M.; Lau, A.; Lenze, D.; Hummel, M.; Chapuy, B.; Leser, U.; Reimann, M.; Lee, S.; Schmitt, C.A. 2020: H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients. Nature Communications 11(1): 3651

Xie, H.; Wan, X-Feng.; Ye, Z.; Plant, E.P.; Zhao, Y.; Xu, Y.; Li, X.; Finch, C.; Zhao, N.; Kawano, T.; Zoueva, O.; Chiang, M-Jung.; Jing, X.; Lin, Z.; Zhang, A.; Zhu, Y. 2015: H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps. Scientific Reports 5: 15279

Wang, H.; Feng, M.; Wang, Y-Fang.; Gu, Z-Yuan. 2016: H3O(+) tetrahedron induction in large negative linear compressibility. Scientific Reports 6: 26015

Chen, C.C.L.; Goyal, P.; Karimi, M.M.; Abildgaard, M.H.; Kimura, H.; Lorincz, M.C. 2018: H3S10ph broadly marks early-replicating domains in interphase ESCs and shows reciprocal antagonism with H3K9me2. Genome Research 28(1): 37-51

Celetti, A.; Cerrato, A.; Merolla, F.; Vitagliano, D.; Vecchio, G.; Grieco, M. 2004: H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization. Oncogene 23(1): 109-121

Saredi, G.; Huang, H.; Hammond, C.M.; Alabert, C.; Bekker-Jensen, S.; Forne, I.; Reverón-Gómez, N.; Foster, B.M.; Mlejnkova, L.; Bartke, T.; Cejka, P.; Mailand, N.; Imhof, A.; Patel, D.J.; Groth, A. 2016: H4K20me0 marks post-replicative chromatin and recruits the TONSL–MMS22L DNA repair complex. Nature 534(7609): 714-718

Nakamura, K.; Saredi, G.; Becker, J.R.; Foster, B.M.; Nguyen, N.V.; Beyer, T.E.; Cesa, L.C.; Faull, P.A.; Lukauskas, S.; Frimurer, T.; Chapman, J.Ross.; Bartke, T.; Groth, A. 2019: H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. Nature Cell Biology 21(3): 311-318

Tjalsma, S.J.D.; Hori, M.; Sato, Y.; Bousard, A.; Ohi, A.; Raposo, A.C.áu.; Roensch, J.; Le Saux, A.; Nogami, J.; Maehara, K.; Kujirai, T.; Handa, T.; Bagés-Arnal, S.; Ohkawa, Y.; Kurumizaka, H.; da Rocha, S.ão.T.; Żylicz, J.J.; Kimura, H.; Heard, E. 2021: H4K20me1 and H3K27me3 are concurrently loaded onto the inactive X chromosome but dispensable for inducing gene silencing. Embo Reports 22(3): E51989

Hunter, P. 2012: H5N1 infects the biosecurity debate. Governments and life scientists are waking up to the problem of dual-use research. Embo Reports 13(7): 604-607

Wong, S-San.; DeBeauchamp, J.; Zanin, M.; Sun, Y.; Tang, L.; Webby, R. 2017: H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines. Npj Vaccines 2: 16

Li, X.; Fu, Z.; Liang, H.; Wang, Y.; Qi, X.; Ding, M.; Sun, X.; Zhou, Z.; Huang, Y.; Gu, H.; Li, L.; Chen, X.; Li, D.; Zhao, Q.; Liu, F.; Wang, H.; Wang, J.; Zen, K.; Zhang, C-Yu. 2018: H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2. Cell Research 28(2): 157-171

Neumann, G.; Chen, H.; Gao, G.F.; Shu, Y.; Kawaoka, Y. 2010: H5N1 influenza viruses: outbreaks and biological properties. Cell Research 20(1): 51-61

Farrar, J. 2012: H5N1 surveillance: Shift expertise to where it matters. Nature 483(7391): 534-535

Wain-Hobson, S. 2013: H5N1 viral-engineering dangers will not go away. Nature 495(7442): 411

Fouchier, R.A.M.; García-Sastre, A.; Kawaoka, Y. 2013: H5N1 virus: Transmission studies resume for avian flu. Nature 493(7434): 609

Kawaoka, Y. 2012: H5N1: Flu transmission work is urgent. Nature 482(7384): 155

Guan, Y.; Webby, R.; Capua, I.; Waldenström, J. 2012: H5N1: How to track a flu virus. Nature 483(7391): 535-536

Li, Y.-T.; Su, Y.C.F.; Smith, G.J.D. 2021: H5Nx Viruses Emerged during the Suppression of H5N1 Virus Populations in Poultry. Microbiology Spectrum 9(2): E0130921

Choi, E.Y.; Choi, K.; Nam, G.; Kim, W.; Chung, M. 2020: H60: a Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect. Frontiers in Immunology 11: 1163

Zhang, Q.-Q.; Jiang, H.; Li, C.-Y.; Liu, Y.-L.; Tian, X.-Y. 2020: H63D CG genotype of HFE is associated with increased risk of sporadic amyotrophic lateral sclerosis in a single population. Journal of Integrative Neuroscience 19(3): 495-499

Kim, Y.; Stahl, M.C.; Huang, X.; Connor, J.R. 2020: H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity. Journal of Neurochemistry 155(2): 177-190

Zaitseva, J.; Jenewein, S.; Jumpertz, T.; Holland, I.Barry.; Schmitt, L. 2005: H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. EMBO Journal 24(11): 1901-1910

Lee, M.Jae.; Miller, Z.; Park, J.Eun.; Bhattarai, D.; Lee, W.; Kim, K.Bo. 2019: H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth. Scientific Reports 9(1): 4089

Lee, D.-H.; Killian, M.L.; Deliberto, T.J.; Wan, X.-F.; Lei, L.; Swayne, D.E.; Torchetti, M.K. 2021: H7N1 Low Pathogenicity Avian Influenza Viruses in Poultry in the United States During 2018. Avian Diseases 65(1): 59-62

Wen, Y-Mei.; Klenk, H-Dieter. 2013: H7N9 avian influenza virus - search and re-search. Emerging Microbes and Infections 2(4): E18

Lee, A.C.Y.; Zhang, A.J.X.; Chu, H.; Li, C.; Zhu, H.; Mak, W.W.N.; Chen, Y.; Kok, K-Hang.; To, K.K.W.; Yuen, K-Yung. 2019: H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses. Cell Death and Disease 10(6): 442

de Jonge, Jørgen.; van Dijken, H.; de Heij, F.; Spijkers, S.; Mouthaan, J.; de Jong, R.; Roholl, P.; Adami, E.Alfredo.; Akamatsu, M.Apetito.; Ho, P.Lee.; Brunner, L.; Collin, N.; Friede, M.; Ferreira, Jé.A.; Luytjes, W. 2020: H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. Npj Vaccines 5: 38

de Jonge, Jørgen.; van Dijken, H.; de Heij, F.; Spijkers, S.; Mouthaan, J.; de Jong, R.; Roholl, P.; Adami, E.Alfredo.; Akamatsu, M.Apetito.; Ho, P.Lee.; Brunner, L.; Collin, N.; Friede, M.; Ferreira, Jé.A.; Luytjes, W. 2020: H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. Npj Vaccines 5(1): 38

Li, B.; Xiang, G.; He, J.; Li, H.; Xu, C.; Yu, A.; Zhao, Z.; Wang, X.; Zhang, L.; Zhang, H.; Zhang, H.; Xie, M.; Wang, P.; Yu, D. 2021: H7N9 influenza virus surveillance in Gansu, China in 2017. Virus Research 296: 198335

Horby, P. 2013: H7N9 is a virus worth worrying about. Nature 496(7446): 399

Adami, E.A.; Chavez Rico, S.L.; Akamatsu, M.A.; Miyaki, C.; Raw, I.ía.; de Oliveira, D.; Comone, P.; Oliveira, R.d.N.; Sarno de Oliveira, M.L.; Estima Abreu, P.íc.A.ôn.; Takano, C.Y.; Meros, M.íc.; Soares-Schanoski, A.; Lee Ho, P. 2021: H7N9 pandemic preparedness: a large-scale production of a split inactivated vaccine. Biochemical and Biophysical Research Communications 545: 145-149

Shi, J.; Deng, G.; Kong, H.; Gu, C.; Ma, S.; Yin, X.; Zeng, X.; Cui, P.; Chen, Y.; Yang, H.; Wan, X.; Wang, X.; Liu, L.; Chen, P.; Jiang, Y.; Liu, J.; Guan, Y.; Suzuki, Y.; Li, M.; Qu, Z.; Guan, L.; Zang, J.; Gu, W.; Han, S.; Song, Y.; Hu, Y.; Wang, Z.; Gu, L.; Yang, W.; Liang, L.; Bao, H.; Tian, G.; Li, Y.; Qiao, C.; Jiang, L.; Li, C.; Bu, Z.; Chen, H. 2017: H7N9 virulent mutants detected in chickens in China pose an increased threat to humans. Cell Research 27(12): 1409-1421

Wang, S.; Liang, T.; Luo, Q.; Li, P.; Zhang, R.; Xu, M.; Su, J.; Xu, T.; Wu, Q. 2020: H9N2 swine influenza virus infection-induced damage is mediated by TRPM2 channels in mouse pulmonary microvascular endothelial cells. Microbial Pathogenesis 148: 104408

Rodrigues, E.T.; Pardal, M.A.; Pereira, E.; Monteiro, J.F.; Certal, A.C.; Oliveira, P.J. 2021: H9c2(2-1)-based sulforhodamine B assay as a possible alternative in vitro platform to investigate effluent and metals toxicity on fish. Chemosphere 275: 130009

Zhao, M.-Z.; Guo, X.; Sun, B.; Sun, X.-F.; Pang, G.-F.; Yang, L.-Y.; Zhao, X.; Sun, L.-X.; Zhang, Q. 2021: HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice. Gene 801: 145854

Van Balen, P.; Jedema, I.; van Loenen, M.M.; de Boer, R.; van Egmond, H.M.; Hagedoorn, R.S.; Hoogstaten, C.; Veld, S.A.J.; Hageman, L.; van Liempt, P.A.G.; Zwaginga, J.-J.; Meij, P.; Veelken, H.; Falkenburg, J.H.F.; Heemskerk, M.H.M. 2020: HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: a Phase 1 Clinical Study. Frontiers in Immunology 11: 1804

Afshar, K.; Herbst, F.A.; Tetzlaff, F.; Stiel, S.; Schneider, N.; Müller-Mundt, G. 2020: HA-BeL ("Hausärztliche Begleitung in der letzten Lebensphase"): Systematic development and adjustment of the German version of the General Practice End of Life Care Index. Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 153-154: 84-96

Fritzwanker, S.; Moulédous, L.; Mollereau, C.; Froment, C.; Burlet-Schiltz, O.; Effah, F.; Bailey, A.; Spetea, M.; Reinscheid, R.K.; Schulz, S.; Kliewer, A. 2021: HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants. Communications Biology 4(1): 1070

Jia, N.; Ma, J.; Gao, Y.; Hu, H.; Chen, D.; Zhao, X.; Yuan, Y.; Qiao, M. 2020: HA-Modified R8-Based Bola-Amphiphile Nanocomplexes for Effective Improvement of siRNA Delivery Efficiency. Acs Biomaterials Science and Engineering 6(4): 2084-2093

Niu, Y.; Stadler, F.J.; Yang, X.; Deng, F.; Liu, G.; Xia, H. 2021: HA-coated collagen nanofibers for urethral regeneration via in situ polarization of M2 macrophages. Journal of Nanobiotechnology 19(1): 283

Casagrande, R.B.; Baldin, E.K.; Steffens, D.; Pavulack, D.; Pranke, P.; Brandalise, R.N.; de Fraga Malfatti, C.él. 2020: HA-hybrid matrix composite coating on Ti-Cp for biomedical application. Journal of Materials Science. Materials in Medicine 31(10): 82

Lee, S-Hoon.; Moon, J-Su.; Pak, B-Yeong.; Kim, G-Woo.; Lee, W.; Cho, H.; Kim, S.; Kim, S-Jun.; Oh, J-Won. 2018: HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice. Scientific Reports 8(1): 12469

Lickliter, J.D.; Wood, N.J.; Johnson, L.; McHugh, G.; Tan, J.; Wood, F.; Cox, J.; Wickham, N.W. 2003: HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. Leukemia 17(11): 2074-2080

Han, C.; Xie, K.; Yang, C.; Zhang, F.; Liang, Q.; Lan, C.; Chen, J.; Huang, K.; Liu, J.; Li, K.; Tang, Y.; Wang, L. 2021: HA15 alleviates bone loss in ovariectomy-induced osteoporosis by targeting HSPA5. Experimental Cell Research 406(2): 112781

Prabhakara, V.; Jannis, D.; Guzzinati, G.; Béché, A.; Bender, H.; Verbeeck, J. 2020: HAADF-STEM block-scanning strategy for local measurement of strain at the nanoscale. Ultramicroscopy 219: 113099

Akhigbe, R.E.; Hamed, M.A.; Odetayo, A.F. 2021: HAART and anti-Koch's impair sexual competence, sperm quality and offspring quality when used singly and in combination in male Wistar rats. Andrologia 53(2): E13951

Jain, D.; Hebden, A.K.; Nakamura, T.M.; Miller, K.M.; Cooper, J.Promisel. 2010: HAATI survivors replace canonical telomeres with blocks of generic heterochromatin. Nature 467(7312): 223-227

Faller, G.; Vollmers, H.P.; Weiglein, I.; Marx, A.; Zink, C.; Pfaff, M.; Müller-Hermelink, H.K. 1990: HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies. British Journal of Cancer 62(4): 595-598

Sponziello, M.; Durante, C.; Filetti, S. 2015: HABP2 Mutation and Nonmedullary Thyroid Cancer. New England Journal of Medicine 373(21): 2085-2086

Tomsic, J.; He, H.; de la Chapelle, A. 2015: HABP2 Mutation and Nonmedullary Thyroid Cancer. New England Journal of Medicine 373(21

Karjalainen, M.; Tossavainen, H.; Hellman, M.; Permi, P. 2020: HACANCOi: a new Hα-detected experiment for backbone resonance assignment of intrinsically disordered proteins. Journal of Biomolecular NMR 74(12): 741-752

Bobeng, B.J.; David, B.D. 1977: HACCP Models for Quality Control of Entree Production in Foodservice Systems. Journal of Food Protection 40(9): 632-638

Kho, J.Seog.; Jeong, J. 2020: HACCP-based Cooperative Model for Smart Factory in South Korea. Procedia Computer Science 175: 778-783

El-Naggar, A.M.; Clarkson, P.W.; Negri, G.Luca.; Turgu, B.; Zhang, F.; Anglesio, M.S.; Sorensen, P.H. 2019: HACE1 is a potential tumor suppressor in osteosarcoma. Cell Death and Disease 10(1): 21

Zhang, L.; Chen, X.; Sharma, P.; Moon, M.; Sheftel, A.D.; Dawood, F.; Nghiem, M.P.; Wu, J.; Li, R-Ke.; Gramolini, A.O.; Sorensen, P.H.; Penninger, J.M.; Brumell, J.H.; Liu, P.P. 2014: HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. Nature Communications 5: 3430

Moradi, P.; Roberton, B.; Osborne, R.; Muhtaseb, M.; Graham, E.M.; Klein, J.; Stanford, M.R. 2006: HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess. Eye 20(2): 254-255

Claudio, J.O.; Zhu, Y.X.; Benn, S.J.; Shukla, A.H.; McGlade, C.J.; Falcioni, N.; Stewart, A.K. 2001: HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells. Oncogene 20(38): 5373-5377

Kwan, J.J.; Slavkovic, S.; Piazza, M.; Wang, D.; Dieckmann, T.; Johnson, P.E.; Wen, X-Yan.; Donaldson, L.W. 2020: HACS1 signaling adaptor protein recognizes a motif in the paired immunoglobulin receptor B cytoplasmic domain. Communications Biology 3(1): 672

Phillips, J.D.; French, S.H.; Hanner, R.H.; Gillis, D.J. 2020: HACSim: an R package to estimate intraspecific sample sizes for genetic diversity assessment using haplotype accumulation curves. PEERJ. Computer Science 6: E243

Rusk, N. 2019: HACs with non-repetitive centromeres. Nature Methods 16(10): 959

Jiang, M.; Gu, J.; Li, Y.; Wei, B.; Zhang, J.; Wang, Z.; Xia, L. 2021: HADLN: Hybrid Attention-Based Deep Learning Network for Automated Arrhythmia Classification. Frontiers in Physiology 12: 683025

Förster, T.M.; Magerl, M.; Maurer, M.; Zülbahar, S.; Zielke, S.; Inhaber, N.; Crocetta, D.; Rolfs, A.; Skrahina, V. 2021: HAE patient self-sampling for biomarker establishment. Orphanet Journal of Rare Diseases 16(1): 399

Rose, J.D. 1964: Haematemesis. Nursing Times 60: 594-596

Mackenzie, D.W. 1932: Haematuria. Canadian Medical Association Journal 27(4): 405-406

Obuchowska, A.; Kamiński, M.; Kimber-Trojnar, Ża.; Grzesik, P.; Standyło, A.; Turżańska, K.; Leszczyńka-Gorzelak, B.że. 2020: Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women. Wiadomosci Lekarskie 73(9 Part 1): 1844-1847

Smith, R.E. 1923: Haemorrhage from the Large Bowel Caused by An Adherent Appendix Epiploica. British Medical Journal 1(3255): 853

Van Essen 1965: Haemorrhoidectomy. Nursing Times 61: 414-415

Abdel-Fatah, T.M.A.; McArdle, S.E.B.; Johnson, C.; Moseley, P.M.; Ball, G.R.; Pockley, A.G.; Ellis, I.O.; Rees, R.C.; Chan, S.Y.T. 2014: HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer 110(10): 2450-2461

Zhang, Q.; Zhou, L.; Xie, H.; Zhang, H.; Gao, X. 2021: HAGLR aggravates neuropathic pain and promotes inflammatory response and apoptosis of lipopolysaccharide-treated SH-SY5Y cells by sequestering miR-182-5p from ATAT1 and activating NLRP3 inflammasome. Neurochemistry International 145: 105001

Wei, B.; Xiao, G.-R.; Wu, C.-L.; Xu, Y.-Q. 2021: HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis. Open Medicine 16(1): 1121-1131

Chen, Y.; Shen, T.; Ding, X.; Cheng, L.; Sheng, L.; Du, X. 2020: HAGLROS is overexpressed and promotes non-small cell lung cancer migration and invasion. Japanese Journal of Clinical Oncology 50(9): 1058-1067

Ma, Y.; Zhang, H.; Li, X.; Liu, Y. 2022: HAGLROS promotes cell proliferation and angiogenesis and inhibits apoptosis by activating multiple signaling pathways in LSCC cells. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 51(6): 510-519

Khurana, P.; Gupta, A.; Sugadev, R.; Sharma, Y.K.; Kumar, B. 2020: HAHmiR.DB: a server platform for high-altitude human miRNA-gene coregulatory networks and associated regulatory circuits. Database: the Journal of Biological Databases and Curation 2020

Arranz-Gibert, P.; Prades, R.; Guixer, B.; Guerrero, Són.; Araya, E.; Ciudad, S.; Kogan, M.J.; Giralt, E.; Teixidó, M. 2018: HAI Peptide and Backbone Analogs-Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles. Scientific Reports 8(1): 17932

Borowicz, S.; Principe, D.R.; Dorman, M.J.; McHenry, A.J.; Sondarva, G.; Kumar, S.; Ananthanarayanan, V.; Simms, P.E.; Hess, A.; Rana, A. 2021: HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization. Plos one 16(6): E0252197

Wu, S-Ru.; Lin, C-Hao.; Shih, H-Po.; Ko, C-Jung.; Lin, H-Ying.; Lan, S-Wei.; Lin, H-Hsien.; Tu, H-Fang.; Ho, C-Chi.; Huang, H-Po.; Lee, M-Shyue. 2019: HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis. British Journal of Cancer 120(5): 499-511

Tsai, C-H.; Teng, C-H.; Tu, Y-T.; Cheng, T-S.; Wu, S-R.; Ko, C-J.; Shyu, H-Y.; Lan, S-W.; Huang, H-P.; Tzeng, S-F.; Johnson, M.D.; Lin, C-Y.; Hsiao, P-W.; Lee, M-S. 2014: HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene 33(38): 4643-4652

Caffiaux, A. 1964: Hallucinations. Revue Medicale du Moyen-Orient 21: 536-541

Sandison, R.A. 1964: Hallucinogens. Practitioner 192: 30-36

Matsuda, K. 1964: Hallucinogens. Nihon Ishikai Zasshi. Journal of the Japan Medical Association 52: 1089-1100

Caffiaux 1964: Hallucinosis. Le Scalpel 117: 1019-1022

Godoy-Santos, A.L.; Giordano, V.; Cesar, C.D.; Sposeto, R.B.; Bitar, R.Ér.C.; Wajnsztejn, A.É; Sakaki, M.H.; Fernandes, T.Úl.D. 2020: Hallux Proximal Phalanx Fracture in Adults: An Overlooked Diagnosis. Acta Ortopedica Brasileira 28(6): 318-322

Garstka, J.; Baszynska, D. 1963: Halotan Anaesthesia in Orthopedic Surgery. Chirurgia Narzadow Ruchu i Ortopedia Polska 28: 1025-1028

Frey, R. 1964: Halothane and Liver Damage. Der Anaesthesist 13: 315-316

Urbinati, G.C.; Soccorsi, F. 1964: Halothane and the Liver. La Clinica Terapeutica 31: 337-362

Cole, F. 1965: Halothane and the Liver. Nebraska State Medical Journal 50: 324-328

Kaya, C.; Caliskan, S.; Sungur, M.; Aydın, C. 2021: HALP score and albumin levels in men with prostate cancer and benign prostate hyperplasia. International Journal of Clinical Practice 75(3): E13766

Zhang, X.; Kaplow, I.M.; Wirthlin, M.; Park, T.Y.; Pfenning, A.R. 2020: HALPER facilitates the identification of regulatory element orthologs across species. Bioinformatics 36(15): 4339-4340

Hubbard, G.; Beeken, R.J.; Taylor, C.; Oliphant, R.; Watson, A.J.M.; Munro, J.; Russell, S.; Goodman, W. 2020: HALT (Hernia Active Living Trial): protocol for a feasibility study of a randomised controlled trial of a physical activity intervention to improve quality of life in people with bowel stoma with a bulge/parastomal hernia. Pilot and Feasibility Studies 6: 142

Akita, S.; Unno, N.; Maegawa, J.; Kimata, Y.; Fukamizu, H.; Yabuki, Y.; Shinaoka, A.; Sano, M.; Kawasaki, Y.; Fujiwara, T.; Hanaoka, H.; Mitsukawa, N. 2020: HAMAMATSU-ICG study: Protocol for a phase III, multicentre, single-arm study to assess the usefulness of indocyanine green fluorescent lymphography in assessing secondary lymphoedema. Contemporary Clinical Trials Communications 19: 100595

Mousavi, S.; Afghah, F.; Acharya, U.R. 2020: HAN-ECG: An interpretable atrial fibrillation detection model using hierarchical attention networks. Computers in Biology and Medicine 127: 104057

Shams, M.Y.; Elzeki, O.M.; Abouelmagd, L.M.; Hassanien, A.E.; Elfattah, M.A.; Salem, H. 2021: HANA: a Healthy Artificial Nutrition Analysis model during COVID-19 pandemic. Computers in Biology and Medicine 135: 104606

Jordre, B.; Schweinle, W. 2020: Hand Grip Strength in Senior Athletes: Normative Data and Community-Dwelling Comparisons. International Journal of Sports Physical Therapy 15(4): 519-525

Pagella, P. 1964: Hand Injuries in a Law of the Middle Ages. Minerva Medicolegale; Archivio di Antropologia Criminale Psichiatria e Medicina Legale 84: 17-19

Doxakis, E.; Howard, L.; Rohrer, H.; Davies, A.M. 2008: HAND transcription factors are required for neonatal sympathetic neuron survival. Embo Reports 9(10): 1041-1047

Hemming, M.L.; Coy, S.; Lin, J.-R.; Andersen, J.L.; Przybyl, J.; Mazzola, E.; Abdelhamid Ahmed, A.H.; van de Rijn, M.; Sorger, P.K.; Armstrong, S.A.; Demetri, G.D.; Santagata, S. 2021: HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(6): 1706-1719

Martinez Hoyos, J.; Ferraro, A.; Sacchetti, S.; Keller, S.; De Martino, I.; Borbone, E.; Pallante, P.; Fedele, M.; Montanaro, D.; Esposito, F.; Cserjesi, P.; Chiariotti, L.; Troncone, G.; Fusco, A. 2009: HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas. Oncogene 28(6): 876-885

Hoyos, J.M.; Ferraro, A.; Sacchetti, S.; Keller, S.; De Martino, I.; Borbone, E.; Pallante, P.; Fedele, M.; Montanaro, D.; Esposito, F.; Cserjesi, P.; Chiariotti, L.; Troncone, G.; Fusco, A. 2016: HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas. Oncogene 35(45): 5930

Xu, Z.; Lv, H.; Wang, Y.; Hu, C.; Chen, S.; Du, Y.; Shi, C.; Cheng, X. 2020: HAND2-AS1 Inhibits Gastric Adenocarcinoma Cells Proliferation and Aerobic Glycolysis via mi RNAs Sponge. Cancer Management and Research 12: 3053-3068

Gu, X.; Zheng, Q.; Chu, Q.; Zhu, H. 2021: HAND2-AS1: a functional cancer-related long non-coding RNA. Biomedicine and PharmacoTherapy 137: 111317

Khan, A.; Belfield, E.J.; Harberd, N.P.; Mithani, A. 2016: HANDS2: accurate assignment of homoeallelic base-identity in allopolyploids despite missing data. Scientific Reports 6: 29234

Han, M.; Günay, S.Y.ğm.; Schirner, G.; Padır, T.şk.ın.; Erdoğmuş, D. 2020: HANDS: a multimodal dataset for modeling toward human grasp intent inference in prosthetic hands. Intelligent Service Robotics 13(1): 179-185

Nuzzi, C.; Pasinetti, S.; Pagani, R.; Coffetti, G.; Sansoni, G. 2021: HANDS: an RGB-D dataset of static hand-gestures for human-robot interaction. Data in Brief 35: 106791

Su, Y.; Xu, Y.; Cui, T.; Gao, X.; Xia, G.; Li, Y.; Qiao, M.; Yu, Y. 2021: HANDY: a device for assessing resistance to mechanical crushing of maize kernel. Plant Methods 17(1): 44

Huang, B.; Seefelder, M.; Buck, E.; Engler, T.; Lindenberg, K.S.; Klein, F.; Landwehrmeyer, G.B.; Kochanek, S. 2021: HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease. Neurobiology of Disease 158: 105476

Timmons, P.Brendan.; Hewage, C.M. 2020: HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks. Scientific Reports 10(1): 10869

Slaten, M.L.; Chan, Y.O.; Shrestha, V.; Lipka, A.E.; Angelovici, R. 2020: HAPPi GWAS: Holistic Analysis with Pre- and Post-Integration GWAS. Bioinformatics 36(17): 4655-4657

O'Sullivan, I.C.; Crossley, K.M.; Kamper, S.J.; van Middelkoop, M.; Vicenzino, B.; Franettovich Smith, M.M.; Menz, H.B.; Smith, A.J.; Tucker, K.; O'Leary, K.T.; Collins, N.J. 2020: HAPPi Kneecaps! Protocol for a participant- and assessor-blinded, randomised, parallel group feasibility trial of foot orthoses for adolescents with patellofemoral pain. Journal of Foot and Ankle Research 13(1): 50

Lupovitch, A. 1964: Haptoglobin. Maryland State Medical Journal 13: 129

Arribas, J.M.; Decastro, S.; Planas, J. 1964: Haptoglobins. Medicina Clinica 42: 3-15

Nishimura, R.; Hayashi, M.; Wu, G-Jiang.; Kouchi, H.; Imaizumi-Anraku, H.; Murakami, Y.; Kawasaki, S.; Akao, S.; Ohmori, M.; Nagasawa, M.; Harada, K.; Kawaguchi, M. 2002: HAR1 mediates systemic regulation of symbiotic organ development. Nature 420(6914): 426-429

Lavagnino, M.N.; Liang, T.; MacMillan, D.W.C. 2020: HARC as an open-shell strategy to bypass oxidative addition in Ullmann-Goldberg couplings. Proceedings of the National Academy of Sciences of the United States of America 117(35): 21058-21064

Batista E Silva, F.; Forzieri, G.; Marin Herrera, M.Alberto.; Bianchi, A.; Lavalle, C.; Feyen, L. 2019: HARCI-EU, a harmonized gridded dataset of critical infrastructures in Europe for large-scale risk assessments. Scientific Data 6(1): 126

Labounek, Ré.; Valošek, J.; Horák, Táš.; Svátková, A.; Bednařík, P.; Vojtíšek, Lír.; Horáková, M.; Nestrašil, I.; Lenglet, C.; Cohen-Adad, J.; Bednařík, J.; Hluštík, P. 2020: HARDI-ZOOMit protocol improves specificity to microstructural changes in presymptomatic myelopathy. Scientific Reports 10(1): 17529

Jiang, S.; Xiao, G.; Koh, A.Y.; Chen, Y.; Yao, B.; Li, Q.; Zhan, X. 2020: HARMONIES: a Hybrid Approach for Microbiome Networks Inference via Exploiting Sparsity. Frontiers in Genetics 11: 445

Vedithi, S.C.; Malhotra, S.; Skwark, M.J.; Munir, A.; Acebrón-García-De-Eulate, M.; Waman, V.P.; Alsulami, A.; Ascher, D.B.; Blundell, T.L. 2020: HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae. Computational and Structural Biotechnology Journal 18: 3692-3704

Hudec, L.O. 2021: Has the Art of Nursing Been Lost to Technology?. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 44(4): 284-287

Moreva, O.V.; Kropacheva, E.S.; Panchenko, E.P.; Dobrovolsky, A.B.; Zemlyanskaya, O.A.; Donnikov, A.E.; Titaeva, E.V.; Guskov, I.A. 2015: HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy. Kardiologiia 55(9): 50-56

Ziviello, F.; Pilgrim, T.; Kroon, H.; Ooms, J.F.; van Wiechen, M.P.; El Azzouzi, I.; Stortecky, S.; Asami, M.; Daemen, J.; de Jaegere, P.P.; Windecker, S.; van Mieghem, N.M. 2020: HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantation. Minerva Medica 111(3): 203-212

Rothemund, P.; Kellaris, N.; Mitchell, S.K.; Acome, E.; Keplinger, C. 2021: HASEL Artificial Muscles for a new Generation of Lifelike Robots-Recent Progress and Future Opportunities. Advanced Materials 33(19): E2003375

Luxton, R.W.; Cooke, R.T. 1965: Hashimoto's Disease. Lancet 1(7381): 386

Glass, H.G.; Waldron, G.W.; Brown, W.G.; Kyle, T.J. 1965: Hashimoto's Disease. Texas State Journal of Medicine 61: 479-481

Haghshenas, E.; Asghari, H.; Stoye, J.; Chauve, C.; Hach, F. 2020: HASLR: Fast Hybrid Assembly of Long Reads. Iscience 23(8): 101389

Brioudes, F.; Jay, F.; Sarazin, A.; Grentzinger, T.; Devers, E.A.; Voinnet, O. 2021: HASTY, the Arabidopsis EXPORTIN5 ortholog, regulates cell-to-cell and vascular microRNA movement. EMBO Journal 40(15): E107455

Shiba, H.; Minami, S.; Shiraishi, A. 2021: HAT Therapy: Really Beneficial?. Chest 159(2): 881

Li, H.; Cuenin, C.; Murr, R.; Wang, Z-Qi.; Herceg, Z. 2004: HAT cofactor Trrap regulates the mitotic checkpoint by modulation of Mad1 and Mad2 expression. EMBO Journal 23(24): 4824-4834

Johnsson, A.; Durand-Dubief, Mël.; Xue-Franzén, Y.; Rönnerblad, M.; Ekwall, K.; Wright, A. 2009: HAT-HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress. Embo Reports 10(9): 1009-1014

Chen, J.-Y.; Chen, T.-W.; Lu, W.-D. 2021: HATCH Score and Left Atrial Size Predict Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices. Frontiers in Cardiovascular Medicine 8: 746225

Sobotzki, N.; Schafroth, M.A.; Rudnicka, A.; Koetemann, A.; Marty, F.; Goetze, S.; Yamauchi, Y.; Carreira, E.M.; Wollscheid, B. 2018: HATRIC-based identification of receptors for orphan ligands. Nature Communications 9(1): 1519

Saha, R.N.; Pahan, K. 2006: HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death and Differentiation 13(4): 539-550

Francis, P.; Forman, L. 2021: HATs Off to Clot Blockers: a Potential new Role for Statins After Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 27(10): 1375-1377

Leuzzi, G.; Taglialatela, A.; Ciccia, A. 2020: HATtracting Nucleases to Stalled Forks. Molecular Cell 80(2): 177-180

Tavana, O.; Li, D.; Dai, C.; Lopez, G.; Banerjee, D.; Kon, N.; Chen, C.; Califano, A.; Yamashiro, D.J.; Sun, H.; Gu, W. 2016: HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nature Medicine 22(10): 1180-1186

Huang, T.T.; D'Andrea, A.D. 2006: HAUSP hunting the FOX(O). Nature Cell Biology 8(10): 1043-1045

Battistini, R.; Rossini, I.; Listorti, V.; Ercolini, C.; Maurella, C.; Serracca, L. 2020: HAV detection from milk-based products containing soft fruits: Comparison between four different extraction methods. International Journal of Food Microbiology 328: 108661

Castro, L.S.; Rezende, G.R.d.; Pires Fernandes, F.R.; Bandeira, L.M.; Cesar, G.A.; do Lago, B.V.; Gomes Gouvêa, M.S.; Motta-Castro, A.R.C. 2021: HAV infection in Brazilian men who have sex with men: the importance of surveillance to avoid outbreaks. Plos one 16(9): E0256818

Butler, A.; Heley, S. 2016: Have you Had the Hpv Vaccine? you Still Need to be Screened for Cervical Cancer. Australian Nursing and Midwifery Journal 24(3): 20

Lasair, S. 2021: HAVE-H: Five Attitudes for a Narratively Grounded and Embodied Spirituality. Journal of Pastoral Care and Counseling: Jpcc 75(1): 13-22

Kwiecinska, A.; Ottosson-Wadlund, A.; Ceder, R.; Grafström, R.C.; Björck, E.; Nordenskjöld, M.; Porwit, A.; Fadeel, B. 2011: HAX-1 expression in human B lymphoma. Leukemia 25(5): 868-872

Klein, C.; Grudzien, M.; Appaswamy, G.; Germeshausen, M.; Sandrock, I.; Schäffer, A.A.; Rathinam, C.; Boztug, K.; Schwinzer, B.; Rezaei, N.; Bohn, G.; Melin, M.; Carlsson, Göran.; Fadeel, B.; Dahl, N.; Palmblad, J.; Henter, J-Inge.; Zeidler, C.; Grimbacher, B.; Welte, K. 2007: HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nature Genetics 39(1): 86-92

Wolkerstorfer, S.; Schwaiger, E.; Rinnerthaler, M.; Karina Gratz, I.; Zoegg, T.; Brandstetter, H.; Achatz-Straussberger, G. 2016: HAX1 deletion impairs BCR internalization and leads to delayed BCR-mediated apoptosis. Cellular and Molecular Immunology 13(4): 451-461

Liang, Z.; Zhong, Y.; Meng, L.; Chen, Y.; Liu, Y.; Wu, A.; Li, X.; Wang, M. 2020: HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway. Thoracic Cancer 11(11): 3155-3167

Plummer, J.P.; Diamond, A.; Chaparro, A.; Ni, R. 2019: Hazard Perception in City and Highway Environments. Proceedings of the Human Factors and Ergonomics Society . Annual Meeting. Human Factors and Ergonomics Society. Annual Meeting 63(1): 1404-1408

Wu, J.; Ru, N-Y.; Zhang, Y.; Li, Y.; Wei, D.; Ren, Z.; Huang, X-F.; Chen, Z-N.; Bian, H. 2011: HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug. Oncogene 30(43): 4410-4427

Sacchetti, R.; Gregori, G.; Moggio, E.; Gobbo, L.; Bonzano, L.; Pellacani, G. 2021: HAc40 is a novel microbiome modulator, effective on atopic dermatitis in children: data from two pilot vehicle-controlled trials. Journal of the European Academy of Dermatology and Venereology: Jeadv 35(11): E767-E768

Debre, R.; Marie, J.; Thieffry, S. 1946: HArler's polydystrophy; the Gargoylism of Ellis. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 22: 309-320

Ray, K. 2019: HAstening the development of liver fibrosis. Nature Reviews. Gastroenterology and Hepatology 16(8): 455

Misztal, T.; Golaszewska, A.; Branska-Januszewska, J.; Marcinczyk, N.; Chabielska, E.; Tomasiak, M.; Rusak, T. 2020: HAuCl4, Putative General Aquaporins Blocker, Reduces Platelet Spreading, Filopodia Formation, Procoagulant Response, and Thrombus Formation Under Flow. Frontiers in Physiology 11: 1025

Wang, L.; Lu, Y.-F.; Wang, C.-S.; Xie, Y.-X.; Zhao, Y.-Q.; Qian, Y.-C.; Liu, W.-T.; Wang, M.; Jiang, B.-H. 2020: HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth. Frontiers in Oncology 10: 1019

Fontaine, J.T.; Rosehart, A.C.; Joutel, A.; Dabertrand, F. 2020: HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease. Mechanisms of Ageing and Development 192: 111389

Nagy, N.; Almaani, N.; Tanaka, A.; Lai-Cheong, J.E.; Techanukul, T.; Mellerio, J.E.; McGrath, J.A. 2011: HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. Journal of Investigative Dermatology 131(8): 1771-1774

Poumay, Y.; de Rouvroit, C.Lambert. 2012: HB-EGF, the growth factor that accelerates keratinocyte migration, but slows proliferation. Journal of Investigative Dermatology 132(9): 2129-2130

Paveliev, M.; Fenrich, K.K.; Kislin, M.; Kuja-Panula, J.; Kulesskiy, E.; Varjosalo, M.; Kajander, T.; Mugantseva, E.; Ahonen-Bishopp, A.; Khiroug, L.; Kulesskaya, N.; Rougon, Gève.; Rauvala, H. 2016: HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix. Scientific Reports 6: 33916

Gałązka-Sobotka, M.łg.; Frączkiewicz-Wronka, A.; Kowalska-Bobko, I.; Kelm, H.; Szymaniec-Mlicka, K. 2021: HB-HTA as an implementation problem in Polish health policy. Plos one 16(9): E0257451

Karlebach, G.; Hansen, P.; Veiga, D.F.; Steinhaus, R.; Danis, D.; Li, S.; Anczukow, O.; Robinson, P.N. 2020: HBA-DEALS: accurate and simultaneous identification of differential expression and splicing using hierarchical Bayesian analysis. Genome Biology 21(1): 171

Liu, X.; Song, S.; Huang, J.; Fu, H.; Ning, X.; He, Y.; Zhang, Z. 2020: HBC-nanofiber hydrogel scaffolds with 3D printed internal microchannels for enhanced cartilage differentiation. Journal of Materials Chemistry. B 8(28): 6115-6127

Shin, C.H.; Robinson, J.P.; Sonnen, J.A.; Welker, A.E.; Yu, D.X.; VanBrocklin, M.W.; Holmen, S.L. 2017: HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss. Oncogene 36(32): 4610-4618

Smith, E.R.; Hewitson, T.D. 2021: HBEGF: an EGF-like growth factor with FGF23-like activity?. Kidney International 99(3): 539-542

Shao, D.; Huang, L.; Wang, Y.; Cui, X.; Li, Y.; Wang, Y.; Ma, Q.; Du, W.; Cui, J. 2021: HBFP: a new repository for human body fluid proteome. Database: the Journal of Biological Databases and Curation 2021

Ablashi, D.V.; Salahuddin, S.Z.; Josephs, S.F.; Imam, F.; Lusso, P.; Gallo, R.C.; Hung, C.; Lemp, J.; Markham, P.D. 1987: HBLV (or HHV-6) in human cell lines. Nature 329(6136): 207

Choi, Y.-K.; Chi, Y.; Qiao, W.; Samardzic, N.; Cong, J. 2021: HBM Connect: High-Performance HLS Interconnect for FPGA HBM. FPGA. Acm International Symposium on Field-Programmable Gate Arrays 2021: 116-126

Santonen, T.; Porras, S.P.; Bocca, B.; Bousoumah, R.; Duca, R.C.; Galea, K.S.; Godderis, L.; Göen, T.; Hardy, E.; Iavicoli, I.; Janasik, B.; Jones, K.; Leese, E.; Leso, V.; Louro, H.; Majery, N.; Ndaw, S.; Pinhal, H.ín.; Ruggieri, F.; Silva, M.J.; van Nieuwenhuyse, A.; Verdonck, J.; Viegas, S.; Wasowicz, W.; Sepai, O.; Scheepers, P.T.J.; Aimonen, K.; Antoine, G.; Anzion, R.; Burgart, M.; Castaño, A.; Cattaneo, A.; Cavallo, D.M.; De Palma, G.; Denis, F.; Gambelunghe, A.; Gomes, B.; Hanser, O.; Helenius, R.; Ladeira, C.; López, M.E.; Lovreglio, P.; Marsan, P.; Melczer, M.; Nogueira, A.; Pletea, E.; Poels, K.; Remes, J.; Ribeiro, E.; Santos, S.íl.R.; Schaefers, F.ço.; Spankie, S.; Spoek, R.; Rizki, M.; Rousset, D.; van Dael, M.; Veijalai 2022: HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium. Environmental Research 204(Part A): 111984

Galea, K.S.; Porras, S.P.; Viegas, S.; Bocca, B.; Bousoumah, R.; Duca, R.C.; Godderis, L.; Iavicoli, I.; Janasik, B.; Jones, K.; Knudsen, L.E.; Leese, E.; Leso, V.; Louro, H.; Ndaw, S.; Ruggieri, F.; Sepai, O.; Scheepers, P.T.J.; Silva, M.J.; Wasowicz, W.; Santonen, T. 2021: HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium. International Journal of Hygiene and Environmental Health 234: 113725

Gilles, L.; Govarts, E.; Rambaud, L.ïc.; Vogel, N.; Castaño, A.; Esteban López, M.; Rodriguez Martin, L.; Koppen, G.; Remy, S.; Vrijheid, M.; Montazeri, P.; Birks, L.; Sepai, O.; Stewart, L.; Fiddicke, U.; Loots, I.; Knudsen, L.E.; Kolossa-Gehring, M.; Schoeters, G. 2021: HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - the HBM4EU survey. International Journal of Hygiene and Environmental Health 237: 113809

Sadiq, Q.; Sekhri, R.; Dibaba, D.T.; Zhao, Q.; Agarwal, S. 2021: HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions. World Journal of Surgical Oncology 19(1): 143

MacPherson, L.; Anokye, J.; Yeung, M.M.; Lam, E.Y.N.; Chan, Y-Chih.; Weng, C-Fang.; Yeh, P.; Knezevic, K.; Butler, M.S.; Hoegl, A.; Chan, K-Lok.; Burr, M.L.; Gearing, L.J.; Willson, T.; Liu, J.; Choi, J.; Yang, Y.; Bilardi, R.A.; Falk, H.; Nguyen, N.; Stupple, P.A.; Peat, T.S.; Zhang, M.; de Silva, M.; Carrasco-Pozo, C.; Avery, V.M.; Khoo, P.Sim.; Dolezal, O.; Dennis, M.L.; Nuttall, S.; Surjadi, R.; Newman, J.; Ren, B.; Leaver, D.J.; Sun, Y.; Baell, J.B.; Dovey, O.; Vassiliou, G.S.; Grebien, F.; Dawson, S-Jane.; Street, I.P.; Monahan, B.J.; Burns, C. 2020: HBO1 is required for the maintenance of leukaemia stem cells. Nature 577(7789): 266-270

Zhong, W.; Liu, H.; Deng, L.; Chen, G.; Liu, Y. 2021: HBO1 overexpression is important for hepatocellular carcinoma cell growth. Cell Death and Disease 12(6): 549

Marois, P.; Vanasse, M. 2007: HBO2 and cerebral palsy in children. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 34(1): 4-6; Author Reply 6

LeGros, T.L.; Murphy-Lavoie, H. 2020: HBO2 for sudden sensorineural hearing loss. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 47(2): 271-295

Freilich, D.; Pearce, L.Bruce.; Pitman, A.; Greenburg, G.; Berzins, M.; Bebris, L.; Ahlers, S.; McCarron, R. 2009: HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials. Journal of Trauma 66(2): 365-376

Guo, Y.; Wang, S.; Yuan, X. 2021: HBOS-CNV: a new Approach to Detect Copy Number Variations from Next-Generation Sequencing Data. Frontiers in Genetics 12: 642473

Yu, C.; Ma, L.; Li, S.; Tan, H.; Zhou, Y.; Yan, D. 2016: HBP Builder: A Tool to Generate Hyperbranched Polymers and Hyperbranched Multi-Arm Copolymers for Coarse-grained and Fully Atomistic Molecular Simulations. Scientific Reports 6: 26264

Auer, T.A.; Walter-Rittel, T.; Geisel, D.; Schöning, W.; Schmelzle, M.; Müller, T.; Sinn, B.; Denecke, T.; Hamm, B.; Fehrenbach, U. 2021: HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRi. Bmc Medical Imaging 21(1): 28

Swanson, K.A.; Knoepfler, P.S.; Huang, K.; Kang, R.S.; Cowley, S.M.; Laherty, C.D.; Eisenman, R.N.; Radhakrishnan, I. 2004: HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations. Nature Structural and Molecular Biology 11(8): 738-746

Liu, W.; Li, W.-C.; Pan, X.-F.; Sha, H.; Gong, W.-Q.; Yan, M. 2020: HBP1 deficiency protects against stress-induced premature senescence of nucleus pulposus. European Review for Medical and Pharmacological Sciences 24(17): 8685-8693

Cao, Z.; Cheng, Y.; Wang, J.; Liu, Y.; Yang, R.; Jiang, W.; Li, H.; Zhang, X. 2021: HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 118

Masrour-Roudsari, J.; Hasanjani-Roushan, M.; Yahyapour, Y.; Barari-Savadkoohi, R.; Bijani, A.; Sadeghi, F.; Mohammadnia-Afroozi, M. 2020: HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection. Caspian Journal of Internal Medicine 11(2): 205-210

Roca Suarez, A.A.; Testoni, B.; Zoulim, F. 2021: HBV 2021: new therapeutic strategies against an old foe. Liver International: Official Journal of the International Association for the Study of the Liver 41(Suppl 1): 15-23

Zhang, D.; Zhang, K.; Protzer, U.; Zeng, C. 2021: HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site. Journal of Clinical and Translational Hepatology 9(3): 399-408

Patel, N.; White, S.J.; Thompson, R.F.; Bingham, R.; Weiß, E.U.; Maskell, D.P.; Zlotnick, A.; Dykeman, E.; Tuma, R.; Twarock, R.; Ranson, N.A.; Stockley, P.G. 2017: HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly. Nature Microbiology 2: 17098

Debnath, P.; Rathi, P. 2021: HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 19(12): 2680-2681

Cao, X.; Wang, Y.; Li, P.; Huang, W.; Lu, X.; Lu, H. 2021: HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 11: 685706

Suwanpakdee, D.; Taweesith, W.; Traivaree, C.; Rujkijyanont, P. 2021: HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors. Global Pediatric Health 8: 2333794x211033452

Kim, S.; Park, S-Y.; Yong, H.; Famulski, J.K.; Chae, S.; Lee, J-H.; Kang, C-M.; Saya, H.; Chan, G.K.; Cho, H. 2008: HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 27(24): 3457-3464

Horng, J.-H.; Lin, W.-H.; Wu, C.-R.; Lin, Y.-Y.; Wu, L.-L.; Chen, D.-S.; Chen, P.-J. 2020: HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice. Journal of Biomedical Science 27(1): 70

Oesterreicher, C.; Hammer, J.; Koch, U.; Pfeffel, F.; Sunder-Plassmann, G.; Petermann, D.; Müller, C. 1995: HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney International 48(6): 1967-1971

Chen, L.; Gu, L.; Gu, Y.; Wang, H.; Deng, M.; Stamataki, Z.; Oo, Y.Htun.; Huang, Y. 2016: HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression. Scientific Reports 6: 35917

Ruan, Y.; Jiang, Y.; Wang, W.; Ma, J.; He, B.; Chen, M. 2020: HBV down-regulates PTEN expression via Nrf2/GSK3β signaling pathway. Zhong Nan da Xue Xue Bao. Yi Xue Ban 45(9): 1009-1014

Maini, M.K.; Bertoletti, A. 2017: HBV in 2016: Global and immunotherapeutic insights into hepatitis B. Nature Reviews. Gastroenterology and Hepatology 14(2): 71-72

Jia, L.; Gao, Y.; He, Y.; Hooper, J.D.; Yang, P. 2020: HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacological Research 159: 104992

Poonia, B.; Ayithan, N.; Nandi, M.; Masur, H.; Kottilil, S. 2018: HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis. Scientific Reports 8(1): 15296

Li, W.; Yu, X.; Chen, X.; Wang, Z.; Yin, M.; Zhao, Z.; Zhu, C. 2021: HBV induces liver fibrosis via the TGF-β1/miR-21-5p pathway. Experimental and Therapeutic Medicine 21(2): 169

Ma, S.; Qin, K.; Ouyang, H.; Zhu, H.; Lei, P.; Shen, G. 2020: HBV infection exacerbates PTEN defects in hepatocellular carcinoma through upregulation of miR-181a/382/362/19a. American Journal of Translational Research 12(7): 3780-3791

Zhao, X.; Guo, X.; Xing, L.; Yue, W.; Yin, H.; He, M.; Wang, J.; Yang, J.; Chen, J. 2018: HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma. Cell Death and Disease 9(2): 61

Shamay, M.; Agami, R.; Shaul, Y. 2001: HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Oncogene 20(47): 6811-6819

Yang, M.; Yang, G.; Li, F.; Ou, M.; Li, C.; Chen, J.; Lin, H.; Zhang, Y.; Xue, W.; Wu, Y.; Xu, Y.; Sui, W.; Dai, Y. 2020: HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas. Molecular and Clinical Oncology 13(6): 79

Li, H.; Zhuang, Q.; Wang, Y.; Zhang, T.; Zhao, J.; Zhang, Y.; Zhang, J.; Lin, Y.; Yuan, Q.; Xia, N.; Han, J. 2014: HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cellular and Molecular Immunology 11(2): 175-183

Su, P-Yi.; Yang, C-Jen.; Chu, T-Hua.; Chang, C-Hsu.; Chiang, C.; Tang, F-Mei.; Lee, C-Yin.; Shih, C. 2016: HBV maintains electrostatic homeostasis by modulating negative charges from phosphoserine and encapsidated nucleic acids. Scientific Reports 6: 38959

Sagnelli, C.; Ciccozzi, M.; Alessio, L.; Cella, E.; Gualdieri, L.; Pisaturo, M.; Minichini, C.; Di Caprio, G.; Starace, M.; Onorato, L.; Capoprese, M.; Occhiello, L.; Angeletti, S.; Scotto, G.; Macera, M.; Sagnelli, E.; Coppola, N. 2018: HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection 46(4): 523-531

Banerjee, P.; Chakraborty, A.; Mondal, R.Kumar.; Khatun, M.; Datta, S.; Das, K.; Pandit, P.; Mukherjee, S.; Banerjee, S.; Ghosh, S.; Chakrabarti, S.; Chowdhury, A.; Datta, S. 2017: HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy. Scientific Reports 7: 44742

Bae, S.Kwan.; Gushima, T.; Saito, N.; Yamanaka, I.; Matsuo, Y.; Yoshida, S.; Kawano, I.; Henzan, H.; Shimoda, S.; Eto, T.; Takahashi, K. 2019: HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. Bone Marrow Transplantation 54(4): 629-631

Doitsh, G.; Shaul, Y. 1999: HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX. Oncogene 18(52): 7506-7513

Wu, X.; Cai, B.; Lu, W.; Fu, Y.; Wei, B.; Niu, Q.; Su, Z.; Li, Y.; Wang, L. 2021: HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway. Clinical Immunology 223: 108650

Baudi, I.; Kawashima, K.; Isogawa, M. 2021: HBV-Specific CD8+ T-Cell Tolerance in the Liver. Frontiers in Immunology 12: 721975

Yuan, K.; Lei, Y.; Chen, H-N.; Chen, Y.; Zhang, T.; Li, K.; Xie, N.; Wang, K.; Feng, X.; Pu, Q.; Yang, W.; Wu, M.; Xiang, R.; Nice, E.C.; Wei, Y.; Huang, C. 2016: HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death and Differentiation 23(4): 616-627

Huang, D.Q.; Hoang, J.K.; Nguyen, M.H. 2021: HBV-related hepatocellular carcinoma: a call to improve surveillance and linkage to care. Liver International: Official Journal of the International Association for the Study of the Liver 41(9): 2238-2239

Zhao, L.; Jin, Y.; Yang, C.; Li, C. 2020: HBV-specific CD8 T cells present higher TNF-α expression but lower cytotoxicity in hepatocellular carcinoma. Clinical and Experimental Immunology 201(3): 289-296

Chen, F.; Zhang, J.; Wen, B.; Luo, S.; Lin, Y.; Ou, W.; Guo, F.; Tang, P.; Liu, W.; Qu, X. 2016: HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection. Scientific Reports 6: 39409

Cheng, Z.; Lin, P.; Cheng, N. 2021: HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Frontiers in Medicine 8: 713981

Farag, M.M.S.; Suef, R.A.; Al-Toukhy, G.M.; Selim, M.A.; Elbahnasawy, M.A.; El Sharkawy, N.; Ezzat, S.; Shebl, N.; Mansour, M.T.M. 2020: HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production. Infection and Drug Resistance 13: 2699-2709

Klein, A.; Guhl, E.; Tzeng, Y-Jeh.; Fuhrhop, J.; Levrero, M.; Graessmann, M.; Graessmann, A. 2003: HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Oncogene 22(19): 2910-2919

Liu, X.; Li, H.; Che, N.; Zheng, Y.; Fan, W.; Li, M.; Li, X.; Xuan, Y. 2021: HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer. Experimental and Molecular Pathology 121: 104665

Terol, M.; Gazon, H.; Lemasson, I.; Duc-Dodon, M.; Barbeau, B.; Césaire, R.; Mesnard, J-M.; Péloponèse, J-M. 2017: HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression. Leukemia 31(10): 2235-2243

Malagnino, V.; Cerva, C.; Cingolani, A.; Ceccherini-Silberstein, F.; Vergori, A.; Cuomo, G.; Perno, C.F.; Puoti, M.; d'Arminio Monforte, A.; Cozzi-Lepri, A.; Andreoni, M.; Sarmati, L.; d'Arminio Monforte, A.; Antinori, A.; Andreoni, M.; Castagna, A.; Castelli, F.; Cauda, R.; Di Perri, G.; Galli, M.; Iardino, R.; Ippolito, G.; Lazzarin, A.; Marchetti, G.C.; Rezza, G.; von Schloesser, F.; Viale, P.; d'Arminio Monforte, A.; Antinori, A.; Castagna, A.; Ceccherini-Silberstein, F.; Cozzi-Lepri, A.; Girardi, E.; Gori, A.; Lo Caputo, S.; Maggiolo, F.; Mussini, C.; Puoti, M.; Perno, C.F.; Antinori, A.; Bai, F.; Bandera, A.; Bonora, S.; Borderi, M.; Calcagno, A.; Capobianchi, M.R.; Castagna, A.; Ceccherini-Silberstein, F.; Cicalini, S. 2021: HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients. Open Forum Infectious Diseases 8(1): Ofaa 566

Malagnino, V.; Cerva, C.; Maffongelli, G.; Teti, E.; Foroghi Biland, L.; Cesta, N.; De Masi, M.; Stingone, C.; Armenia, D.; Svicher, V.; Salpini, R.; Andreoni, M.; Sarmati, L. 2019: HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy. Scientific Reports 9(1): 11942

Li, M.; Sun, X-Hua.; Zhu, X-Jun.; Jin, S-Gen.; Zeng, Z-Jun.; Zhou, Z-Hua.; Yu, Z.; Gao, Y-Qiu. 2012: HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Laboratory Investigation; a Journal of Technical Methods and Pathology 92(2): 295-304

Li, J.; Wu, W.; Peng, G.; Chen, F.; Bai, M.; Zheng, M.; Chen, Z. 2010: HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunology and Cell Biology 88(8): 834-841

Arase, Y. 2004: HBe antigen and HBe antibody. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 8): 124-128

Xie, X.; Lv, H.; Liu, C.; Su, X.; Yu, Z.; Song, S.; Bian, H.; Tian, M.; Qin, C.; Qi, J.; Zhu, Q. 2021: HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. Bmc Medicine 19(1): 247

Samal, J.; Kandpal, M.; Vivekanandan, P. 2017: HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene. Scientific Reports 7(1): 14371

Kostaridou, S.; Ladis, V.; Kattamis, A.; Laras, A.; Hadziyannis, S.J. 1998: HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD. Bone Marrow Transplantation 22(9): 919-921

Maggiore, Q.; Bartolomeo, F.; L'Abbate, A.; Misefari, V. 1981: HBsAg glomerular deposits in glomerulonephritis: fact or artifact?. Kidney International 19(4): 579-586

Wiwanitkit, V. 2010: HBsAg seroclearance and mortality. American Journal of Gastroenterology 105(9): 2113; Author Reply 2113-4

Yang, S.; Liu, Y.; Feng, X.; Wang, X.; Wu, M.; Gong, L.; Shu, B.; Lu, Q.; Dong, J. 2021: HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 53(3): 360-366

Liu, G.-Z.; Xu, X.-W.; Tao, S.-H.; Gao, M.-J.; Hou, Z.-H. 2021: HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression. Journal of Biomedical Science 28(1): 67

Kim, C.M.; Koike, K.; Saito, I.; Miyamura, T.; Jay, G. 1991: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351(6324): 317-320

Ochi, M.; Otsuka, M.; Maruyama, R.; Koike, K. 2020: HBx increases EGFR expression by inhibiting miR129-5p function. Biochemical and Biophysical Research Communications 529(2): 198-203

Liu, L-P.; Hu, B-G.; Ye, C.; Ho, R.L.K.; Chen, G.G.; Lai, P.B.S. 2014: HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma. British Journal of Cancer 110(4): 1066-1073

Tian, Y.; Xiao, X.; Gong, X.; Peng, F.; Xu, Y.; Jiang, Y.; Gong, G. 2017: HBx promotes cell proliferation by disturbing the cross-talk between miR-181a and PTEN. Scientific Reports 7: 40089

Wang, J.; Li, N.; Huang, Z-Bing.; Fu, S.; Yu, S-Man.; Fu, Y-Ming.; Zhou, P-Cheng.; Chen, R-Chan.; Zhou, R-Rong.; Huang, Y.; Hu, X-Wang.; Fan, X-Gong. 2019: HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma. Oncogene 38(40): 6696-6710

Yuan, H.; Zhao, L.; Yuan, Y.; Yun, H.; Zheng, W.; Geng, Y.; Yang, G.; Wang, Y.; Zhao, M.; Zhang, X. 2021: HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver. Theranostics 11(17): 8362-8378

Duan, L.; Wu, R.; Zhang, X.; Wang, D.; You, Y.; Zhang, Y.; Zhou, L.; Chen, W. 2018: HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells. Cell Death and Disease 9(6): 629

Qiu, X.; Dong, S.; Qiao, F.; Lu, S.; Song, Y.; Lao, Y.; Li, Y.; Zeng, T.; Hu, J.; Zhang, L.; Zhang, L.; Fan, H. 2013: HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 32(27): 3296-3305

Zhang, F.; Li, Y.; Gan, L.; Tong, X.; Qi, D.; Wang, Q.; Ye, X. 2021: HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(5): e21529

Hu, J-Jiao.; Song, W.; Zhang, S-Dan.; Shen, X-Hui.; Qiu, X-Mei.; Wu, H-Zhang.; Gong, P-Hai.; Lu, S.; Zhao, Z-Jiang.; He, M-Liang.; Fan, H. 2016: HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Scientific Reports 6: 23521

Huang, P.; Xu, Q.; Yan, Y.; Lu, Y.; Hu, Z.; Ou, B.; Zhang, H.; Mao, K.; Zhang, J.; Wang, J.; Xiao, Z. 2020: HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene 39(18): 3774-3789

Lin, Y.; Liu, Y.; Xu, D.; Guo, F.; Zhang, W.; Zhang, Y.; Bai, G. 2021: HBxAg promotes HBV replication and EGFR activation in human placental trophoblasts. Experimental and Therapeutic Medicine 22(5): 1211

Zhao, Y.; Li, M.; Yao, X.; Fei, Y.; Lin, Z.; Li, Z.; Cai, K.; Zhao, Y.; Luo, Z. 2020: HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and its Therapeutic Implications. Cell Reports 33(10): 108487

Kapolka, N.J.; Isom, D.G. 2020: HCAR3: an underexplored metabolite sensor. Nature Reviews. Drug Discovery 19(11): 745

Yan, D.; Wang, S.; Temkin-Greener, H.; Cai, S. 2022: HCBS Service Spending and Nursing Home Placement for Patients with Alzheimer's Disease and Related Dementias: Does Race Matter?. Journal of Applied Gerontology: the Official Journal of the Southern Gerontological Society 41(3): 638-649

Kim, N.; Cheng, J.C.H.; Ohri, N.; Huang, W.Y.; Kimura, T.; Zeng, Z.C.; Lee, V.H.F.; Kay, C.S.; Seong, J. 2021: HCC Etiology-Dependent Tumor Control Probability Model After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study. International Journal of Radiation Oncology Biology Physics 111(3s): E554

Sokolich, J.; Buggs, J.; LaVere, M.; Robichaux, K.; Rogers, E.; Nyce, S.; Kumar, A.; Bowers, V. 2020: HCC Liver Transplantation Wait List Dropout Rates Before and After the Mandated 6-Month Wait time. American Surgeon 86(11): 1592-1595

Sartoris, R.; Gregory, J.; Dioguardi Burgio, M.; Ronot, M.; Vilgrain, V.ér. 2021: HCC advances in diagnosis and prognosis: Digital and Imaging. Liver International: Official Journal of the International Association for the Study of the Liver 41(Suppl 1): 73-77

Ozgor, D.; Otan, E. 2020: HCC and Tumor Biomarkers: Does one Size Fits All?. Journal of Gastrointestinal Cancer 51(4): 1122-1126

Zhu, A.X.; Duda, D.G.; Sahani, D.V.; Jain, R.K. 2011: HCC and angiogenesis: possible targets and future directions. Nature Reviews. Clinical Oncology 8(5): 292-301

Shiha, G.; Soliman, R.; Mikhail, N.; Zaky, S. 2021: HCC developed in CHC patients who achieved SVR following DAAs tend to display less aggressive pattern. Clinics and Research in Hepatology and Gastroenterology 45(3): 101608

Pascut, D.; Pratama, M.Y.; Tiribelli, C. 2020: HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance. Hepatic Oncology 7(2): Hep21

Wu, S.; Zeng, N.; Sun, F.; Zhou, J.; Wu, X.; Sun, Y.; Wang, B.; Zhan, S.; Kong, Y.; Jia, J.; You, H.; Yang, H.-I. 2021: Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: a Systematic Review of 14 Models and External Validation. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 19(12): 2499-2513

Costentin, C.E.; Nahon, P. 2021: HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?. Jhep Reports: Innovation in Hepatology 3(4): 100320

Yip, T.C.-F.; Wong, G.L.-H. 2020: HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: not perfect, not good enough. Journal of Gastroenterology and Hepatology 35(10): 1661-1662

Wörns, M-Alexander.; Galle, P.Robert. 2014: HCC therapies--lessons learned. Nature Reviews. Gastroenterology and Hepatology 11(7): 447-452

Kawagishi, N. 2020: HCC with portal vein tumor thrombosis: how to manage?. Hepatology International 14(5): 609-611

Attallah, A.M.; Omran, M.M.; Attallah, A.A.; Abdallah, S.O.; Farid, K.; Darwish, H.; El-Dosoky, I.; Shaker, Y.M. 2013: HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. British Journal of Cancer 109(6): 1657-1665

Omar, M.; Farid, K.; Emran, T.; El-Taweel, F.; Tabll, A.; Omran, M. 2020: HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma. British Journal of Biomedical Science 2020: 1-6

Chen, L.; Guo, P.; He, Y.; Chen, Z.; Chen, L.; Luo, Y.; Qi, L.; Liu, Y.; Wu, Q.; Cui, Y.; Fang, F.; Zhang, X.; Song, T.; Guo, H. 2018: HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death and Disease 9(5): 513

He, B.; Qiu, X.; Li, P.; Wang, L.; Lv, Q.; Shi, T. 2010: HCCNet: an integrated network database of hepatocellular carcinoma. Cell Research 20(6): 732-734

Gan, Y.; Zhao, X.; Hu, J.; Wang, Z.G.; Zhao, X.T. 2008: HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS1 disruption in mice causes placental abnormality. Cell Death and Differentiation 15(9): 1481-1490

Chen, Z.-M.; Jin, X.; Zhao, B.-R.; Zhang, X.; Guo, Y. 2021: HCE: Hierarchical Context Embedding for Region-Based Object Detection. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 6917-6929

Tachibana, A.; Hamajima, R.; Tomizaki, M.; Kondo, T.; Nanba, Y.; Kobayashi, M.; Yamada, H.; Ikeda, M. 2017: HCF-1 encoded by baculovirus AcMNPV is required for productive nucleopolyhedrovirus infection of non-permissive Tn368 cells. Scientific Reports 7(1): 3807

Xiang, P.; Li, F.; Ma, Z.; Yue, J.; Lu, C.; You, Y.; Hou, L.; Yin, B.; Qiang, B.; Shu, P.; Peng, X. 2020: HCF-1 promotes cell cycle progression by regulating the expression of CDC42. Cell Death and Disease 11(10): 907

Tokarski, C. 1990: HCFA's new area wage index to create big payment swings. Modern Healthcare 20(18): 4

Sharpe, R.M.; Fraser, H.M. 1980: HCG stimulation of testicular LHRH-like activity. Nature 287(5783): 642-643

Andrabi, S.W.; Saini, P.; Joshi, M.; Mehta, P.; Makker, G.C.; Mishra, G.; Rajender, S. 2022: HCG therapy in azoospermic men with lower or borderline testosterone levels and the prognostic value of Y-deletion analysis in its outcome. Andrologia 54(1): E14251

Frowein, J.; Engel, W.; Weise, H.C. 1973: HCG-receptor present in the gonadotrophin insensitive Leydig cell of the immature rat. Nature: new Biology 246(153): 148-150

Long, R.; Liu, Z.; Li, J.; Zhang, Y.; Yu, H. 2021: HCG11 up-regulation induced by ELK4 suppressed proliferation in vestibular schwannoma by targeting miR-620/ELK4. Cancer Cell International 21(1): 5

Li, W.; Pan, T.; Jiang, W.; Zhao, H. 2020: HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma. Biomedicine and PharmacoTherapy 129: 110217

Peach, R.L.; Arnaudon, A.; Schmidt, J.A.; Palasciano, H.A.; Bernier, N.R.; Jelfs, K.E.; Yaliraki, S.N.; Barahona, M. 2021: HCGA: Highly comparative graph analysis for network phenotyping. Patterns 2(4): 100227

Gambino, O.; Rundo, L.; Pirrone, R.; Vitabile, S. 2020: HCi for biomedical decision-making: from diagnosis to therapy. Journal of Biomedical Informatics 111: 103593

Mlaga, K.D.; Mathieu, A.; Beauparlant, C.J.; Ott, A.; Khodr, A.; Perin, O.; Droit, A. 2021: HCK and ABAA: a Newly Designed Pipeline to Improve Fungi Metabarcoding Analysis. Frontiers in Microbiology 12: 640693

Zhu, X.; Zhang, Y.; Bai, Y.; Gu, X.; Chen, G.; Sun, L.; Wang, Y.; Qiao, X.; Ma, Q.; Zhu, T.; Bu, J.; Xue, J.; Liu, C. 2020: HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients. International Journal of Medical Sciences 17(17): 2773-2789

Li, Z.; Wang, F.; Tian, X.; Long, J.; Ling, B.; Zhang, W.; Xu, J.; Liang, A. 2021: HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 210

Collis, S.J.; Barber, L.J.; Clark, A.J.; Martin, J.S.; Ward, J.D.; Boulton, S.J. 2007: HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nature Cell Biology 9(4): 391-401

Wu, H.; Wang, X.; Chu, M.; Li, D.; Cheng, L.; Zhou, K. 2021: HCMB: a stable and efficient algorithm for processing the normalization of highly sparse Hi-C contact data. Computational and Structural Biotechnology Journal 19: 2637-2645

Hsu, C-Hung.; Chang, M.D.T.; Tai, K-Yu.; Yang, Y-Ting.; Wang, P-Shan.; Chen, C-Ju.; Wang, Y-Hsiung.; Lee, S-Chung.; Wu, C-Wen.; Juan, L-Jung. 2004: HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO Journal 23(11): 2269-2280

Park, A.; Ra, E.A.; Lee, T.A.; Choi, H.Jin.; Lee, E.; Kang, S.; Seo, J-Young.; Lee, S.; Park, B. 2019: HCMV-encoded US7 and US8 act as antagonists of innate immunity by distinctively targeting TLR-signaling pathways. Nature Communications 10(1): 4670

Liang, Q.; Wang, K.; Wang, B.; Cai, Q. 2017: HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3. Scientific Reports 7: 44705

Fulkerson, H.L.; Chesnokova, L.S.; Kim, J.H.; Mahmud, J.; Frazier, L.E.; Chan, G.C.; Yurochko, A.D. 2020: HCMV-induced signaling through gB-EGFR engagement is required for viral trafficking and nuclear translocation in primary human monocytes. Proceedings of the National Academy of Sciences of the United States of America 117(32): 19507-19516

Johard, H.; Omelyanenko, A.; Fei, G.; Zilberter, M.; Dave, Z.; Abu-Youssef, R.; Schmidt, L.éa.; Harisankar, A.; Vincent, C.T.; Walfridsson, J.; Nelander, S.; Harkany, T.; Blomgren, K.; Andäng, M. 2020: HCN Channel Activity Balances Quiescence and Proliferation in Neural Stem Cells and Is a Selective Target for Neuroprotection During Cancer Treatment. Molecular Cancer Research: Mcr 18(10): 1522-1533

Ferris, J.P.; Ishikawa, Y.; Ferris, J.P. 1987: HCN and chromophore formation on Jupiter. Nature 326: 777-778

Chan, C.Savio.; Glajch, K.E.; Gertler, T.S.; Guzman, J.N.; Mercer, J.N.; Lewis, A.S.; Goldberg, A.B.; Tkatch, T.; Shigemoto, R.; Fleming, S.M.; Chetkovich, D.M.; Osten, P.; Kita, H.; Surmeier, D.James. 2011: HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. Nature Neuroscience 14(1): 85-92

Omrani, A.; van der Vaart, T.; Mientjes, E.; van Woerden, G.M.; Hojjati, M.R.; Li, K.W.; Gutmann, D.H.; Levelt, C.N.; Smit, A.B.; Silva, A.J.; Kushner, S.A.; Elgersma, Y. 2015: HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Molecular Psychiatry 20(11): 1311-1321

George, M.S.; Abbott, L.F.; Siegelbaum, S.A. 2009: HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K(+) channels. Nature Neuroscience 12(5): 577-584

de Kok, R.J.; Teanby, N.A.; Maltagliati, L.; Irwin, P.G.J.; Vinatier, S. 2014: HCN ice in Titan's high-altitude southern polar cloud. Nature 514(7520): 65-67

He, Y.; Ma, Y.; Tong, Y.; Yu, X.; Tittel, F.K. 2018: HCN ppt-level detection based on a QEPAS sensor with amplified laser and a miniaturized 3D-printed photoacoustic detection channel. Optics Express 26(8): 9666-9675

Han, Y.; Heuermann, R.J.; Lyman, K.A.; Fisher, D.; Ismail, Q-A.; Chetkovich, D.M. 2017: HCN-channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects. Molecular Psychiatry 22(3): 458-465

Huang, Z.; Li, G.; Aguado, C.; Lujan, R.; Shah, M.M. 2017: HCN1 channels reduce the rate of exocytosis from a subset of cortical synaptic terminals. Scientific Reports 7: 40257

Pai, V.P.; Cervera, J.; Mafe, S.; Willocq, V.; Lederer, E.K.; Levin, M. 2020: HCN2 Channel-Induced Rescue of Brain Teratogenesis via Local and Long-Range Bioelectric Repair. Frontiers in Cellular Neuroscience 14: 136

Pai, V.P.; Pietak, A.; Willocq, V.; Ye, B.; Shi, N-Qing.; Levin, M. 2018: HCN2 Rescues brain defects by enforcing endogenous voltage pre-patterns. Nature Communications 9(1): 998

Hernandez, A.; Hernández-Centeno, R.; Espino-Saldaña, Án.E.; Martínez-Torres, A.úl. 2020: HCN2 activation modulation: An electrophysiological and molecular study of the well-preserved LCi sequence in the pore channel. Archives of Biochemistry and Biophysics 689: 108436

Herrmann, S.; Stieber, J.; Stöckl, G.; Hofmann, F.; Ludwig, A. 2007: HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice. EMBO Journal 26(21): 4423-4432

Chen, X.; Millet, D.B.; Neuman, J.A.; Veres, P.R.; Ray, E.A.; Commane, R.ói.ín.; Daube, B.C.; McKain, K.; Schwarz, J.P.; Katich, J.M.; Froyd, K.D.; Schill, G.P.; Kim, M.J.; Crounse, J.D.; Allen, H.M.; Apel, E.C.; Hornbrook, R.S.; Blake, D.R.; Nault, B.A.; Campuzano-Jost, P.; Jimenez, J.L.; Dibb, J.E. 2021: HCOOH in the remote atmosphere: Constraints from Atmospheric Tomography (ATom) airborne observations. Acs Earth and Space Chemistry 5(6): 1436-1454

Cady-Pereira, K.E.; Chaliyakunnel, S.; Shephard, M.W.; Millet, D.B.; Luo, M.; Wells, K.C. 2014: HCOOH measurements from space: TES retrieval algorithm and observed global distribution. Atmospheric Measurement Techniques 7(7): 2297-2311

Liu, Y.; Jing, X.-B.; Wang, Z.-C.; Han, Q.-K. 2021: HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression. Human Genomics 15(1): 38

Zeng, S.; Ou, H.; Gao, Z.; Zhang, J.; Li, C.; Liu, Q.; Ding, D. 2021: HCPT-peptide prodrug with tumor microenvironment -responsive morphology transformable characteristic for boosted bladder tumor chemotherapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 330: 715-725

Mahendran, A.J.; Gupta, N.; Ish, P. 2020: HCQ induced QT prolongation- Primum non nocere. Indian Pacing and Electrophysiology Journal 20(5): 206-207

Jha, S.; Batra, N.; Siddiqui, S.; Yadav, A.; Misra, A.; Loomba, M.; Sethi, S.; Waghdhare, S. 2021: HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers. Indian Heart Journal 73(1): 74-76

Onuora, S. 2020: HCQ use not protective against SARS-CoV-2. Nature Reviews. Rheumatology 16(12): 666

Chen, F.; Zhang, L.; Wu, J.; Huo, F.; Ren, X.; Zheng, J.; Pei, D. 2018: HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer. Cell Death and Disease 9(12): 1176

Chen, F.; Deng, J.; Liu, X.; Li, W.; Zheng, J. 2015: HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma. Scientific Reports 5: 13470

Morris, E.C. 2020: HCT for CGD? Yes, and the sooner the better. Blood 136(10): 1121-1123

Jadoul, M.; Labriola, L.; Gordon, C.E. 2021: HCV can and Should be Eliminated from Dialysis Units. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 78(4): 487-488

Song, X.; Gao, X.; Wang, Y.; Raja, R.; Zhang, Y.; Yang, S.; Li, M.; Yao, Z.; Wei, L. 2021: HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages. Frontiers in Immunology 12: 654998

Brochado-Kith, Ós.; Martínez, I.; Berenguer, J.; González-García, J.; Salgüero, S.; Sepúlveda-Crespo, D.; Díez, C.; Hontañón, V.íc.; Ibañez-Samaniego, L.; Pérez-Latorre, L.; Fernández-Rodríguez, A.; Ángeles Jiménez-Sousa, M.ía.; Resino, S. 2021: HCV Cure with Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients. Frontiers in Immunology 12: 723196

Cassel, K.; Carlson, G. 2020: HCV Elimination in a Health Network Serving Indigenous Communities in Northern California. Clinical Liver Disease 16(1): 2-4

Caballero-Marcos, A.án.; Romero-Cristóbal, M.; Puerto, M.; Fernández-Yunquera, A.; Dieguez, L.; Navarrete, C.; Clemente, A.; Diaz-Fontenla, F.; Catalán, P.; Rincón, D.; López-Baena, J.é-Án.; Bañares Cañizares, R.; Salcedo, M. 2021: HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation. Transplant International: Official Journal of the European Society for Organ Transplantation 34(11): 2214-2225

Lee, M-Hsuan.; Hsiao, T.I.; Subramaniam, S.R.; Le, A.K.; Vu, V.D.; Trinh, H.N.; Zhang, J.; Jin, M.; Wong, V.Wai-Sun.; Wong, G.Lai-Hung.; Nguyen, M.H. 2017: HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis. American Journal of Gastroenterology 112(7): 1111-1119

Bulut, M.E.; Topalca, U.S.; Murat, A.; Teke, L.; Canalp, H.Z.; Ocal, M.; Bayraktar, B. 2021: HCV Genotype Distribution of Patients with Chronic Hepatitis C in Istanbul. Sisli Etfal Hastanesi Tip Bulteni 55(1): 86-92

Sakata, K.; Hara, M.; Terada, T.; Watanabe, N.; Takaya, D.; Yaguchi, S-ichi.; Matsumoto, T.; Matsuura, T.; Shirouzu, M.; Yokoyama, S.; Yamaguchi, T.; Miyazawa, K.; Aizaki, H.; Suzuki, T.; Wakita, T.; Imoto, M.; Kojima, S. 2013: HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor. Scientific Reports 3: 3243

Lan, K-Hsin.; Sheu, M-Ling.; Hwang, S-Jang.; Yen, S-Hue.; Chen, S-Yi.; Wu, J-Ching.; Wang, Y-Jan.; Kato, N.; Omata, M.; Chang, F-Young.; Lee, S-Dong. 2002: HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21(31): 4801-4811

Paraskevis, D.; Stylianou, D.C.; Hezka, J.; Stern, Z.; Oikonomopoulou, M.; Mamais, I.; Kostrikis, L.G.; Georgiou, C.; Savvopoulou, N.; Veresies, K.L.; Pavlou, T.; Argyriou, A.; Zarouna, E. 2019: HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection. Scientific Reports 9(1): 10077

Zhang, Y.; El-Far, M.; Dupuy, F.P.; Abdel-Hakeem, M.S.; He, Z.; Procopio, F.Andrea.; Shi, Y.; Haddad, E.K.; Ancuta, P.; Sekaly, R-Pierre.; Said, E.A. 2016: HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses. Scientific Reports 6: 29447

Xu, D-zhen.; Li, Z-qin.; Xie, Y. 2004: HCV RNA in PBMC as predictor of the response to antiviral therapy in chronic hepatitis C. Zhonghua Gan Zang Bing Za Zhi 12(2): 76-78

Lin, S.-H.; Wu, K.-T.; Wang, C.-C.; Huang, K.-T.; Chen, K.-D.; Lin, C.-C.; Hsu, L.-W.; Chiu, K.-W. 2021: HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation. Journal of International Medical Research 49(8): 3000605211034945

Cobb, B.; Pockros, P.J.; Vilchez, R.A.; Vierling, J.M. 2013: HCV RNA viral load assessments in the era of direct-acting antivirals. American Journal of Gastroenterology 108(4): 471-475

Feng, J.Y.; Ray, A.S. 2021: HCV RdRp, sofosbuvir and beyond. Enzymes 49: 63-82

Altshuler, P.J.; Helmers, M.; Iyengar, A.; Han, J.; Atluri, P. 2020: HCV Seropositive Donors Positively Impact Heart Transplantation Rates and Waitlist Mortality without Compromising Outcomes. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 39(4s): S118-S119

Abd Alla, M.Darwish.Ahmed.; Elibiary, S.Ahmed.; Elshaboury, R.Hassan.; Wu, G.Y.; Dawood, R.M.; El Awady, M.Kamel. 2018: HCV Therapy Follow-up Fractionation (CTF2) by Intra-PBMC Nested RNA PCR Recognizes Early Virologic Response and Relapse. Journal of Clinical and Translational Hepatology 6(2): 147-154

Bunchorntavakul, C.; Reddy, R.K. 2018: HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary. American Journal of Gastroenterology 113(4): 449-452

Locker, N.; Easton, L.E.; Lukavsky, P.J. 2007: HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly. EMBO Journal 26(3): 795-805

Elhendawy, M.; Abo-Ali, L.; Abd-Elsalam, S.; Hagras, M.M.; Kabbash, I.; Mansour, L.; Atia, S.; Esmat, G.; Abo-ElAzm, A.-R.; El-Kalla, F.; Kobtan, A. 2020: HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection. Environmental Science and Pollution Research International 27(27): 33659-33667

Thinh, V.T.; Li, L.; Matthieu, D.éa.; Hoa, V.D.; Anh, N.H.; Giang, L.M. 2020: HCV and HIV co-infection among people who inject drugs in Vietnam. Journal of Health and Social Sciences 5(4): 573-586

Chen, J.Y.; Feeney, E.R.; Chung, R.T. 2014: HCV and HIV co-infection: mechanisms and management. Nature Reviews. Gastroenterology and Hepatology 11(6): 362-371

Capobianchi, M.R.; Abbate, I.; Cappiello, G.; Solmone, M. 2003: HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle. Cell Death and Differentiation 10 Suppl. 1: S22-S24

Biliotti, E.; Palazzo, D.; Tinti, F.; D'Alessandro, M.D.; Esvan, R.; Labriola, R.; Cappoli, A.; Umbro, I.; Volpicelli, L.; Bachetoni, A.; Villa, E.; Mitterhofer, A.P.; Rucci, P.; Taliani, G. 2021: HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearance. Liver International: Official Journal of the International Association for the Study of the Liver 41(1): 158-167

Pramukti, I.; Liu, H.-Y.; Chen, C.-C.; Chen, Y.-C.; Yeh, C.-Y.; Fetzer, S.; Ibrahim, K.; Tai, T.-W.; Ko, W.-C.; Ko, N.-Y. 2020: HCV co-infection among people living with HIV Is associated with Higher fracture risk. Journal of Infection and Public Health 13(11): 1724-1728

Gesinde, M.O.; Love, E.M.; Lee, D. 1992: HCV confirmatory testing of blood donors. Lancet 339(8798): 928-929

Boudart, D.; Lucas, J.C.; Adjou, C.; Muller, J.Y. 1992: HCV confirmatory testing of blood donors. Lancet 339(8798): 929

Crawford, R.J.; Frame, W.D.; Mitchell, R. 1992: HCV confirmatory testing of blood donors. Lancet 339(8798): 928

Wang, Y.; Jie, W.; Ling, J.; Yuanshuai, H. 2021: HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. Journal of clinical laboratory analysis 35(6): e23755

Zhang, Q.; Wang, Y.; Zhai, N.; Song, H.; Li, H.; Yang, Y.; Li, T.; Guo, X.; Chi, B.; Niu, J.; Crispe, I.Nicholas.; Su, L.; Tu, Z. 2016: HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway. Scientific Reports 6: 36160

Shin, J.Yeop.; Hur, W.; Wang, J.Sang.; Jang, J.Won.; Kim, C.Wook.; Bae, S.Hyun.; Jang, S.Key.; Yang, S-Hwan.; Sung, Y.Chul.; Kwon, O-Joo.; Yoon, S.Kew. 2005: HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Experimental and Molecular Medicine 37(2): 138-145

Chang, M-Ling.; Yeh, H-Chung.; Tsou, Y-Kuan.; Wang, C-Jan.; Cheng, H-Yang.; Sung, C-Mu.; Ho, Y-Pin.; Chen, T-Hsing.; Yeh, C-Ting. 2012: HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration. Obesity 20(7): 1474-1480

Granato, M.; Zompetta, C.; Vescarelli, E.; Rizzello, C.; Cardi, A.; Valia, S.; Antonelli, G.; Marchese, C.; Torrisi, M.R.; Faggioni, A.; Cirone, M. 2016: HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2. Scientific Reports 6: 30649

Nasrullah, M.; Sergeenko, D.; Gamkrelidze, A.; Averhoff, F. 2017: HCV elimination - lessons learned from a small Eurasian country, Georgia. Nature Reviews. Gastroenterology and Hepatology 14(8): 447-448

Bruchfeld, A. 2020: HCV eradication in chronic kidney disease: ready for prime time?. LANCET. Gastroenterology and Hepatology 5(10): 880-882

Ifeachor, A.P.; Houck, K.K.; Schulte, S.; Ansara, E.; Johnson, A.J.; Carr, T.A.; Liangpunsakul, S. 2020: HCV eradication in veterans with underlying mental health disorders and substance use. Journal of the American Pharmacists Association: Japha 60(6): 1037-1043.E3

Brochado, Ós.; Martínez, I.; Berenguer, J.; Medrano, L.; González-García, J.; Jiménez-Sousa, M.ía.Án.; Carrero, A.; Hontañón, V.íc.; Navarro, J.; Guardiola, J.M.; Fernández-Rodríguez, A.; Resino, S.; Carrero, A.; Miralles, P.; López, J.C.; Parras, F.; Padilla, B.; Aldamiz-Echevarría, T.; Tejerina, F.; Díez, C.; Pérez-Latorre, L.; Fanciulli, C.; Gutiérrez, I.; Ramírez, M.; Carretero, S.; Bellón, J.M.; Bermejo, J.; Berenguer, J.; Hontañón, V.; Arribas, J.R.; Montes, M.L.; Bernardino, I.; Pascual, J.F.; Zamora, F.; Peña, J.M.; Arnalich, F.; Díaz, M.; González-García, J.; Domingo, P.; Guardiola, J.M.; Van den Eynde, E.; Pérez, M.; Ribera, E.; Crespo, M.; Casado, J.L.; Dronda, F.; Moreno, A.; Pérez-Elías, M.J.; Sanfru 2021: HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients. Journal of Biomedical Science 28(1): 23

Muir, A.J. 2005: HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?. Nature Clinical Practice. Gastroenterology and Hepatology 2(12): 568-569

Keikha, M.; Eslami, M.; Yousefi, B.; Ali-Hassanzadeh, M.; Kamali, A.; Yousefi, M.; Karbalaei, M. 2020: HCV genotypes and their determinative role in hepatitis C treatment. Virusdisease 31(3): 235-240

Li, H.; Li, T.; Crispe, I.Nicholas.; Tu, Z. 2018: HCV immune evasion and regulatory T cell activation: cause or consequence?. Cellular and Molecular Immunology 15(5): 536-538

Willberg, C.; Barnes, E.; Klenerman, P. 2003: HCV immunology--death and the maiden T cell. Cell Death and Differentiation 10 Suppl. 1: S39-S47

Rehermann, B. 2016: HCV in 2015: Advances in hepatitis C research and treatment. Nature Reviews. Gastroenterology and Hepatology 13(2): 70-72

Borsetto, D.; Fussey, J.; Fabris, L.; Bandolin, L.; Gaudioso, P.; Phillips, V.; Polesel, J.; Boscolo-Rizzo, P. 2020: HCV infection and the risk of head and neck cancer: a meta-analysis. Oral Oncology 109: 104869

James, V. 1994: HCV infection in blood donors. British Journal of Hospital Medicine 52(10): 541

Giuliani, R.; Casigliani, V.; Fornili, M.; Sebastiani, T.; Freo, E.; Arzilli, G.; Scardina, G.; Baglietto, L.; Tavoschi, L.; Ranieri, R. 2020: HCV micro-elimination in two prisons in Milan, Italy: a model of care. Journal of Viral Hepatitis 27(12): 1444-1454

Guerra Veloz, M.ía.F.; Del Pino Bellido, P.; Cordero Ruiz, P.; Vega Rodriguez, F.; Bellido Muñoz, F.; Ramirez de Arellano, E.ón.; Caunedo Álvarez, A.; Pascual Hernandez, A.; Carmona Soria, I. 2021: HCV microelimination strategies: An interventional study in diagnosed patients without access to the system. Liver International: Official Journal of the International Association for the Study of the Liver 41(5): 928-933

Filskov, J.; Andersen, P.; Agger, E.Marie.; Bukh, J. 2019: HCV p7 as a novel vaccine-target inducing multifunctional CD4 + and CD8 + T-cells targeting liver cells expressing the viral antigen. Scientific Reports 9(1): 14085

Adu, P.A.; Rossi, C.; Binka, M.; Wong, S.; Wilton, J.; Wong, J.; Butt, Z.A.; Bartlett, S.; Jeong, D.; Pearce, M.; Darvishian, M.; Yu, A.; Alvarez, M.; Velásquez García, H.éc.A.; Krajden, M.; Janjua, N.Z. 2021: HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men. Liver International: Official Journal of the International Association for the Study of the Liver 41(3): 482-493

Parczewski, M.ło.; Janczewska, E.; Pisula, A.; Dybowska, D.; Łojewski, W.ła.ła.; Witor, A.; Wawrzynowicz-Syczewska, M.; Socha, Łu.; Krygier, R.ł; Knysz, B.; Musialik, J.; Urbańska, A.; Scheibe, K.; Jaroszewicz, J. 2021: HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from Poland. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 93: 104949

Ryan, P.; Valencia, J.; Cuevas, G.; Troya, J.ús.; Ramon, C.; Rodríguez, A.; Torres-Macho, J.; Muñoz-Gómez, M.ía.J.é; Canorea, I.; Vázquez-Morón, S.; Resino, S. 2021: HCV screening based on dried blood samples and linkage to care in people who use drugs: a prospective study. International Journal on Drug Policy 92: 103134

Parigi, T.L.; Aghemo, A. 2020: HCV screening: Moving from theory to practice. Liver International: Official Journal of the International Association for the Study of the Liver 40(7): 1538-1540

Fiore, V.; De Matteis, G.; Ranieri, R.; Saderi, L.; Pontali, E.; Muredda, A.; Ialungo, A.M.; Caruso, R.; Madeddu, G.; Sotgiu, G.; Babudieri, S. 2021: HCV testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C. International Journal on Drug Policy 90: 103055

Colombo, M.; Boccaccio, V. 2018: HCV therapy and risk of liver cancer recurrence: who to treat?. Nature Reviews. Gastroenterology and Hepatology 15(7): 392-393

Thursz, M.; Fontanet, A. 2014: HCV transmission in industrialized countries and resource-constrained areas. Nature Reviews. Gastroenterology and Hepatology 11(1): 28-35

Meunier, L.; Pageaux, G.-P.; Coilly, A. 2020: HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant. Journal of Hepatology 73(4): 984-985

Fromentin, D. 2006: HCV vaccine : a new approach. Virologie 10(2): 149-150

Roger, S.; Ducancelle, A.; Le Guillou-Guillemette, H.él.èn.; Gaudy, C.; Lunel, F.ço. 2021: HCV virology and diagnosis. Clinics and Research in Hepatology and Gastroenterology 45(3): 101626

De Re, V.; Sansonno, D.; Simula, M.P.; Caggiari, L.; Gasparotto, D.; Fabris, M.; Tucci, F.A.; Racanelli, V.; Talamini, R.; Campagnolo, M.; Geremia, S.; Dammacco, F.; De Vita, S. 2006: HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20(6): 1145-1154

Moiseev, S.; Novikov, P.; Mukhin, N. 2017: HCV-associated cryoglobulinemia vasculitis: are its days numbered?. Annals of the Rheumatic Diseases 76(3): E5

Wang, L.; Cao, D.; Wang, L.; Zhao, J.; Nguyen, L.Nhat.; Dang, X.; Ji, Y.; Wu, X.Y.; Morrison, Z.D.; Xie, Q.; El Gazzar, M.; Ning, S.; Moorman, J.P.; Yao, Z.Q. 2018: HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function. Cell Discovery 4: 51

Dickson, I. 2019: HCV-infected lungs and hearts can be safely transplanted into non-infected individuals. Nature Reviews. Gastroenterology and Hepatology 16(6): 326

Ackermann, C.; Smits, M.; Woost, R.; Eberhard, J.M.; Peine, S.; Kummer, S.; Marget, M.; Kuntzen, T.; Kwok, W.W.; Lohse, A.W.; Jacobs, T.; Boettler, T.; Schulze Zur Wiesch, J. 2019: HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules. Scientific Reports 9(1): 10624

Malik, A.A.; Phanus-Umporn, C.; Schaduangrat, N.; Shoombuatong, W.; Isarankura-Na-Ayudhya, C.; Nantasenamat, C. 2020: HCVpred: a web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. Journal of Computational Chemistry 41(20): 1820-1834

Wang, C.; Shou, H.; Chen, S.; Wei, S.; Lin, Y.; Zhang, P.; Liu, Z.; Zhu, K.; Guo, X.; Wu, X.; Ajayan, P.M.; Song, L. 2021: HCl-Based Hydrothermal Etching Strategy toward Fluoride-Free MXenes. Advanced Materials 33(27): E2101015

Liu, Y.; Li, J.; Felker, P.M.; Bačić, Z. 2021: HCl-H2O dimer: an accurate full-dimensional potential energy surface and fully coupled quantum calculations of intra- and intermolecular vibrational states and frequency shifts. Physical Chemistry Chemical Physics: Pccp 23(12): 7101-7114

El-Shahat, R.A.; El-Demerdash, R.S.; El Sherbini, E.S.; Saad, E.A. 2021: HCl-induced acute lung injury: a study of the curative role of mesenchymal stem/stromal cells and cobalt protoporphyrin. Journal Genetic Engineering and Biotechnology 19(1): 41

Wu, M.; Wu, W.; Duan, Y.; Liu, X.; Wang, M.; Phan, C.U.; Qi, G.; Tang, G.; Liu, B. 2020: HClO-Activated Fluorescence and Photosensitization from an AIE Nanoprobe for Image-Guided Bacterial Ablation in Phagocytes. Advanced Materials 32(47): E2005222

Mudshinge, S.R.; Potnis, C.S.; Xu, B.; Hammond, G.B. 2020: HCl•DMPU-Assisted One-pot and Metal-free Conversion of Aldehydes to Nitriles. Green Chemistry: An International Journal and Green Chemistry Resource: Gc 22(13): 4161-4164

Steiner, S.; Sotzny, F.; Bauer, S.; Na, I.-K.; Schmueck-Henneresse, M.; Corman, V.M.; Schwarz, T.; Drosten, C.; Wendering, D.és.ée.J.; Behrends, U.; Volk, H.-D.; Scheibenbogen, C.; Hanitsch, L.G. 2020: HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients. Frontiers in Immunology 11: 607918

Niemczura, E.; Hümmerich, S.; Castelli, F.; Paunzen, E.; Bernhard, K.; Hambsch, F-Josef.; Hełminiak, K. 2017: HD 66051, an eclipsing binary hosting a highly peculiar, HgMn-related star. Scientific Reports 7(1): 5906

Furutani, K.; Tsumoto, K.; Kurachi, Y. 2017: HD Physiology Project-Japanese efforts to promote multilevel integrative systems biology and physiome research. Npj Systems Biology and Applications 3: 1

Mheich, A.; Dufor, O.; Yassine, S.; Kabbara, A.; Biraben, A.; Wendling, F.; Hassan, M. 2021: HD-EEG for tracking sub-second brain dynamics during cognitive tasks. Scientific Data 8(1): 32

Desrousseaux, B.; Konings, M.; Loreau, J.ér.ôm.; Lique, F.ço. 2021: HD-H+ collisions: statistical and quantum state-to-state studies. Physical Chemistry Chemical Physics: Pccp 23(35): 19202-19208

Sun, S.; Pandelia, M.-E. 2020: HD-[HD-GYP] Phosphodiesterases: Activities and Evolutionary Diversification within the HD-GYP Family. Biochemistry 59(25): 2340-2350

Johari, K.; Riccardi, N.; Malyutina, S.; Modi, M.; Desai, R.H. 2021: HD-tDCS over motor cortex facilitates figurative and literal action sentence processing. Neuropsychologia 159: 107955

Garcia, S.; Hampstead, B.M. 2020: HD-tDCS as a neurorehabilitation technique for a case of post-anoxic leukoencephalopathy. Neuropsychological Rehabilitation 2020: 1-21

Lin, J.; Hung, F.-Y.; Ye, C.; Hong, L.; Shih, Y.-H.; Wu, K.; Li, Q.Q. 2020: HDA6-dependent histone deacetylation regulates mRNA polyadenylation in Arabidopsis. Genome Research 30(10): 1407-1417

Stockhammer, P.; Okumus, Öz.; Hegedus, L.; Rittler, D.; Ploenes, T.; Herold, T.; Kalbourtzis, S.; Bankfalvi, A.; Sucker, A.; Kimmig, R.; Aigner, C.; Hegedus, B. 2021: HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line. Pathology Oncology Research: Por 27: 636088

Hegedűs, L.; Rittler, D.; Garay, T.ás.; Stockhammer, P.; Kovács, I.ó; Döme, B.áz.; Theurer, S.; Hager, T.; Herold, T.; Kalbourtzis, S.; Bankfalvi, A.; Schmid, K.W.; Führer, D.; Aigner, C.; Hegedűs, B.áz. 2020: HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line. Pathology Oncology Research: Por 26(4): 2523-2535

Gillette, T.G. 2021: HDAC Inhibition in the Heart: Erasing Hidden Fibrosis. Circulation 143(19): 1891-1893

He, Y.; Xu, L.; Feng, J.; Wu, K.; Zhao, Y.; Huang, H. 2020: HDAC Inhibitor LBH589 Suppresses the Proliferation but Enhances the Antileukemic Effect of Human γδT Cells. Molecular Therapy Oncolytics 18: 623-630

Voss, S.Randal.; Ponomareva, L.V.; Dwaraka, V.B.; Pardue, K.E.; Baddar, N.W.Al.Haj.; Rodgers, A.Katherine.; Woodcock, M.Ryan.; Qiu, Q.; Crowner, A.; Blichmann, D.; Khatri, S.; Thorson, J.S. 2019: HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration. Scientific Reports 9(1): 6751

Aarenstrup, L.; Flindt, E.Noerregaard.; Otkjaer, K.; Kirkegaard, M.; Andersen, J.Skorstensgaard.; Kristiansen, K. 2008: HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes. Journal of Investigative Dermatology 128(5): 1095-1106

Gong, P.; Li, K.; Li, Y.; Liu, D.; Zhao, L.; Jing, Y. 2018: HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue. Cell Death and Disease 9(6): 623

Brandão, F.; Esher, S.K.; Ost, K.S.; Pianalto, K.; Nichols, C.B.; Fernandes, L.; Bocca, Aélia.L.; Poças-Fonseca, M.José.; Alspaugh, J.Andrew. 2018: HDAC genes play distinct and redundant roles in Cryptococcus neoformans virulence. Scientific Reports 8(1): 5209

Song, W.; Tai, Y-T.; Tian, Z.; Hideshima, T.; Chauhan, D.; Nanjappa, P.; Exley, M.A.; Anderson, K.C.; Munshi, N.C. 2011: HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells. Leukemia 25(1): 161-168

Zhou, L.; Ruvolo, V.R.; McQueen, T.; Chen, W.; Samudio, I.J.; Conneely, O.; Konopleva, M.; Andreeff, M. 2013: HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML. Leukemia 27(6): 1358-1368

Ruscetti, M.; Dadashian, E.L.; Guo, W.; Quach, B.; Mulholland, D.J.; Park, J.W.; Tran, L.M.; Kobayashi, N.; Bianchi-Frias, D.; Xing, Y.; Nelson, P.S.; Wu, H. 2016: HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene 35(29): 3781-3795

Oliveira, T.; Hermann, E.; Lin, D.; Chowanadisai, W.; Hull, E.; Montgomery, M. 2021: HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells. Redox Biology 47: 102149

Villain, Hélène.; Florian, Cédrick.; Roullet, P. 2016: HDAC inhibition promotes both initial consolidation and reconsolidation of spatial memory in mice. Scientific Reports 6: 27015

Gaub, P.; Tedeschi, A.; Puttagunta, R.; Nguyen, T.; Schmandke, A.; Di Giovanni, S. 2010: HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death and Differentiation 17(9): 1392-1408

Yang, H.; Ni, W.; Wei, P.; Li, S.; Gao, X.; Su, J.; Jiang, H.; Lei, Y.; Zhou, L.; Gu, Y. 2021: HDAC inhibition reduces white matter injury after intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 41(5): 958-974

Slaughter, M.J.; Shanle, E.K.; Khan, A.; Chua, K.F.; Hong, T.; Boxer, L.D.; Allis, C.D.; Josefowicz, S.Z.; Garcia, B.A.; Rothbart, S.B.; Strahl, B.D.; Davis, I.J. 2021: HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies. Cell Reports 34(3): 108638

Bridle, B.W.; Chen, L.; Lemay, C.G.; Diallo, J-Simon.; Pol, J.; Nguyen, A.; Capretta, A.; He, R.; Bramson, J.L.; Bell, J.C.; Lichty, B.D.; Wan, Y. 2013: HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy. Molecular Therapy: the Journal of the American Society of Gene Therapy 21(4): 887-894

Lebrun, N.; Delépine, C.é; Selloum, M.; Meziane, H.; Nectoux, J.; Herault, Y.; Bienvenu, T. 2021: HDAC inhibitor ameliorates behavioral deficits in Mecp2308/y mouse model of Rett syndrome. Brain Research 1772: 147670

Frame, F.M.; Pellacani, D.; Collins, A.T.; Simms, M.S.; Mann, V.M.; Jones, G.D.D.; Meuth, M.; Bristow, R.G.; Maitland, N.J. 2013: HDAC inhibitor confers radiosensitivity to prostate stem-like cells. British Journal of Cancer 109(12): 3023-3033

Bhadra, U.; Mondal, T.; Bag, I.; Mukhopadhyay, D.; Das, P.; Parida, B.B.; Mainkar, P.S.; Reddy, C.Raji.; Bhadra, M.Pal. 2015: HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway. Scientific Reports 5: 14747

Kashio, T.; Shirakura, K.; Kinoshita, M.; Morita, M.; Ishiba, R.; Muraoka, K.; Kanbara, T.; Tanaka, M.; Funatsu, R.; Hino, N.; Koyama, S.; Suzuki, R.; Yoshioka, Y.; Aoshi, T.; Doi, T.; Okada, Y. 2021: HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells. Tissue Barriers 2021: 1911195

Adcock, I.M. 2007: HDAC inhibitors as anti-inflammatory agents. British Journal of Pharmacology 150(7): 829-831

Shimizu, R.; Kikuchi, J.; Wada, T.; Ozawa, K.; Kano, Y.; Furukawa, Y. 2010: HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia 24(10): 1760-1768

Singh, T.Ramsing.; Shankar, S.; Srivastava, R.K. 2005: HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. Oncogene 24(29): 4609-4623

Wightman, F.; Ellenberg, P.; Churchill, M.; Lewin, S.R. 2012: HDAC inhibitors in HIV. Immunology and Cell Biology 90(1): 47-54

Khan, O.; La Thangue, N.B. 2012: HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunology and Cell Biology 90(1): 85-94

Andrews, K.T.; Haque, A.; Jones, M.K. 2012: HDAC inhibitors in parasitic diseases. Immunology and Cell Biology 90(1): 66-77

Kim, Y.J.; Greer, C.B.; Cecchini, K.R.; Harris, L.N.; Tuck, D.P.; Kim, T.H. 2013: HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene 32(23): 2828-2835

Bolden, J.E.; Shi, W.; Jankowski, K.; Kan, C-Y.; Cluse, L.; Martin, B.P.; MacKenzie, K.L.; Smyth, G.K.; Johnstone, R.W. 2013: HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death and Disease 4: E519

Garber, K. 2007: HDAC inhibitors overcome first hurdle. Nature Biotechnology 25(1): 17-19

Friedrich, M.; Gerbeth, L.; Gerling, M.; Rosenthal, R.; Steiger, K.; Weidinger, C.; Keye, J.; Wu, H.; Schmidt, F.; Weichert, W.; Siegmund, B.; Glauben, R. 2019: HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation. Mucosal Immunology 12(3): 656-667

Ji, T.; Feng, W.; Zhang, X.; Zang, K.; Zhu, X.; Shang, F. 2020: HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis. Human Cell 33(4): 1006-1016

Krishnan, M.; Singh, A.B.; Smith, J.J.; Sharma, A.; Chen, X.; Eschrich, S.; Yeatman, T.J.; Beauchamp, R.D.; Dhawan, P. 2010: HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Oncogene 29(2): 305-312

Montalvo-Ortiz, J.L.; Keegan, J.; Gallardo, C.; Gerst, N.; Tetsuka, K.; Tucker, C.; Matsumoto, M.; Fang, D.; Csernansky, J.G.; Dong, H. 2014: HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 39(6): 1469-1478

Guha, M. 2015: HDAC inhibitors still need a home run, despite recent approval. Nature Reviews. Drug Discovery 14(4): 225-226

Hsieh, T-Hua.; Hsu, C-Yi.; Tsai, C-Fang.; Long, C-Yu.; Wu, C-Hu.; Wu, D-Chyang.; Lee, J-Nan.; Chang, W-Chun.; Tsai, E-Mei. 2015: HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells. Molecular Therapy: the Journal of the American Society of Gene Therapy 23(4): 656-666

Romero, D. 2019: HDAC inhibitors tested in phase III trial. Nature Reviews. Clinical Oncology 16(8): 465

Finzer, P.; Krueger, A.; Stöhr, M.; Brenner, D.; Soto, U.; Kuntzen, C.; Krammer, P.H.; Rösl, F. 2004: HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene 23(28): 4807-4817

Sandonà, M.; Consalvi, S.; Tucciarone, L.; De Bardi, M.; Scimeca, M.; Angelini, D.Francesca.; Buffa, V.; D'Amico, A.; Bertini, E.Silvio.; Cazzaniga, S.; Bettica, P.; Bouché, M.; Bongiovanni, A.; Puri, P.Lorenzo.; Saccone, V. 2020: HDAC inhibitors tune mi RNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells. Embo Reports 21(9): E50863

Sweet, M.J.; Shakespear, M.R.; Kamal, N.A.; Fairlie, D.P. 2012: HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation. Immunology and Cell Biology 90(1): 14-22

Xing, S.; Nie, F.; Xu, Q.; Deng, Y.; Li, W.; Yang, Z.; Zhao, X.; Zhu, P.; Wang, X.; Gao, Y.; He, Z. 2015: HDAC is essential for epigenetic regulation of Thy-1 gene expression during LPS/TLR4-mediated proliferation of lung fibroblasts. Laboratory Investigation; a Journal of Technical Methods and Pathology 95(10): 1105-1116

Metzger, J.M. 2002: HDAC lightens a heavy heart. Nature Medicine 8(10): 1078-1079

Ghazzaui, N.; Ferrad, Mélissa.; Issaoui, H.; Lecardeur, S.; Cook-Moreau, J.; Pollet, J.; Le Noir, S.; Denizot, Y. 2021: HDAC recruitment in the IgH locus 3' regulatory region is different between mature B-cells and mature B-cell lymphomas. Leukemia and Lymphoma 2021: 1-5

Liang, T.; Zhou, Y.; Elhassan, R.M.; Hou, X.; Yang, X.; Fang, H. 2020: HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in Hela Cells. Journal of Medicinal Chemistry 63(20): 12083-12099

Chen, Y.; Wang, H.; Yoon, S.Ok.; Xu, X.; Hottiger, M.O.; Svaren, J.; Nave, K.A.; Kim, H.A.; Olson, E.N.; Lu, Q.Richard. 2011: HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nature Neuroscience 14(4): 437-441

Aygün, O.; Mehta, S.; Grewal, S.I.S. 2013: HDAC-mediated suppression of histone turnover promotes epigenetic stability of heterochromatin. Nature Structural and Molecular Biology 20(5): 547-554

Mayr, C.; Kiesslich, T.; Erber, S.; Bekric, D.; Dobias, H.; Ritter, M.; Jäger, T.; Neumayer, B.; Winkelmann, P.; Klieser, E.; Neureiter, D. 2021: HDAC-targeting epigenetic drug screening for biliary tract cancer. AnnalsofHepato-Biliary-PancreaticSurgery 25(Suppl.1):S397

Cao, F.; Xiao, Z.; Chen, S.; Zhao, C.; Chen, D.; Haisma, H.J.; Dekker, F.J. 2021: HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway. Bioorganic Chemistry 117: 105396

Hu, C.; Peng, K.; Wu, Q.; Wang, Y.; Fan, X.; Zhang, D.-M.; Passerini, A.G.; Sun, C. 2021: HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the GATA6 promoter. Theranostics 11(11): 5605-5619

Ma, P.; Schultz, R.M. 2016: HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation. Cell Death and Differentiation 23(7): 1119-1127

Gonneaud, A.; Turgeon, N.; Jones, C.; Couture, C.; Lévesque, D.; Boisvert, Fçois-Michel.; Boudreau, Fçois.; Asselin, C. 2019: HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids. Scientific Reports 9(1): 5363

Göder, A.; Emmerich, C.; Nikolova, T.; Kiweler, N.; Schreiber, M.; Kühl, T.; Imhof, D.; Christmann, M.; Heinzel, T.; Schneider, Günter.; Krämer, O.H. 2018: HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130. Nature Communications 9(1): 764

Stojanovic, N.; Hassan, Z.; Wirth, M.; Wenzel, P.; Beyer, M.; Schäfer, C.; Brand, P.; Kroemer, A.; Stauber, R.H.; Schmid, R.M.; Arlt, A.; Sellmer, A.; Mahboobi, S.; Rad, R.; Reichert, M.; Saur, D.; Krämer, O.H.; Schneider, G. 2017: HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer. Oncogene 36(13): 1804-1815

Ye, F.; Chen, Y.; Hoang, T.; Montgomery, R.L.; Zhao, X-hui.; Bu, H.; Hu, T.; Taketo, M.M.; van Es, J.H.; Clevers, H.; Hsieh, J.; Bassel-Duby, R.; Olson, E.N.; Lu, Q.Richard. 2009: HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nature Neuroscience 12(7): 829-838

Huang, Y.; Chen, J.; Lu, C.; Han, J.; Wang, G.; Song, C.; Zhu, S.; Wang, C.; Li, G.; Kang, J.; Wang, J. 2014: HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation. Cell Death and Disease 5: E1491

Chen, J-Sheng.; Wang, H-Kuang.; Hsu, C-Yu.; Su, Y-Ting.; Chen, J-Shing.; Liang, C-Loong.; Hsieh, P.Ching-Ho.; Wu, C-Chun.; Kwan, A-Lie. 2021: HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis. Scientific Reports 11(1): 16354

Wu, C.-C.; Jin, L.-W.; Wang, I.-F.; Wei, W.-Y.; Ho, P.-C.; Liu, Y.-C.; Tsai, K.-J. 2020: HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies. Embo Molecular Medicine 12(6): E10622

Sanna, S.; Esposito, S.; Masala, A.; Sini, P.; Nieddu, G.; Galioto, M.; Fais, M.; Iaccarino, C.; Cestra, G.; Crosio, C. 2020: HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death and Disease 11(5): 369

Rossi, L.; Battistelli, C.; de Turris, V.; Noce, V.; Zwergel, C.; Valente, S.; Moioli, A.; Manzione, A.; Palladino, M.; Bordoni, V.; Domenici, A.; Menè, P.; Mai, A.; Tripodi, M.; Strippoli, R. 2018: HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. Scientific Reports 8(1): 8492

Pao, P-Chieh.; Patnaik, D.; Watson, L.Ashley.; Gao, F.; Pan, L.; Wang, J.; Adaikkan, C.; Penney, J.; Cam, H.P.; Huang, W-Chin.; Pantano, L.; Lee, A.; Nott, A.; Phan, T.X.; Gjoneska, E.; Elmsaouri, S.; Haggarty, S.J.; Tsai, L-Huei. 2020: HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease. Nature Communications 11(1): 2484

Kim, J.Young.; Shen, S.; Dietz, K.; He, Y.; Howell, O.; Reynolds, R.; Casaccia, P. 2010: HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nature Neuroscience 13(2): 180-189

Chen, J.; Peng, L.; Zhao, Z.; Yang, Q.; Yin, F.; Liu, M.; Luo, X.; He, C.; He, Y. 2021: HDAC1 potentiates CD4 + T cell activation by inhibiting miR-124 and promoting IRF1 in systemic lupus erythematosus. Cellular Immunology 362: 104284

Gao, Y.; Pan, L.; Zhao, L.; Dang, X. 2021: HDAC1 promotes artery injury through activation of VAV3 by binding to miR-182-5p in atherosclerotic mice model. Cellular Signalling 78: 109840

Ding, S.; Tang, Z.; Jiang, Y.; Luo, P.; Qing, B.; Wei, Y.; Zhang, S.; Tang, R. 2021: HDAC1 regulates the chemosensitivity of laryngeal carcinoma cells via modulation of interleukin-8 expression. European Journal of Pharmacology 896: 173923

Simboeck, E.; Di Croce, L. 2010: HDAC1, a novel marker for benign teratomas. EMBO Journal 29(23): 3893-3895

Tharkar-Promod, S.; Johnson, D.P.; Bennett, S.E.; Dennis, E.M.; Banowsky, B.G.; Jones, S.S.; Shearstone, J.R.; Quayle, S.N.; Min, C.; Jarpe, M.; Mosbruger, T.; Pomicter, A.D.; Miles, R.R.; Chen, W.Y.; Bhalla, K.N.; Zweidler-McKay, P.A.; Shrieve, D.C.; Deininger, M.W.; Chandrasekharan, M.B.; Bhaskara, S. 2018: HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia 32(1): 49-60

Leus, N.G.J.; van den Bosch, T.; van der Wouden, P.E.; Krist, K.; Ourailidou, M.E.; Eleftheriadis, N.; Kistemaker, L.E.M.; Bos, S.; Gjaltema, R.A.F.; Mekonnen, S.A.; Bischoff, R.; Gosens, R.; Haisma, H.J.; Dekker, F.J. 2017: HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Scientific Reports 7: 45047

Tang, C.; Hu, J. 2021: HDAC1-Mediated MicroRNA-124-5p Regulates NPY to Affect Learning and Memory Abilities in Rats with Depression. Nanoscale Research Letters 16(1): 28

Zhou, J.; Zhou, H.; Liu, C.; Huang, L.; Lu, D.; Gao, C. 2020: HDAC1-mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure. Journal of Cellular and Molecular Medicine 24(15): 8636-8649

Afaloniati, H.; Angelopoulou, K.; Giakoustidis, A.; Hardas, A.; Pseftogas, A.; Makedou, K.; Gargavanis, A.; Goulopoulos, T.; Iliadis, S.; Papadopoulos, V.; Papalois, A.; Mosialos, G.; Poutahidis, T.; Giakoustidis, D. 2020: HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice. Oncotargets and Therapy 13: 5575-5588

Li, Y.; Zhang, X.; Zhu, S.; Dejene, E.A.; Peng, W.; Sepulveda, A.; Seto, E. 2020: HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma. Cancer Research 80(16): 3265-3278

Dahiya, S.; Beier, U.H.; Wang, L.; Han, R.; Jiao, J.; Akimova, T.; Angelin, A.; Wallace, D.C.; Hancock, W.W. 2020: HDAC10 deletion promotes Foxp3 + T-regulatory cell function. Scientific Reports 10(1): 424

Liu, S.-S.; Wu, F.; Jin, Y.-M.; Chang, W.-Q.; Xu, T.-M. 2020: HDAC11: a rising star in epigenetics. Biomedicine and PharmacoTherapy 131: 110607

Ree, A.Hansen.; Folkvord, S.; Flatmark, K. 2008: HDAC2 deficiency and histone acetylation. Nature Genetics 40(7): 812

Li, J.; Jin, C.; Sun, L.; Wang, B.; Hua, P.; Zhang, Y. 2021: HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10. Clinical Epigenetics 13(1): 96

Hu, X.-T.; Xing, W.; Zhao, R.-S.; Tan, Y.; Wu, X.-F.; Ao, L.-Q.; Li, Z.; Yao, M.-W.; Yuan, M.; Guo, W.; Li, S.-Z.; Yu, J.; Ao, X.; Xu, X. 2020: HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 270

Wang, Z.; Zhou, N.; Wang, W.; Yu, Y.; Xia, L.; Li, N. 2021: HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis. Arthritis Research and Therapy 23(1): 78

Cooley, C.; Su, L. 2021: HDAC2 links ubiquitination to tumor suppression in synovial sarcoma. Molecular and Cellular Oncology 8(3): 1914291

Guan, J-Song.; Haggarty, S.J.; Giacometti, E.; Dannenberg, J-Hermen.; Joseph, N.; Gao, J.; Nieland, T.J.F.; Zhou, Y.; Wang, X.; Mazitschek, R.; Bradner, J.E.; DePinho, R.A.; Jaenisch, R.; Tsai, L-Huei. 2009: HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243): 55-60

Kurita, M.; Holloway, T.; García-Bea, A.; Kozlenkov, A.; Friedman, A.K.; Moreno, Jé.L.; Heshmati, M.; Golden, S.A.; Kennedy, P.J.; Takahashi, N.; Dietz, D.M.; Mocci, G.; Gabilondo, A.M.; Hanks, J.; Umali, A.; Callado, L.F.; Gallitano, A.L.; Neve, R.L.; Shen, L.; Buxbaum, J.D.; Han, M-Hu.; Nestler, E.J.; Meana, J.Javier.; Russo, S.J.; González-Maeso, J. 2012: HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nature Neuroscience 15(9): 1245-1254

Aufhauser, D.D.; Hernandez, P.; Concors, S.J.; O'Brien, C.; Wang, Z.; Murken, D.R.; Samanta, A.; Beier, U.H.; Krumeich, L.; Bhatti, T.R.; Wang, Y.; Ge, G.; Wang, L.; Cheraghlou, S.; Wagner, F.F.; Holson, E.B.; Kalin, J.H.; Cole, P.A.; Hancock, W.W.; Levine, M.H. 2021: HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injury. Scientific Reports 11(1): 9018

de la Fuente Revenga, M.; Ibi, D.; Saunders, J.M.; Cuddy, T.; Ijaz, M.K.; Toneatti, R.; Kurita, M.; Holloway, T.; Shen, L.; Seto, J.; Dozmorov, M.G.; González-Maeso, J. 2018: HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. Neuroscience 388: 102-117

Rahm, A.-K.; Wieder, T.; Gramlich, D.; Müller, M.E.; Wunsch, M.N.; El Tahry, F.A.; Heimberger, T.; Weis, T.; Most, P.; Katus, H.A.; Thomas, D.; Lugenbiel, P. 2021: HDAC2-dependent remodeling of KCa2.2 (KCNN2) and KCa2.3 (KCNN3) K+ channels in atrial fibrillation with concomitant heart failure. Life Sciences 266: 118892

Campbell, R.R.; Kramár, E.A.; Pham, L.; Beardwood, J.H.; Augustynski, A.S.; López, A.J.; Chitnis, O.S.; Delima, G.; Banihani, J.; Matheos, D.P.; Wood, M.A. 2021: HDAC3 Activity within the Nucleus Accumbens Regulates Cocaine-Induced Plasticity and Behavior in a Cell-Type-Specific Manner. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 41(13): 2814-2827

Nishimoto, K.; Niida, H.; Uchida, C.; Ohhata, T.; Kitagawa, K.; Motegi, A.; Suda, T.; Kitagawa, M. 2020: HDAC3 Is Required for XPC Recruitment and Nucleotide Excision Repair of DNA Damage Induced by UV Irradiation. Molecular Cancer Research: Mcr 18(9): 1367-1378

Ghiboub, M.; Zhao, J.; Li Yim, A.Y.F.; Schilderink, R.; Verseijden, C.; van Hamersveld, P.H.P.; Duarte, J.M.; Hakvoort, T.B.M.; Admiraal, I.; Harker, N.R.; Tough, D.F.; Henneman, P.; de Winther, M.P.J.; de Jonge, W.J. 2020: HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages. Frontiers in Immunology 11: 550769

Mehdipour, P.; Santoro, F.; Botrugno, O.A.; Romanenghi, M.; Pagliuca, C.; Matthews, G.M.; Johnstone, R.W.; Minucci, S. 2017: HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia. Leukemia 31(4): 995-997

Williams, G.M.; Paschalis, V.; Ortega, J.; Muskett, F.W.; Hodgkinson, J.T.; Li, G.-M.; Schwabe, J.W.R.; Lahue, R.S. 2020: HDAC3 deacetylates the DNA mismatch repair factor MutSβ to stimulate triplet repeat expansions. Proceedings of the National Academy of Sciences of the United States of America 117(38): 23597-23605

Li, J.; Hu, M.; Liu, N.; Li, H.; Yu, Z.; Yan, Q.; Zhou, M.; Wang, Y.; Song, Y.; Pan, G.; Liang, F.; Chen, R. 2020: HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 248

Szigety, K.M.; Liu, F.; Yuan, C.Y.; Moran, D.J.; Horrell, J.; Gochnauer, H.R.; Cohen, R.N.; Katz, J.P.; Kaestner, K.H.; Seykora, J.T.; Tobias, J.W.; Lazar, M.A.; Xu, M.; Millar, S.E. 2020: HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity. Genes and Development 34(13-14): 973-988

Chen, Z.; Pei, L.; Zhang, D.; Xu, F.; Zhou, E.; Chen, X. 2021: HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p. International Journal of Biochemistry and Cell Biology 135: 105967

Liao, Y.; Cheng, J.; Kong, X.; Li, S.; Li, X.; Zhang, M.; Zhang, H.; Yang, T.; Dong, Y.; Li, J.; Xu, Y.; Yuan, Z. 2020: HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway. Theranostics 10(21): 9644-9662

Kuboyama, T.; Wahane, S.; Huang, Y.; Zhou, X.; Wong, J.K.; Koemeter-Cox, A.; Martini, M.; Friedel, R.H.; Zou, H. 2017: HDAC3 inhibition ameliorates spinal cord injury by immunomodulation. Scientific Reports 7(1): 8641

Campo, M.; Heater, S.; Peterson, G.J.; Simmons, J.D.; Skerrett, S.J.; Mayanja-Kizza, H.; Stein, C.M.; Boom, W.H.; Hawn, T.R. 2021: HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection. Tuberculosis 127: 102062

Chen, L.; Shang, C.; Wang, B.; Wang, G.; Jin, Z.; Yao, F.; Yue, Z.; Bai, L.; Wang, R.; Zhao, S.; Liu, E.; Wang, W. 2021: HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis. Biochemical Pharmacology 192: 114716

Ferrari, A.; Longo, R.; Fiorino, E.; Silva, R.; Mitro, N.; Cermenati, G.; Gilardi, F.; Desvergne, Béatrice.; Andolfo, A.; Magagnotti, C.; Caruso, D.; Fabiani, E.De.; Hiebert, S.W.; Crestani, M. 2017: HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning. Nature Communications 8(1): 93

Wang, H.; Cai, H.; Wang, X.; Zhang, M.; Liu, B.; Chen, Z.; Yang, T.; Fang, J.; Zhang, Y.; Liu, W.; Han, J.; Guo, Q.; Zhang, H.; Wang, H.; Xia, G.; Wang, C. 2019: HDAC3 maintains oocyte meiosis arrest by repressing amphiregulin expression before the LH surge. Nature Communications 10(1): 5719

Wang, J.; Xu, X.; Li, P.; Zhang, B.; Zhang, J. 2021: HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis. Atherosclerosis 323: 1-12

Harada, T.; Ohguchi, H.; Grondin, Y.; Kikuchi, S.; Sagawa, M.; Tai, Y-T.; Mazitschek, R.; Hideshima, T.; Anderson, K.C. 2017: HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications. Leukemia 31(12): 2670-2677

López-Soto, A.; Folgueras, A.R.; Seto, E.; Gonzalez, S. 2009: HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene 28(25): 2370-2382

Muoio, D.M. 2017: HDAC3 sets the timer on muscle fuel switching. Nature Medicine 23(2): 148-150

Karagianni, P.; Wong, J. 2007: HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26(37): 5439-5449

Ghosh, T.K.; Aparicio-Sánchez, Jé.J.; Buxton, S.; Brook, J.David. 2019: HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1. Scientific Reports 9(1): 17992

Wei, Q.; Dong, Z. 2014: HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy. Kidney International 86(4): 666-668

Lee, B-Soon.; Kim, Y.Soo.; Kim, H-Jun.; Kim, D-Ho.; Won, H-Ryun.; Kim, Y-Sung.; Kim, C-Ho. 2018: HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells. Scientific Reports 8(1): 12520

Wei, W.; Chen, W.; He, N. 2021: HDAC4 induces the development of asthma by increasing Slug-upregulated CXCL12 expression through KLF5 deacetylation. Journal of Translational Medicine 19(1): 258

Huang, F.; Sun, J.; Chen, W.; He, X.; Zhu, Y.; Dong, H.; Wang, H.; Li, Z.; Zhang, L.; Khaled, S.; Marcucci, G.; Huang, J.; Li, L. 2020: HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML. Aging 12(17): 16759-16774

Pan, L.; Pan, H.; Jiang, H.; Du, J.; Wang, X.; Huang, B.; Lu, J. 2010: HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1. Cellular and Molecular Immunology 7(3): 221-226

Chauchereau, A.; Mathieu, M.; de Saintignon, J.; Ferreira, R.; Pritchard, L.L.; Mishal, Z.; Dejean, A.; Harel-Bellan, A. 2004: HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene 23(54): 8777-8784

Cheng, C.; Yang, J.; Li, S-Wei.; Huang, G.; Li, C.; Min, W-Ping.; Sang, Y. 2021: HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death and Disease 12(2): 137

Marroncelli, N.; Bianchi, M.; Bertin, M.; Consalvi, S.; Saccone, V.; De Bardi, M.; Puri, P.Lorenzo.; Palacios, D.; Adamo, S.; Moresi, V. 2018: HDAC4 regulates satellite cell proliferation and differentiation by targeting P21 and Sharp1 genes. Scientific Reports 8(1): 3448

Mottet, D.; Pirotte, S.; Lamour, V.; Hagedorn, M.; Javerzat, S.; Bikfalvi, A.; Bellahcène, A.; Verdin, E.; Castronovo, V. 2009: HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28(2): 243-256

Bai, L.; Kee, H.J.; Choi, S.Y.; Seok, Y.M.; Kim, G.R.; Kee, S.-J.; Kook, H.; Jeong, M.H. 2021: HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model. Biomedicine and PharmacoTherapy 134: 111162

Cho, Y.; Cavalli, V. 2012: HDAC5 is a novel injury-regulated tubulin deacetylase controlling axon regeneration. EMBO Journal 31(14): 3063-3078

Peixoto, P.; Castronovo, V.; Matheus, N.; Polese, C.; Peulen, O.; Gonzalez, A.; Boxus, M.; Verdin, E.; Thiry, M.; Dequiedt, F.; Mottet, D. 2012: HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death and Differentiation 19(7): 1239-1252

Li, B.; Zhang, L.; Zhu, L.; Cao, Y.; Dou, Z.; Yu, Q. 2021: HDAC5 promotes intestinal sepsis via the Ghrelin/E2F1/NF-κB axis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(7): e21368

Xue, Y.; Lian, W.; Zhi, J.; Yang, W.; Li, Q.; Guo, X.; Gao, J.; Qu, H.; Lin, W.; Li, Z.; Lai, L.; Wang, Q. 2019: HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer. British Journal of Cancer 121(12): 1039-1049

Maharaj, K.; Powers, J.J.; Mediavilla-Varela, M.; Achille, A.; Gamal, W.; Quayle, S.; Jones, S.S.; Sahakian, E.; Pinilla-Ibarz, J. 2020: HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. Frontiers in Immunology 11: 590072

Wang, Y.; Wang, K.; Fu, J. 2020: HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric Oxide Production in the Blood During Endotoxemia. Frontiers in Immunology 11: 1893

Wang, Y.; Wang, K.; Fu, J. 2020: HDAC6 Mediates Poly (I:C)-Induced TBK1 and Akt Phosphorylation in Macrophages. Frontiers in Immunology 11: 1776

Banik, D.; Noonepalle, S.; Hadley, M.; Palmer, E.; Gracia-Hernandez, M.; Zevallos-Delgado, C.; Manhas, N.; Simonyan, H.; Young, C.N.; Popratiloff, A.; Chiappinelli, K.B.; Fernandes, R.; Sotomayor, E.M.; Villagra, A. 2020: HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer. Cancer Research 80(17): 3649-3662

Zhan, Y.; Wang, H.; Zhang, L.; Pei, F.; Chen, Z. 2020: HDAC6 Regulates the Fusion of Autophagosome and Lysosome to Involve in Odontoblast Differentiation. Frontiers in Cell and Developmental Biology 8: 605609

Balmik, A.A.; Chidambaram, H.; Dangi, A.; Marelli, U.K.; Chinnathambi, S. 2020: HDAC6 ZnF UBP as the Modifier of Tau Structure and Function. Biochemistry 59(48): 4546-4562

Tsushima, H.; Emanuele, M.; Polenghi, A.; Esposito, A.; Vassalli, M.; Barberis, A.; Difato, F.; Chieregatti, E. 2015: HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity. Nature Communications 6: 7781

Lee, J-Yong.; Koga, H.; Kawaguchi, Y.; Tang, W.; Wong, E.; Gao, Y-Sheng.; Pandey, U.B.; Kaushik, S.; Tresse, E.; Lu, J.; Taylor, J.Paul.; Cuervo, A.Maria.; Yao, T-Pang. 2010: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO Journal 29(5): 969-980

Rosenjack, J.; Hodges, C.A.; Darrah, R.J.; Kelley, T.J. 2019: HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge. Scientific Reports 9(1): 10282

Ma, C.; Gao, J.; Liang, J.; Dai, W.; Wang, Z.; Xia, M.; Chen, T.; Huang, S.; Na, J.; Xu, L.; Feng, S.; Dai, K.; Liu, G. 2021: HDAC6 inactivates Runx2 promoter to block osteogenesis of bone marrow stromal cells in age-related bone loss of mice. Stem Cell Research and Therapy 12(1): 484

Leyk, J.; Daly, C.; Janssen-Bienhold, U.; Kennedy, Bán.N.; Richter-Landsberg, C. 2017: HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness. Cell Death and Disease 8(8): E3028

Fazal, R.; Boeynaems, S.; Swijsen, A.; De Decker, M.; Fumagalli, L.; Moisse, M.; Vanneste, J.; Guo, W.; Boon, R.; Vercruysse, T.; Eggermont, K.; Swinnen, B.; Beckers, J.; Pakravan, D.; Vandoorne, T.; Vanden Berghe, P.; Verfaillie, C.; Van Den Bosch, L.; Van Damme, P. 2021: HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO Journal 40(7): E106177

Guo, W.; Naujock, M.; Fumagalli, L.; Vandoorne, T.; Baatsen, P.; Boon, R.; Ordovás, L.; Patel, A.; Welters, M.; Vanwelden, T.; Geens, N.; Tricot, T.; Benoy, V.; Steyaert, J.; Lefebvre-Omar, C.; Boesmans, W.; Jarpe, M.; Sterneckert, J.; Wegner, F.; Petri, S.; Bohl, D.; Vanden Berghe, P.; Robberecht, W.; Van Damme, P.; Verfaillie, C.; Van Den Bosch, L. 2017: HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nature Communications 8(1): 861

Sun, S.; Zhang, Y.; Zheng, J.; Duan, B.; Cui, J.; Chen, Y.; Deng, W.; Ye, B.; Liu, L.; Chen, Y.; Du, J.; Gu, L. 2018: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation. Cell Death and Disease 9(9): 929

Karnam, K.; Sedmaki, K.; Sharma, P.; Routholla, G.; Goli, S.; Ghosh, B.; Venuganti, V.V.K.; Kulkarni, O.P. 2020: HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice. Biochimica et Biophysica Acta. Molecular Basis of Disease 1866(11): 165903

d'Ydewalle, C.; Krishnan, J.; Chiheb, D.M.; Van Damme, P.; Irobi, J.; Kozikowski, A.P.; Vanden Berghe, P.; Timmerman, V.; Robberecht, W.; Van Den Bosch, L. 2011: HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nature Medicine 17(8): 968-974

Alothaim, T.; Charbonneau, M.; Tang, X. 2021: HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation. Scientific Reports 11(1): 10956

Hubbert, C.; Guardiola, A.; Shao, R.; Kawaguchi, Y.; Ito, A.; Nixon, A.; Yoshida, M.; Wang, X-Fan.; Yao, T-Pang. 2002: HDAC6 is a microtubule-associated deacetylase. Nature 417(6887): 455-458

Xie, S.; Zhang, L.; Dong, D.; Ge, R.; He, Q.; Fan, C.; Xie, W.; Zhou, J.; Li, D.; Liu, M. 2020: HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21. Journal of Biological Chemistry 295(42): 14343-14351

Jia, Y.J.; Liu, Z.B.; Wang, W.G.; Sun, C.B.; Wei, P.; Yang, Y.L.; You, M.J.; Yu, B.H.; Li, X.Q.; Zhou, X.Y. 2018: HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma. Leukemia 32(3): 703-711

Zhang, T.; He, M.; Zhao, L.; Qin, S.; Zhu, Z.; Du, X.; Zhou, B.; Yang, Y.; Liu, X.; Xia, G.; Chen, T.; Wang, Y.; Zhang, H.; Wang, C. 2021: HDAC6 regulates primordial follicle activation through mTOR signaling pathway. Cell Death and Disease 12(6): 559

Pandey, U.Bhan.; Nie, Z.; Batlevi, Y.; McCray, B.A.; Ritson, G.P.; Nedelsky, N.B.; Schwartz, S.L.; DiProspero, N.A.; Knight, M.A.; Schuldiner, O.; Padmanabhan, R.; Hild, M.; Berry, D.L.; Garza, D.; Hubbert, C.C.; Yao, T-Pang.; Baehrecke, E.H.; Taylor, J.Paul. 2007: HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447(7146): 859-863

Shao, Y.; Zhu, F.; Zhu, S.; Bai, L. 2021: HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulation. International Journal of Biochemistry and Cell Biology 136: 106000

Boyault, C.; Sadoul, K.; Pabion, M.; Khochbin, S. 2007: HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 26(37): 5468-5476

Zheng, Y.; Yang, X.; Wang, C.; Zhang, S.; Wang, Z.; Li, M.; Wang, Y.; Wang, X.; Yang, X. 2020: HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway. Scientific Reports 10(1): 3576

Du, Y.; Yang, X.; Li, Z.; Le, W.; Hao, Y.; Song, Y.; Wang, F.; Guan, Y. 2021: HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy. Neurochemistry International 149: 105141

Liang, T.; Qi, C.; Lai, Y.; Xie, J.; Wang, H.; Zhang, L.; Lin, T.; Jv, M.; Li, J.; Wang, Y.; Zhang, Y.; Chen, Z.; Qiu, X.; Li, R.; Li, Z.; Ye, Z.; Liu, S.; Liang, X.; Shi, W.; Wang, W. 2020: HDAC6-mediated α-tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy. Journal of Cellular and Molecular Medicine 24(19): 11558-11572

Boyault, C.; Gilquin, B.; Zhang, Y.; Rybin, V.; Garman, E.; Meyer-Klaucke, W.; Matthias, P.; Müller, C.W.; Khochbin, S. 2006: HDAC6-p97/VCP controlled polyubiquitin chain turnover. EMBO Journal 25(14): 3357-3366

Yoo, J.; Jeon, Y.H.; Lee, D.H.; Kim, G.W.; Lee, S.W.; Kim, S.Y.; Park, J.; Kwon, S.H. 2021: HDAC6-selective inhibitors enhance anticancer effects of paclitaxel in ovarian cancer cells. Oncology Letters 21(3): 201

Zhou, W.; Yang, J.; Saren, G.; Zhao, H.; Cao, K.; Fu, S.; Pan, X.; Zhang, H.; Wang, A.; Chen, X. 2020: HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1α pathway in acute lung allograft rejection in mice. Theranostics 10(15): 6790-6805

Wang, N.; Chen, M.; Ni, Z.; Li, T.; Zeng, J.; Lu, G.; Wang, J.; Zhang, J.; Wu, S.; Shi, Y. 2021: HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24(1): 103-116

English, K.; Barton, M.C. 2021: HDAC6: a Key Link Between Mitochondria and Development of Peripheral Neuropathy. Frontiers in Molecular Neuroscience 14: 684714

Boucherat, O.; Chabot, S.; Paulin, R.; Trinh, I.; Bourgeois, A.; Potus, Fçois.; Lampron, M-Claude.; Lambert, C.; Breuils-Bonnet, S.; Nadeau, Vérie.; Paradis, Rée.; Goncharova, E.A.; Provencher, S.; Bonnet, Sébastien. 2017: HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension. Scientific Reports 7(1): 4546

Peixoto, P.; Blomme, A.; Costanza, B.; Ronca, R.; Rezzola, S.; Palacios, A.P.; Schoysman, L.; Boutry, S.; Goffart, N.; Peulen, O.; Maris, P.; Di Valentin, E.; Hennequière, V.; Bianchi, E.; Henry, A.; Meunier, P.; Rogister, B.; Muller, R.N.; Delvenne, P.; Bellahcène, A.; Castronovo, V.; Turtoi, A. 2016: HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. Oncogene 35(34): 4481-4494

Burgess, M.; Chen, U.C.E.; Mapp, S.; Blumenthal, A.; Mollee, P.; Gill, D.; Saunders, N.A. 2020: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients. Oncogene 39(35): 5756-5767

Li, Q-Guang.; Xiao, T.; Zhu, W.; Yu, Z-Zheng.; Huang, X-Pu.; Yi, H.; Lu, S-Shan.; Tang, Y-Yun.; Huang, W.; Xiao, Z-Qiang. 2020: HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis. Cell Death and Disease 11(5): 322

Caslini, C.; Hong, S.; Ban, Y.J.; Chen, X.S.; Ince, T.A. 2019: HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells. Oncogene 38(39): 6599-6614

Miano, J.M.; Berk, B.C. 2006: HDAC7 supports vascular integrity. Nature Medicine 12(9): 997-998

Kang, Y.; Nian, H.; Rajendran, P.; Kim, E.; Dashwood, W.M.; Pinto, J.T.; Boardman, L.A.; Thibodeau, S.N.; Limburg, P.J.; Löhr, C.V.; Bisson, W.H.; Williams, D.E.; Ho, E.; Dashwood, R.H. 2014: HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death and Disease 5: E1476

Chen, Y.; Pan, C.; Lu, Y.; Miao, Y.; Xiong, B. 2021: HDAC8 drives spindle organization during meiotic maturation of porcine oocytes. Cell proliferation 54(10): e13119

Deardorff, M.A.; Bando, M.; Nakato, R.; Watrin, E.; Itoh, T.; Minamino, M.; Saitoh, K.; Komata, M.; Katou, Y.; Clark, D.; Cole, K.E.; De Baere, E.; Decroos, C.; Di Donato, N.; Ernst, S.; Francey, L.J.; Gyftodimou, Y.; Hirashima, K.; Hullings, M.; Ishikawa, Y.; Jaulin, C.; Kaur, M.; Kiyono, T.; Lombardi, P.M.; Magnaghi-Jaulin, L.; Mortier, G.R.; Nozaki, N.; Petersen, M.B.; Seimiya, H.; Siu, V.M.; Suzuki, Y.; Takagaki, K.; Wilde, J.J.; Willems, P.J.; Prigent, C.; Gillessen-Kaesbach, G.; Christianson, D.W.; Kaiser, F.J.; Jacks 2012: HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 489(7415): 313-317

Wu, J.; Zhang, L.; Feng, Y.; Khadka, B.; Fang, Z.; Liu, J. 2021: HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8. Biological Chemistry 402(4): 461-468

An, P.; Chen, F.; Li, Z.; Ling, Y.; Peng, Y.; Zhang, H.; Li, J.; Chen, Z.; Wang, H. 2020: HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals. Oncogene 39(26): 4956-4969

Zhang, R.; Shen, M.; Wu, C.; Chen, Y.; Lu, J.; Li, J.; Zhao, L.; Meng, H.; Zhou, X.; Huang, G.; Zhao, X.; Liu, J. 2020: HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Cell Death and Disease 11(12): 1036

Spreafico, M.; Gruszka, A.M.; Valli, D.; Mazzola, M.; Deflorian, G.; Quintè, A.; Totaro, M.G.; Battaglia, C.; Alcalay, M.; Marozzi, A.; Pistocchi, A. 2020: HDAC8: a Promising Therapeutic Target for Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology 8: 844

Zhong, L.; Yan, J.; Li, H.; Meng, L. 2020: HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury via miR-20a-Dependent Downregulation of NeuroD1. Frontiers in Cellular Neuroscience 14: 544285

Malhotra, R.; Mauer, A.C.; Lino Cardenas, C.L.; Guo, X.; Yao, J.; Zhang, X.; Wunderer, F.; Smith, A.V.; Wong, Q.; Pechlivanis, S.; Hwang, S-Jen.; Wang, J.; Lu, L.; Nicholson, C.J.; Shelton, G.; Buswell, M.D.; Barnes, H.J.; Sigurslid, H.H.; Slocum, C.; Rourke, C.O'.; Rhee, D.K.; Bagchi, A.; Nigwekar, S.U.; Buys, E.S.; Campbell, C.Y.; Harris, T.; Budoff, M.; Criqui, M.H.; Rotter, J.I.; Johnson, A.D.; Song, C.; Franceschini, N.; Debette, S.; Hoffmann, U.; Kälsch, H.; Nöthen, M.M.; Sigurdsson, S.; Freedman, B.I.; Bowden, D.W.; Jöckel, K-Heinz 2019: HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nature Genetics 51(11): 1580-1587

Fernández-Ruiz, I. 2020: HDAC9 linked to aortic calcification. Nature Reviews. Cardiology 17(1): 6-7

Cilenšek, I.; Lapuh, V.; Globočnik Petrovič, M.; Petrovič, D. 2021: HDAC9 rs11984041 polymorphism is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes mellitus. Gene: 796-797: 145802

Das, S.; Natarajan, R. 2020: HDAC9: An Inflammatory Link in Atherosclerosis. Circulation Research 127(6): 824-826

Suliman, B.Ali.; Xu, D.; Williams, B.R.G. 2012: HDACi: molecular mechanisms and therapeutic implications in the innate immune system. Immunology and Cell Biology 90(1): 23-32

Fairlie, D.P.; Sweet, M.J. 2012: HDACs and their inhibitors in immunology: teaching anticancer drugs new tricks. Immunology and Cell Biology 90(1): 3-5

Fernández-Ruiz, I. 2020: HDACs as a therapeutic target in HFpEF. Nature Reviews. Cardiology 17(3): 132

Robert, T.; Vanoli, F.; Chiolo, I.; Shubassi, G.; Bernstein, K.A.; Rothstein, R.; Botrugno, O.A.; Parazzoli, D.; Oldani, A.; Minucci, S.; Foiani, M. 2011: HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 471(7336): 74-79

Gallinari, P.; Di Marco, S.; Jones, P.; Pallaoro, M.; Steinkühler, C. 2007: HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Research 17(3): 195-211

Hu, X.; Wang, L.; Cheng, S.; Li, Y. 2021: HDC-Net: a hierarchical dilation convolutional network for retinal vessel segmentation. Plos one 16(9): E0257013

Ostvar, N.; Eftekhari Moghadam, A.M. 2020: HDEC: a Heterogeneous Dynamic Ensemble Classifier for Binary Datasets. Computational Intelligence and Neuroscience 2020: 8826914

Guimarães, I.C.B. 2021: HDI, Technological and Human Resources for the Diagnosis and Treatment of Circulatory System Malformations in Brazil - Analysis of the Reality in Brazil. Arquivos Brasileiros de Cardiologia 117(1): 72-73

Salim, T.R.; Andrade, T.M.; Klein, C.H.; Oliveira, G.áu.M.M.d. 2021: HDI, Technological and Human Resources in the Diagnosis and Treatment of Malformations of the Circulatory System in Brazil. Arquivos Brasileiros de Cardiologia 117(1): 63-71

Ben-Aicha, S.; Casaní, L.; Muñoz-García, N.àl.; Joan-Babot, O.; Peña, E.; Aržanauskaitė, M.; Gutierrez, M.; Mendieta, G.; Padró, T.; Badimon, L.; Vilahur, G. 2020: HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model. Arteriosclerosis Thrombosis and Vascular Biology 40(10): 2481-2493

El Khoudary ( سمر رياض الخضري ), S.R.; Chen (陈曦润), X.; Nasr ( ألكسس نصر ), A.; Billheimer, J.; Brooks, M.M.; McConnell, D.; Orchard, T.J.; Crawford, S.L.; Matthews, K.A.; Rader, D.J. 2021: HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study. Arteriosclerosis Thrombosis and Vascular Biology 41(2): 951-961

Mancuso, E.; Mannino, G.C.; Fuoco, A.; Leo, A.; Citraro, R.; Averta, C.; Spiga, R.; Russo, E.; De Sarro, G.; Andreozzi, F.; Sesti, G. 2020: HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion. Arteriosclerosis Thrombosis and Vascular Biology 40(12): 2941-2952

Zanotti, I.; Potì, F.; Cuchel, M. 2022: HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1867(1): 159065

Park, H.Suk.; Kim, C.Joon.; Hwang, B-Hee.; Kim, T-Hoon.; Koh, Y.Seok.; Park, H-Jun.; Her, S-Ho.; Jang, S.Won.; Park, C-Soo.; Lee, J.Min.; Kim, H-Yeol.; Jeon, D.Soo.; Kim, P-Joon.; Yoo, K-Dong.; Chang, K.; Jin, D.Chan.; Seung, K-Bae. 2016: HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI. Scientific Reports 6: 35774

Krishnan, S.; Shimoda, M.; Sacchi, R.; Kailemia, M.J.; Luxardi, G.; Kaysen, G.A.; Parikh, A.N.; Ngassam, V.N.; Johansen, K.; Chertow, G.M.; Grimes, B.; Smilowitz, J.T.; Maverakis, E.; Lebrilla, C.B.; Zivkovic, A.M. 2017: HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. Scientific Reports 7: 43728

Di Bartolo, B.A.; Cartland, S.ân.P.; Genner, S.; Manuneedhi Cholan, P.; Vellozzi, M.; Rye, K.-A.; Kavurma, M.M. 2021: HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis. Journal of Diabetes Research 2021: 6668506

Vaziri, N.D. 2016: HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nature Reviews. Nephrology 12(1): 37-47

Kontush, A. 2020: HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease. Trends in Molecular Medicine 26(12): 1086-1100

Rosenson, R.S.; Brewer, H.Bryan.; Barter, P.J.; Björkegren, J.L.M.; Chapman, M.John.; Gaudet, D.; Kim, D.Seung.; Niesor, E.; Rye, K-Anne.; Sacks, F.M.; Tardif, J-Claude.; Hegele, R.A. 2018: HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nature Reviews. Cardiology 15(1): 9-19

Navab, M.; Reddy, S.T.; Van Lenten, B.J.; Fogelman, A.M. 2011: HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nature Reviews. Cardiology 8(4): 222-232

Yu, B-lian.; Wang, S-hui.; Peng, D-quan.; Zhao, S-ping. 2010: HDL and immunomodulation: an emerging role of HDL against atherosclerosis. Immunology and Cell Biology 88(3): 285-290

Linsel-Nitschke, P.; Tall, A.R. 2005: HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nature Reviews. Drug Discovery 4(3): 193-205

Yahya, R.; Jainandunsing, S.; Rashid, M.; van der Zee, L.; Touw, A.; de Rooij, F.W.M.; Sijbrands, E.J.G.; Verhoeven, A.J.M.; Mulder, M.T. 2021: HDL associates with insulin resistance and beta-cell dysfunction in South Asian families at risk of type 2 diabetes. Journal of Diabetes and its Complications 35(10): 107993

Sulliman, N.Cassam.; Ghaddar, B.; Gence, L.; Patche, J.; Rastegar, S.; Meilhac, O.; Diotel, N. 2021: HDL biodistribution and brain receptors in zebrafish, using HDLs as vectors for targeting endothelial cells and neural progenitors. Scientific Reports 11(1): 6439

Kjeldsen, E.W.; Thomassen, J.Q.; Frikke-Schmidt, R. 2022: HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease - Insights from randomized clinical trials and human genetics. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1867(1): 159063

Almeida, O.P.; Yeap, B.B.; Hankey, G.J.; Golledge, J.; Flicker, L. 2014: HDL cholesterol and the risk of depression over 5 years. Molecular Psychiatry 19(6): 637-638

Ferraz-Amaro, I.án.; Delgado-Frías, E.; Hernández-Hernández, V.; Sánchez-Pérez, H.; de Armas-Rillo, L.; Armas-González, E.ía.; Machado, J.é D.; Diaz-González, F. 2021: HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis. Arthritis Research and Therapy 23(1): 62

Hunjadi, M.; Lamina, C.; Kahler, P.; Bernscherer, T.; Viikari, J.; Lehtimäki, T.; Kähönen, M.; Hurme, M.; Juonala, M.; Taittonen, L.; Laitinen, T.; Jokinen, E.; Tossavainen, Päivi.; Hutri-Kähönen, N.; Raitakari, O.; Ritsch, A. 2020: HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study. Scientific Reports 10(1): 19223

Blanco-Rojo, R.; Perez-Martinez, P.; Lopez-Moreno, J.; Martinez-Botas, J.; Delgado-Lista, J.; van-Ommen, B.; Yubero-Serrano, E.; Camargo, A.; Ordovas, J.M.; Perez-Jimenez, F.; Gomez-Coronado, D.; Lopez-Miranda, J. 2017: HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial. Scientific Reports 7(1): 12499

Dergunova, L.V.; Nosova, E.V.; Dmitrieva, V.G.; Rozhkova, A.V.; Bazaeva, E.V.; Limborska, S.A.; Dergunov, A.D. 2020: HDL cholesterol is associated with PBMC expression of genes involved in HDL metabolism and atherogenesis. Journal of Medical Biochemistry 39(3): 372-383

Després, J-Pierre. 2013: HDL cholesterol studies--more of the same?. Nature Reviews. Cardiology 10(2): 70-72

Müller-Deile, J.; Schmitt, R. 2014: HDL in CKD: not protective any longer?. Kidney International 85(3): 712

Rohatgi, A.; Westerterp, M.; von Eckardstein, A.; Remaley, A.; Rye, K-Anne. 2021: HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research. Circulation 143(23): 2293-2309

Stock, J.K. 2020: HDL markers in cardiovascular risk prediction: Ethnicity matters. Atherosclerosis 311: 105-106

Vaziri, N.D.; Navab, M.; Fogelman, A.M. 2010: HDL metabolism and activity in chronic kidney disease. Nature Reviews. Nephrology 6(5): 287-296

Zhang, Y.; Zhu, C-Gang.; Xu, R-Xia.; Li, S.; Li, X-Lin.; Guo, Y-Lin.; Wu, N-Qiong.; Gao, Y.; Qing, P.; Cui, C-Jue.; Sun, J.; Li, J-Jun. 2016: HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort. Scientific Reports 6: 30741

Doğan, K.üb.; Şeneş, M.; Karaca, A.; Kayalp, D.; Kan, S.; Gülçelik, N.şe.E.öz.; Aral, Y.çın.; Yücel, D.ğa. 2021: HDL subgroups and their paraoxonase-1 activity in the obese, overweight and normal weight subjects. International Journal of Clinical Practice 75(12): E14969

Pietiläinen, K.H.; Söderlund, S.; Rissanen, A.; Nakanishi, S.; Jauhiainen, M.; Taskinen, M-Riitta.; Kaprio, J. 2009: HDL subspecies in young adult twins: heritability and impact of overweight. Obesity 17(6): 1208-1214

Zhang, M.; Charles, R.; Tong, H.; Zhang, L.; Patel, M.; Wang, F.; Rames, M.J.; Ren, A.; Rye, K-Anne.; Qiu, X.; Johns, D.G.; Charles, M.Arthur.; Ren, G. 2015: HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation. Scientific Reports 5: 8741

Ng, D.S.; Wong, N.C.W.; Hegele, R.A. 2013: HDL--is it too big to fail?. Nature Reviews. Endocrinology 9(5): 308-312

Cho, Y.K.; Jung, C.H. 2021: HDL-C and Cardiovascular Risk: you Don't Need to Worry about Extremely High HDL-C Levels. Journal of Lipid and Atherosclerosis 10(1): 57-61

Yang, Z.-M.; Wu, M.-Y.; Lu, J.-M.; Zhu, Y.; Li, D.; Yu, Z.-B.; Shen, P.; Tang, M.-L.; Jin, M.-J.; Lin, H.-B.; Shui, L.-M.; Chen, K.; Wang, J.-B. 2021: HDL-C, longitudinal change and risk of mortality in a Chinese cohort study. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 31(9): 2669-2677

Sun, L.; Guo, M.; Xu, C.; Qiao, X.; Hua, Y.; Tuerhongjiang, G.; Lou, B.; Li, R.; Bai, X.; Zhou, J.; Wu, Y.; She, J.; Yuan, Z. 2021: HDL-C/apoA-i Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome. Disease Markers 2021: 6689056

Fan, Y.; Chen, J.; Liu, D.; Li, W.; Wang, H.; Huang, Y.; Gao, C. 2020: HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro. International Journal of Biochemistry and Cell Biology 126: 105819

Blaho, V.A.; Galvani, S.; Engelbrecht, E.; Liu, C.; Swendeman, S.L.; Kono, M.; Proia, R.L.; Steinman, L.; Han, M.H.; Hla, T. 2015: HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 523(7560): 342-346

Kalantar-Zadeh, K.; Kopple, J.D.; Kamranpour, N.; Fogelman, A.M.; Navab, M. 2007: HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney International 72(9): 1149-1156

Ferretti, G.; Bacchetti, T.; Masciangelo, S.; Bicchiega, V. 2010: HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity 18(6): 1079-1084

Vickers, K.C.; Michell, D.L. 2021: HDL-small RNA Export, Transport, and Functional Delivery in Atherosclerosis. Current Atherosclerosis Reports 23(7): 38

Kingwell, B.A.; Chapman, M.John.; Kontush, A.; Miller, N.E. 2014: HDL-targeted therapies: progress, failures and future. Nature Reviews. Drug Discovery 13(6): 445-464

Tabet, F.; Vickers, K.C.; Cuesta Torres, L.F.; Wiese, C.B.; Shoucri, B.M.; Lambert, G.; Catherinet, C.; Prado-Lourenco, L.; Levin, M.G.; Thacker, S.; Sethupathy, P.; Barter, P.J.; Remaley, A.T.; Rye, K-Anne. 2014: HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nature Communications 5: 3292

Allard-Ratick, M.P.; Kindya, B.R.; Khambhati, J.; Engels, M.C.; Sandesara, P.B.; Rosenson, R.S.; Sperling, L.S. 2021: HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk. European Journal of Preventive Cardiology 28(2): 166–173

Muller, C.; Salvayre, R.; Nègre-Salvayre, A.; Vindis, C. 2011: HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death and Differentiation 18(5): 817-828

Lau, L.M.S.; Nugent, J.K.; Zhao, X.; Irwin, M.S. 2008: HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 27(7): 997-1003

Weber, H.Oliver.; Ludwig, R.L.; Morrison, D.; Kotlyarov, A.; Gaestel, M.; Vousden, K.H. 2005: HDM2 phosphorylation by MAPKAP kinase 2. Oncogene 24(12): 1965-1972

Han, X.; Garcia-Manero, G.; McDonnell, T.J.; Lozano, G.; Medeiros, L.Jeffrey.; Xiao, L.; Rosner, G.; Nguyen, M.; Fernandez, M.; Valentin-Vega, Y.A.; Barboza, J.; Jones, D.M.; Rassidakis, G.Z.; Kantarjian, H.M.; Bueso-Ramos, C.E. 2007: HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 20(1): 54-62

Liang, M.; Han, X.; Vadhan-Raj, S.; Nguyen, M.; Zhang, Y.H.; Fernandez, M.; Drakos, E.; Konoplev, S.N.; Yin, C.Cameron.; Miranda, R.N.; McDonnell, T.J.; Medeiros, L.Jeffrey.; Bueso-Ramos, C.E. 2010: HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 23(3): 381-391

Tritt, A.J.; Rübel, O.; Dichter, B.; Ly, R.; Kang, D.; Chang, E.F.; Frank, L.M.; Bouchard, K. 2019: HDMF: Hierarchical Data Modeling Framework for Modern Science Data Standards. Proceedings: . IEEE International Conference on Big Data. IEEE International Conference on Big Data 2019: 165-179

Seidel, S.; Kowalski, T.; Margold, M.; Baraniskin, A.; Schroers, R.; Martus, P.; Schlegel, U. 2020: HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series. Therapeutic Advances in Neurological Disorders 13: 1756286420951087

Qi, X.; Zhang, X.; Liu, X.; Tang, W.; Dai, J.; Chen, A.; Lin, Q.; Zhu, T.; Li, J. 2021: HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90. Toxicology and Applied Pharmacology 417: 115459

He, H.; Chen, D.; Cui, S.; Wu, G.; Piao, H.; Wang, X.; Ye, P.; Jin, S. 2020: HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma. Bmc Medical Genomics 13(1): 118

Kalathur, R.Kiran.Reddy.; Pedro Pinto, Jé.; Sahoo, B.; Chaurasia, G.; Futschik, M.E. 2017: HDNetDB: A Molecular Interaction Database for Network-Oriented Investigations into Huntington's Disease. Scientific Reports 7(1): 5216

Mahar, R.; Donabedian, P.L.; Merritt, M.E. 2020: HDO production from [ 2 H 7 ]glucose Quantitatively Identifies Warburg Metabolism. Scientific Reports 10(1): 8885

Yau, T-On.; Chan, C-Yiu.; Chan, K-Lung.; Lee, M-Fong.; Wong, C-Ming.; Fan, S-Tat.; Ng, I.Oi-Lin. 2005: HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene 24(9): 1607-1614

Wu, C-Hui.; Liao, Y-Jen.; Shiau, A-Cheng.; Lin, H-Yu.; Hsueh Liu, Y-Wan.; Hsu, S-Ming. 2015: HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator. Scientific Reports 5: 17863

Walter, F.; Fuchs, F.; Gerum, S.; Rottler, M.C.; Erdelkamp, R.; Neumann, J.; Nierer, L.; Guba, M.; De Toni, E.N.; Seidensticker, M.; Ricke, J.; Belka, C.; Corradini, S. 2021: HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: a Single-Center Experience. Frontiers in Oncology 11: 717792

Niu, Y.; Wu, J.; Liu, W.; Guo, W.; Lau, R.W.H. 2021: HDR-GAN: HDR Image Reconstruction from Multi-Exposed LDR Images with Large Motions. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 3885-3896

Imai, A.; Kohda, M.; Nakaya, A.; Sakata, Y.; Murayama, K.; Ohtake, A.; Lathrop, M.; Okazaki, Y.; Ott, J. 2016: HDR: a statistical two-step approach successfully identifies disease genes in autosomal recessive families. Journal of Human Genetics 61(11): 959-963

Rohr, M.; Schrader, A. 2021: HDRS - Hybrid Diffuse Reflectance Spectroscopy: Non-Erythemal in Vivo Driven SPF and UVA-PF Testing. Current Problems in Dermatology 55: 144-156

Coppola, N.; Alessio, L.; Onorato, L.; Sagnelli, C.; Sagnelli, E.; Pisaturo, M. 2019: HDV infection in immigrant populations. Journal of Medical Virology 91(12): 2049-2058

Binh, M.Thanh.; Hoan, N.Xuan.; Van Tong, H.; Giang, D.Phuong.; Sy, B.Tien.; Toan, N.Linh.; Song, L.Huu.; Bang, M.Hong.; Wedemeyer, H.; Meyer, C.G.; Kremsner, P.G.; Bock, C-Thomas.; Velavan, T.P. 2018: HDV infection rates in northern Vietnam. Scientific Reports 8(1): 8047

Wood, V.E.; Groves, K.; Cryar, A.; Quaglia, M.; Matejtschuk, P.; Dalby, P.A. 2020: HDX and in Silico Docking Reveal that Excipients Stabilize G-CSF via a Combination of Preferential Exclusion and Specific Hotspot Interactions. Molecular Pharmaceutics 17(12): 4637-4651

Zheng, J.; Chang, M.Ra.; Stites, R.E.; Wang, Y.; Bruning, J.B.; Pascal, B.D.; Novick, S.J.; Garcia-Ordonez, R.D.; Stayrook, K.R.; Chalmers, M.J.; Dodge, J.A.; Griffin, P.R. 2017: HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions. Nature Communications 8(1): 923

Zheng, J.; Wang, C.; Chang, M.Ra.; Devarkar, S.C.; Schweibenz, B.; Crynen, G.C.; Garcia-Ordonez, R.D.; Pascal, B.D.; Novick, S.J.; Patel, S.S.; Marcotrigiano, J.; Griffin, P.R. 2018: HDX-MS reveals dysregulated checkpoints that compromise discrimination against self RNA during RIG-I mediated autoimmunity. Nature Communications 9(1): 5366

Salmas, R.Ekhteiari.; Borysik, A.James. 2021: HDXmodeller: an online webserver for high-resolution HDX-MS with auto-validation. Communications Biology 4(1): 199

Moore, R.G.; Hill, E.K.; Horan, T.; Yano, N.; Kim, K.; MacLaughlan, S.; Lambert-Messerlian, G.; Tseng, Y.Don.; Padbury, J.F.; Miller, M.Craig.; Lange, T.S.; Singh, R.K. 2014: HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Scientific Reports 4: 3574

Mirmohseni Namini, N.; Abdollahi, A.; Movahedi, M.; Emami Razavi, A.; Saghiri, R. 2021: HE4, a new Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression. Iranian Journal of Pathology 16(3): 284-296

Lokich, E.; Singh, R.K.; Han, A.; Romano, N.; Yano, N.; Kim, K.; Moore, R.G. 2014: HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation. Scientific Reports 4: 5500

Salminen, L.; Gidwani, K.; Grènman, S.; Carpén, O.; Hietanen, S.; Pettersson, K.; Huhtinen, K.; Hynninen, J. 2020: HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma. Acta Oncologica 59(12): 1461-1468

Ørbo, A.; Arnes, M.; Lyså, L.Myreng.; Borgfeldt, C.; Straume, Børn. 2016: HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia. British Journal of Cancer 115(6): 725-730

Ørbo, A.; Arnes, M.; Lyså, L.Myreng.; Borgfeldt, C.; Straume, Børn. 2016: HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia. British Journal of Cancer 115(9): E15

Rius, M.; Fusté, P.; Ros, C.; Martínez-Zamora, Án.; deGuirior, C.; Gracia, M.; Mension, E.; Carmona, F. 2021: HE4 might be a more useful tumor biomarker to detect malignancy in patients with ovarian endometrioma when malignancy is suspected. Journal of International Medical Research 49(9): 3000605211047701

Guo, F.; Li, J.; Qi, Y.; Hou, J.; Chen, H.; Jiang, S.-W. 2020: HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation. Cancer Cell International 20: 163

Lore, J.M. 1964: Head and Neck Surgery. Surgery Gynecology and Obstetrics 118: 117-118

Ovbiagele, B. 2020: HEADS-UP: Understanding and Problem-Solving: Seeking Hands-Down Solutions to Major Inequities in Stroke. Stroke 51(11): 3375-3381

Vezhnovets, T.A.; Gurianov, V.G.; Prus, N.V.; Korotkyi, O.V.; Antonyuk, O.Y. 2021: Health Care Expenditures of 179 Countries with different Gni per Capita in 2018. Wiadomosci Lekarskie 74(3 Cz 2: 678-683

Linville, C.H. 1964: Health Care of the Aged. California Medicine 100: 217-219

Mytrofanov, I.І; Lysenko, I.V.; Riabushko, M.М; Hryn, V.H.; Riabushko, R.M.; Bilash, V.P. 2021: Health Disorder Assosiated with Permanent Disability as the Sign of Bodily Harm. Wiadomosci Lekarskie 74(6): 1396-1400

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(7): 621-624

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(8): 710-713

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(9): 803-805

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(10): 893-894

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(11): 984-988

Routzahn, E.G. 1923: Health Education and Publicity. American Journal of Public Health 13(12): 1068-1071

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(1): 89-90

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(2): 172-176

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(3): 275-277

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(4): 372-373

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(6): 554-557

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(7): 641-643

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(9): 811-812

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(10): 912-914

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(11): 1005-1006

Routzahn, E.G. 1924: Health Education and Publicity. American Journal of Public Health 14(12): 1091-1092

Crittenden, L.B.; Okazaki, W.; Reamer, R. 1963: Health Education in the Ussr. Who Chronicle 17: 299-305

Ellis, E.V. 1965: Health Education--Vital Cog in Public Health and Medicine. Pennsylvania Medical Journal 68: 54-55

Gruzieva, T.S.; Diachuk, M.аi.D.; Inshakova, H.V.; Soroka, I.M.; Dufynets, V.A. 2021: Health of the Elderly people as the Basis for Formation of Medical and Social Needs. Wiadomosci Lekarskie 74(3 Cz 2: 658-664

Tomczyk, K.; Dziubanek, G.; Kowalska, A.; Szymala, I.; Łabuz-Roszak, B. 2021: Health Risk Related to Exposure to Toxic Compounds Contained in Mineral and Spring Waters. Wiadomosci Lekarskie 74(7): 1587-1594

Machón, M.; Mateo-Abad, M.; Vrotsou, K.; Vergara, I. 2021: Health Status and Lifestyle Habits of Vulnerable, Community-Dwelling Older people during the Covid-19 Lockdown. Journal of Frailty and Aging 10(3): 286-289

Tucker-Retter, E.K.; Velsey-Gross, Z.ë; Deresienski, D.; Ulloa, C.; Muñoz-Pérez, J.-P.; Skehel, A.; Passingham, R.K.; Castaneda, J.; Lewbart, G.A.; Valle, C.A. 2021: Health Status of Nazca Boobies (Sula Granti) on Daphne Major Island in the Galápagos determined by Hematology, Biochemistry, and Physical Examination. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(2): 671-679

Luksamijarulkul, P.; Suknongbung, S.; Vatanasomboon, P.; Sujirarut, D. 2017: Health Status, Environmental Living Conditions and Microbial Indoor Air Quality Among Migrant Worker Households. Southeast Asian Journal of Tropical Medicine and Public Health 48(2): 396-406

Fauntroy, V.; Nolton, E.C.; Ambegaonkar, J.P. 2020: Health-Related Quality of Life (Hrqol) Measures Used in Dance: a Systematic Review. International Journal of Sports Physical Therapy 15(3): 333-342

Brener, A.; Segev-Becker, A.; Weintrob, N.; Stein, R.; Interator, H.; Schachter-Davidov, A.; Israeli, G.; Elkon-Tamir, E.; Lebenthal, Y.; Eyal, O.; Oren, A. 2019: Health-Related Quality of Life in Children and Adolescents with Nonclassic Congenital Adrenal Hyperplasia. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 25(8): 794-799

Sesar, I.; Pušić-Sesar, A.; Jurišić, D.; Sesar, A.; Merdžo, I.; Ćavar, I. 2020: Health-Related Quality of Life in Primary Open-Angle Glaucoma Patients. Acta Clinica Croatica 59(4): 623-631

Salmanov, A.G.; Suslikova, L.V.; Pandei, S.A.; Rud, V.O.; Kokhanov, I.V.; Butska, V.Y.; Tymchenko, A.G. 2021: Healthcare Associated Deep Pelvic Tissue Infection and other Infections of the Female Reproductive Tract in Ukraine. Wiadomosci Lekarskie 74(3 Cz 1: 406-412

Ivats-Chabina, A.R.; Korolchuk, O.L.; Kachur, A.Y.; Smiianov, V.A. 2021: Healthcare in Ukraine during the Epidemic: Difficulties, Challenges and Solutions. Wiadomosci Lekarskie 74(5): 1256-1261

Mozgovaya, E.I.; Vodolazova, Z.M.; Gorsky, A.A.; Volkova, O.A. 2021: Healthy Lifestyle of the Population in the Context of a Pandemic: Expert Opinions of Researchers and Emploees of Non-Profit Organizations. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 29(Special Issue): 763-767

Hirst, K.; Baranowski, T.; DeBar, L.; Foster, G.D.; Kaufman, F.; Kennel, P.; Linder, B.; Schneider, M.; Venditti, E.M.; Yin, Z.; Kaufman, F.R.; Baranowski, T.; Adams, L.; Baranowski, J.; Canada, A.; Cullen, K.W.; Dobbins, M.H.; Jago, R.; Oceguera, A.; Rodriguez, A.X.; Speich, C.; Tatum, L.T.; Thompson, D.; White, M.A.; Williams, C.G.; Goldberg, L.; Cusimano, D.; DeBar, L.; Elliot, D.; Grund, H.M.; Kuel, K.; McCormick, S.; Moe, E.; Roullet, J.B.; Stadler, D.; Foster, G.D.; Brown, J.; Creighton, B.; Faith, M.; Ford, E.G.; Glick, H.; Kumanyika, S.; Nachmani, J.; Rosen, J.; Rosen, L.; Sherman, S.; Solomon, S.; Virus, A.; Volpe, S.L.; Willi, S.; Cooper, D.; Bassin, S.; Bruecker, S.; Ford, D.;, 2009: HEALTHY study rationale, design and methods: moderating risk of type 2 diabetes in multi-ethnic middle school students. International Journal of Obesity 33 Suppl. 4: S4-20

Roberson, J.B.; Goldsztein, H.; Balaker, A.; Schendel, S.A.; Reinisch, J.F. 2013: HEAR MAPS a classification for congenital microtia/atresia based on the evaluation of 742 patients. International Journal of Pediatric Otorhinolaryngology 77(9): 1551-1554

Tolk, J. 1964: Hearing Disorders in Children. Nederlands Tijdschrift Voor Geneeskunde 108: 2048-2051

Fasunla, A.J.; Ogunkeyede, S.A.; Afolabi, S.O. 2019: Hearing Loss Among Adolescents on Antiretroviral Therapy: a Need for Periodic Hearing Assessment. Annals of Ibadan Postgraduate Medicine 17(1): 14-18

Joob, B.; Wiwanikit, V. 2020: Hearing Loss is Strongly, Cognitive Decline and Apoe4 Polymorphism. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 41(5): 718

Joob, B.; Wiwanikit, V. 2020: Hearing Loss Is Strongly, Cognitive Decline and Apoe4 Polymorphism. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 41(5): 718

Parin, V.V.; Baevsky, R.M.; Gazenko, O.G. 1965: Heart and Circulation under Space Conditions. Cor et Vasa 7: 165-184

Casiello, A. 1963: Heart Disease and Pregnancy. El Dia Medico 35: 1917-1920

Young, C. 1931: Heart Disease and Pregnancy. Canadian Medical Association Journal 25(2): 154-158

Besterman, E.M. 1964: Heart Disease in Pregnancy. Nursing Times 60: 1698-1701

Murray, L.M. 1930: Heart Disease in Pregnancy. Canadian Medical Association Journal 23(4): 535-536

Parent, M.B.; Ferreira-Neto, H.C.; Kruemmel, A.R.; Althammer, F.; Patel, A.A.; Keo, S.; Whitley, K.E.; Cox, D.N.; Stern, J.E. 2021: Heart failure impairs mood and memory in male rats and down-regulates the expression of numerous genes important for synaptic plasticity in related brain regions. Behavioural Brain Research 414: 113452

Yepanchintseva, Оl.А; Zharinov, Оl.J.; Mikhaliev, Кy.О 2020: Heart Failure with Mid-Range left Ventricular Ejection Fraction. Wiadomosci Lekarskie 73(8): 1765-1770

Todd, M.; McCall, D. 2021: Heart in the right Place:the Ambulatory Cardiology Unit. Ulster Medical Journal 90(1): 43

Stopyra, J.P.; Snavely, A.C.; Lenoir, K.M.; Wells, B.J.; Herrington, D.M.; Hiestand, B.C.; Miller, C.D.; Mahler, S.A. 2020: HEART Pathway Implementation Safely Reduces Hospitalizations at one year in Patients with Acute Chest Pain. Annals of Emergency Medicine 76(5): 555-565

Perek, S.; Raz-Pasteur, A. 2021: Heart Rate Variability: the Age-Old Tool Still Remains Current. Harefuah 160(8): 533-536

Webb, J.L.; Streitz, M.; Hyams, J.; April, M.; Oliver, J.J. 2020: HEART Score of Four for Age and Risk Factors: a Case Series. Cureus 12(8): E9576

Shannon, C.P.; Hollander, Z.; Dai, D.L.Y.; Chen, V.; Assadian, S.; Lam, K.K.; McManus, J.E.; Zarzycki, M.; Kim, Y.; Kim, J.-Y.V.; Balshaw, R.; Gidlöf, O.; Öhman, J.; Smith, J.G.; Toma, M.; Ignaszewski, A.; Davies, R.A.; Delgado, D.; Haddad, H.; Isaac, D.; Kim, D.; Mui, A.; Rajda, M.; West, L.; White, M.; Zieroth, S.; Tebbutt, S.J.; Keown, P.A.; McMaster, W.R.; Ng, R.T.; McManus, B.M. 2020: HEARTBiT: a Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients. Canadian Journal of Cardiology 36(8): 1217-1227

Wang, N.; Liu, W.; Yu, L.; Guo, Z.; Chen, Z.; Jiang, S.; Xu, H.; Fang, H.; Wang, Y.; Zhang, Z.; Chen, X. 2020: Heat Shock Factor A8a Modulates Flavonoid Synthesis and Drought Tolerance. Plant Physiology 184(3): 1273-1290

Tuleubaev, B.; Saginova, D.; Saginov, A.; Tashmetov, E.; Koshanova, A. 2020: Heat Treated Bone Allograft as an Antibiotic Carrier for Local Application. Georgian Medical News 306: 142-146

Andrade, M.A.; Bork, P. 1995: HEAT repeats in the Huntington's disease protein. Nature Genetics 11(2): 115-116

Fang, Y.; Han, X.; Li, J.; Kuang, T.; Lou, W. 2020: HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer. Journal of Oncology 2020: 3181596

Zhao, J.; Zhu, Y.; Fu, Q.; Zhu, Y.; Zhao, G. 2020: HEATR1 promotes proliferation in gastric cancer in vitro and in vivo. Acta Biochimica et Biophysica Sinica 52(9): 1030-1039

Nakamura, A.; Kakihara, Y.; Funayama, A.; Haga, K.; Mikami, T.; Kobayashi, D.; Yoshida, Y.; Izumi, K.; Kobayashi, T.; Saeki, M. 2021: HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma. Biochemical and Biophysical Research Communications 557: 294-301

Berz, J.; Simm, S.; Schuster, S.; Scharf, K-Dieter.; Schleiff, E.; Ebersberger, I. 2019: HEATSTER: A Database and Web Server for Identification and Classification of Heat Stress Transcription Factors in Plants. Bioinformatics and Biology Insights 13: 1177932218821365

Bernard, R. 1964: Heatstroke. La Revue du Praticien 14: 169-174

Yoon, S-Jin.; Foley, J.W.; Baker, J.C. 2015: HEB associates with PRC2 and SMAD2/3 to regulate developmental fates. Nature Communications 6: 6546

In, T.S.H.; Trotman-Grant, A.; Fahl, S.; Chen, E.L.Y.; Zarin, P.; Moore, A.J.; Wiest, D.L.; Zúñiga-Pflücker, J.Carlos.; Anderson, M.K. 2017: HEB is required for the specification of fetal IL-17-producing γδ T cells. Nature Communications 8(1): 2004

Forlani, S.; Cozzi, C.; Rosa, S.; Tadini, L.; Masiero, S.; Mizzotti, C. 2020: HEBE, a novel positive regulator of senescence in Solanum lycopersicum. Scientific Reports 10(1): 11021

Bettles, R. 1985: HEC dental health campaign 1985. British Dental Journal 158(3): 83

Memon, S.A.; Khan, K.A.; Naveed, H. 2020: HECNet: a hierarchical approach to enzyme function classification using a Siamese Triplet Network. Bioinformatics 36(17): 4583-4589

Pandolfi, S.; Montagnani, V.; Lapucci, A.; Stecca, B. 2015: HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth. Cell Death and Differentiation 22(12): 2006-2019

Press, W.H.; Hawkins, J.A.; Jones, S.K.; Schaub, J.M.; Finkelstein, I.J. 2020: HEDGES error-correcting code for DNA storage corrects indels and allows sequence constraints. Proceedings of the National Academy of Sciences of the United States of America 117(31): 18489-18496

Bertolami, C.N.; Bloom, E.; McIntosh, J.D. 2021: HEED: NYU's Mentor-Protégé Model of Dental Education. Compendium of Continuing Education in Dentistry 42(2): 97

Natarajan, M.; Stewart, J.E.; Golemis, E.A.; Pugacheva, E.N.; Alexandropoulos, K.; Cox, B.D.; Wang, W.; Grammer, J.R.; Gladson, C.L. 2006: HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25(12): 1721-1732

Li, Y.; Bavarva, J.H.; Wang, Z.; Guo, J.; Qian, C.; Thibodeau, S.N.; Golemis, E.A.; Liu, W. 2011: HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene 30(23): 2633-2643

Tsuji, S.; Washimi, K.; Kageyama, T.; Yamashita, M.; Yoshihara, M.; Matsuura, R.; Yokose, T.; Kameda, Y.; Hayashi, H.; Morohoshi, T.; Tsuura, Y.; Yusa, T.; Sato, T.; Togayachi, A.; Narimatsu, H.; Nagasaki, T.; Nakamoto, K.; Moriwaki, Y.; Misawa, H.; Hiroshima, K.; Miyagi, Y.; Imai, K. 2017: HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Scientific Reports 7: 45768

Singh, M.K.; Nicolas, E.; Gherraby, W.; Dadke, D.; Lessin, S.; Golemis, E.A. 2007: HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins. Oncogene 26(33): 4825-4832

Pottie, K.; Agic, B.; Archibald, D.; Ratnayake, A.; Tapia, M.; Thanos, J. 2019: HEIA tools: inclusion of migrants in health policy in Canada. Health Promotion International 34(4): 697-705

Singh, S.; Jatana, N.; Goel, V. 2021: HELF (Haptic Encoded Language Framework): a digital script for deaf-blind and visually impaired. Universal Access in the Information Society 2021: 1-11

Coelho, M.C.F.; Ribeiro, H.G.; Gomes, C.G.d.O.; Marinho, F.P.; Barbosa, A.J.A.; Coelho, L.G.V. 2021: Helicobacter Pylori Chronic Gastritis on Patients with Premalignant Conditions: Olga and Olgim Evaluation and Serum Biomarkers Performance. Arquivos de Gastroenterologia 58(1): 39-47

Ramachandran, A.; Lumetta, S.S.; Klee, E.W.; Chen, D. 2021: HELLO: improved neural network architectures and methodologies for small variant calling. Bmc Bioinformatics 22(1): 404

Rath, W.; Tsikouras, P.; Stelzl, P. 2020: HELLP Syndrome or Acute Fatty Liver of Pregnancy: a Differential Diagnostic Challenge: Common Features and Differences. Geburtshilfe und Frauenheilkunde 80(5): 499-507

Arigita Lastra, M.; Martínez Fernández, G.S. 2020: HELLP syndrome: controversies and prognosis. Hipertension y Riesgo Vascular 37(4): 147-151

Azimi-Ghomi, O.; Miller, G.; Guida, C.; Marimon, A.; Boneva, D.; McKenney, M. 2021: HELLP! the Novel use of Continuous Renal Replacement Therapy and Nitric Oxide in the Treatment of Acute Respiratory Failure in HELLP Syndrome. Case Reports in Critical Care 2021: 8895319

Wang, F.-J.; Jing, Y.-H.; Cheng, C.-S.; Cao, Z.-Q.; Jiao, J.-Y.; Chen, Z. 2021: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer. Bmc Medical Genomics 14(1): 189

Wilcocks, C. 1963: Helminthiasis. Tropical Diseases Bulletin 60: 805

Burke-Gaffney, H.J. 1964: Helminthiasis. Tropical Diseases Bulletin 61: 729-752

Burke-Gaffney, H.J. 1964: Helminthiasis. Tropical Diseases Bulletin 61: 865-891 Contd

Le Guen, M.; Coppere, Z.é; Dufour, G.; Ouattara, J.; Trichereau, J.; Fischler, M. 2020: HELP-VDL: study protocol for a multicentre, open, randomised, controlled clinical trial comparing the use of the head-elevated laryngoscopy position and the use of a videolaryngoscope to facilitate orotracheal intubation in a patient population without predictable difficulty of intubation. Bmj Open 10(7): E036570

Buckingham, S.; Kendall, M.; Ferguson, S.; MacNee, W.; Sheikh, A.; White, P.; Worth, A.; Boyd, K.; Murray, S.A.; Pinnock, H. 2015: HELPing older people with very severe chronic obstructive pulmonary disease (HELP-COPD): mixed-method feasibility pilot randomised controlled trial of a novel intervention. Npj Primary Care Respiratory Medicine 25: 15020

Guo, C.; Gao, Y.-Y.; Ju, Q.-Q.; Zhang, C.-X.; Gong, M.; Li, Z.-L. 2021: HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia. Journal of Translational Medicine 19(1): 42

Adelman, C.A.; Lolo, R.L.; Birkbak, N.J.; Murina, O.; Matsuzaki, K.; Horejsi, Z.; Parmar, K.; Borel, Vérie.; Skehel, J.Mark.; Stamp, G.; D'Andrea, A.; Sartori, A.A.; Swanton, C.; Boulton, S.J. 2013: HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. Nature 502(7471): 381-384

Cook, S.A.; Comrie, W.A.; Poli, M.C.; Similuk, M.; Oler, A.J.; Faruqi, A.J.; Kuhns, D.B.; Yang, S.; Vargas-Hernández, A.; Carisey, A.F.; Fournier, B.; Anderson, D.E.; Price, S.; Smelkinson, M.; Abou Chahla, W.; Forbes, L.R.; Mace, E.M.; Cao, T.N.; Coban-Akdemir, Z.H.; Jhangiani, S.N.; Muzny, D.M.; Gibbs, R.A.; Lupski, J.R.; Orange, J.S.; Cuvelier, G.D.E.; Al Hassani, M.; Al Kaabi, N.; Al Yafei, Z.; Jyonouchi, S.; Raje, N.; Caldwell, J.W.; Huang, Y.; Burkhardt, J.K.; Latour, S.; Chen, B.; ElGhazali, G.; Rao, V.K.; Chinn, I.K.; Lenardo, M.J. 2020: HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science 369(6500): 202-207

Torres, Mía.Luz.; Oberti, T.G.; Fernández, J.Manuel. 2020: HEMA and Alginate-based chondrogenic semi-interpenetrated hydrogels: Synthesis and Biological Characterization. Journal of Biomaterials Science. Polymer Edition 2020: 1-15

Sia, C.Feng.; Levey, C. 2018: HEMA-free or HEMA-containing adhesive systems for non-carious cervical lesions. Evidence-Based Dentistry 19(4): 114-115

Schweikl, H.; Birke, M.; Gallorini, M.; Petzel, C.; Bolay, C.; Waha, C.; Hiller, K.-A.; Buchalla, W. 2021: HEMA-induced oxidative stress inhibits NF-κB nuclear translocation and TNF release from LTA- and LPS-stimulated immunocompetent cells. Dental Materials: Official Publication of the Academy of Dental Materials 37(1): 175-190

Piso, H.J. 1963: Hemangioma. Geneeskundige Gids 41: 292-293

Lund, B.A.; Dahlin, D.C. 1965: Hemangiomas of the Mandible and Maxilla. Northwest Dentistry 44: 165-166

Fuehr, J. 1963: Hematocrit. Therapie der Gegenwart 102: 1160-1164

Ratliff, C.; Kingsley, L.; Kusmierczyk, J.; Gentry, J.; Russell, K.E.; Heatley, J.J. 2019: Hematologic and Biochemical Values of the Juvenile Eastern Gray Squirrel (Sciurus Carolinensis). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 50(3): 644-649

García, G.án.O.; Castano, M.V.; Paz, J.A.; Paterlini, C.A.; Zumpano, F.; Favero, M. 2021: Hematologic Metrics from Olrog's Gull (Larus Atlanticus) during the Nonbreeding Season in Argentina. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(1): 348-356

Vieira, K.ás.R.A.; Faillace, A.C.L.; Lobo-Jr, A.R.; Santana, M.I.S. 2021: Hematologic Values of Captive Healthy Red-and-Green Macaws (Ara Chloropterus). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(2): 737-741

Debray, J. 1963: Hematology. Therapie 18: 775-806

Lamglait, B.; Vandenbunder, M. 2020: Hematology and Serum Biochemistry Values of Captive Southern Lechwes (Kobus Leche). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 51(2): 438-442

Wu, Z.; Wen, Y.; Fan, G.; He, H.; Zhou, S.; Chen, L. 2021: HEMGN and SLC2A1 might be potential diagnostic biomarkers of steroid-induced osteonecrosis of femoral head: study based on WGCNA and DEGs screening. Bmc Musculoskeletal Disorders 22(1): 85

Rodrigues, N.V.M.; Guarniero, R.; Boas, P.J.é F.V.; de Miranda, B.R.; Montenegro, N.B. 2020: Hemiepiphysiodesis using Eight-Plate versus Blount Staple to Correct Genu Valgum and Genu Varum. Acta Ortopedica Brasileira 28(4): 195-198

Neimark, E.Z.; Panchenko, E.N. 1964: Hemihypertrophy. Pediatriia 43: 34-35

Harastani, M.; Eltsov, M.; Leforestier, A.él.; Jonic, S. 2021: HEMNMA-3D: Cryo Electron Tomography Method Based on Normal Mode Analysis to Study Continuous Conformational Variability of Macromolecular Complexes. Frontiers in Molecular Biosciences 8: 663121

Pestel, M. 1964: Hemochromatosis. La Presse Medicale 72: 1139-1141

Verhaegen-Declercq, M.L.; Verhaegen, H.; De Groot, E.J. 1964: Hemochromatosis. Belgisch Tijdschrift Voor Geneeskunde 20: 1165-1174

Braier, L.; Sabagh, R.A. 1964: Hemochromatosis. Prensa Medica Argentina 51: 1246-1250

Novosel, D. 1964: Hemochromatosis. Medicinski Glasnik 18: 108-112

Grytsuliak, V.B.; Vasylechko, M.M.; Kocherzhat, O.І; Hotiur, O.I. 2021: Hemodynamic Andcytologic Changesinprostate Glandcaused by Chronic Hepatitis. Wiadomosci Lekarskie 74(4): 954-956

Guyton, A.C. 1964: Hemodynamics. A Listing of Research in the Cardiovascular Field 10: 73-77

De Traverse, P.M.; Buri, J.F. 1965: Hemoglobin. La Revue du Praticien 15: 291-294

Merzon, E.; Green, I.; Shpigelman, M.; Vinker, S.; Raz, I.; Golan-Cohen, A.; Eldor, R. 2021: Hemoglobin A1c and Mortality from Covid-19. Harefuah 160(10): 645-650

Capdevila-Armengol, J. 1963: Hemoglobinopathies. Medicina Clinica 41: 16-19

Tsirkina, A.S. 1964: Hemoglobinopathies. Pediatriia 43: 75-81

Farhat, M. 1964: Hemoglobinopathies. La Tunisie Medicale 42: 353-361

Marti, H.R. 1965: Hemoglobinopathies. Schweizerische Medizinische Wochenschrift 95: 37-41

Jonxis, J.H. 1964: Hemoglobinopathy. Folia Medica Neerlandica 7: 62-81

Sanchezmedal, L. 1965: Hemolysis and Erythropoietic Activity. Sangre 10: 195-201

Charmot, G.; Dodin, A.; Plouvier, S. 1965: Hemolytic Anemia Caused by Glucose-6-Phosphate Dehydrogenase Deficiency. Medecine Tropicale: Revue du Corps de Sante Colonial 25: 11-20

Medinaaguilar, R. 1964: Hemolytic Disease of the Newborn. Ginecologia y Obstetricia de Mexico 19: 205-216

Farias, M.G.; Freitas, P.A.C.; Spagnol, F.; Souza, M.V.d.; Alegretti, A.P.; Riegel, M.; Taniguchi, A.N.R.; Daudt, L.E. 2021: Hemophagocytosis by Blasts in a Child with Acute Monocytic Leukemia after Chemotherapy. Revista Paulista de Pediatria: Orgao Oficial da Sociedade de Pediatria de Sao Paulo 39: E2019290

Ottenberg, D.J.; Richardson, F.M. 1963: Hemoptysis. Medical Science 14: 56-65

Nakamura, T.; Okubo, T. 1964: Hemoptysis. NAIKA. Internal Medicine 13: 863-867

Harambasic, H. 1964: Hemoptysis. Lijecnicki Vjesnik 86: 491-499

Sancho, G.; Bloch, M. 1964: Hemorrhagiparous Syndromes. Review. Archivos del Colegio Medico de El Salvador 17: 238-244

Carstensen, R.; Reil, J.C.R. 1964: Hemorrhoids. Medicina 32: 567-569

Odartchenko, N. 1964: Hemostasis. Nouvelle Revue Francaise d'Hematologie 4: 539-549

Baylo, A.E.; Maksymets, T.O.; Shypulіn, V.P.; Chernyavskyi, V.V.; Parunian, L.M. 2021: Hemostatic Potential Assessment of Patients with Liver Cirrhosis and Atrial Fibrillation by Low-Frequency Piezoelectric Thromboelastography. Wiadomosci Lekarskie 74(3 Cz 2: 578-583

Sügis, E.; Dauvillier, J.; Leontjeva, A.; Adler, P.; Hindie, V.; Moncion, T.; Collura, V.; Daudin, R.; Loe-Mie, Y.; Herault, Y.; Lambert, J-Charles.; Hermjakob, H.; Pupko, T.; Rain, J-Christophe.; Xenarios, I.; Vilo, J.; Simonneau, M.; Peterson, H. 2019: HENA, heterogeneous network-based data set for Alzheimer's disease. Scientific Data 6(1): 151

Ali, B.; Salim, A.; Alam, A.; Zuberi, B.F.; Ali, Z.; Azam, Z.; Kamani, L.; Farooqi, J.I.; Salih, M.; Nawaz, A.A.; Chaudhry, A.A.; Hashmi, Z.Y.; Siddique, M. 2020: HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan. Pakistan Journal of Medical Sciences 36(5): 1117-1132

Curtis, L. 2021: HEPA Filters and Airborne Viruses, Bacteria, and Fungi. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 2021: 1945998211035104

Sobel, E. 1994: HEPA respirators and tuberculosis in hospital workers. New England Journal of Medicine 331(24): 1658-1659; Author Reply 1659-1660

Sherertz, R.J.; Streed, S.A. 1994: HEPA respirators and tuberculosis in hospital workers. New England Journal of Medicine 331(24): 1659; Author Reply 1659-1660

Smith, R.; Hobsley, M.; Stephen, J.L. 1964: Hepatectomy. Proceedings of the Royal Society of Medicine 57: 547-551

Nielsen, B.L.; Kessing, S.V. 1965: Hepatic Cirrhosis and Atherosclerotic Heart Disease. Geriatrics 20: 374-378

Avellana Moreno, R.ío.; De la Serna Esteban, S.ía.; García-Botella, A. 2021: Hepatic reactive lymphoid hyperplasia: a difficult differential diagnosis with hepatocarcinoma. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(7): 552

Abzianidze, T.; Butsashvili, M.; Kajaia, M.; Kochlamazashvili, M.; Kipiani, E.; McNutt, L.A.; Kamkamidze, G. 2019: Hepatitis B Vaccination: Knowledge and Attitude Among Women of Reproductive Age in Georgia. Georgian Medical News 2019(295): 109-114

Quintero García, D.; Sebastián Cuevas, F.J.é; Crehuá Gaudiza, E. 2021: Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(2): 150-151

Michels, F.B.L.; Amaral, A.C.d.C.; Carvalho-Filho, R.J.é d.; Vieira, G.d.A.; Souza, A.L.d.S.; Ferraz, M.L.G. 2020: Hepatitis C Treatment of Renal Transplant and Chronic Kidney Disease Patients: Efficacy and Safety of Direct-Acting Antiviral Regimens Containing Sofosbuvir. Arquivos de Gastroenterologia 57(1): 45-49

Rodríguez, S.; Fleck, A.d.M.; Mucenic, M.; Marroni, C.áu.; Brandão, A. 2020: Hepatocellular Carcinoma Patients Are Advantaged in the Current Brazilian Liver Transplant Allocation System. a Competing Risk Analysis. Arquivos de Gastroenterologia 57(1): 19-23

Monahan, C.F.; Garner, M.M.; Kiupel, M. 2018: Hepatocellular Neoplasms in Captive Fennec Foxes ( Vulpes Zerda). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 49(4): 996-1001

Berndt, N.; Bulik, S.; Wallach, I.; Wünsch, T.; König, M.; Stockmann, M.; Meierhofer, D.; Holzhütter, H-Georg. 2018: HEPATOKIN1 is a biochemistry-based model of liver metabolism for applications in medicine and pharmacology. Nature Communications 9(1): 2386

Lods, J.C.; Dupuy, R. 1963: Hepatology. Gazette Medicale de France 70: 3904-3907

Lods, J.C.; Dupuy, R. 1964: Hepatology. Gazette Medicale de France 71: 4171-4172

Uyzbayeva, I.; Akpolatova, G.; Tarzhanova, D.; Mukanov, K. 2021: Hepatoprotective Efficiency of G10 Substance from Zhuzgun Plant in Experimental Toxic Hepatitis. Georgian Medical News 312: 138-145

Avramovic, G.; Reilly, M.; Cullen, W.; Macías, J.; McCombe, G.; McHugh, T.; Oprea, C.; Story, A.; Surey, J.; Sabin, C.; Bivegete, S.; Vickerman, P.; Walker, J.; Ward, Z.; Lambert, J.S. 2020: HEPCARE EUROPE- a case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 101: 374-379

Fisk, A.; Pathak, S. 1969: HEPES-buffered medium for organ culture. Nature 224(5223): 1030-1031

Pillon, M.C.; Gordon, J.; Frazier, M.N.; Stanley, R.E. 2020: HEPN RNases - an emerging class of functionally distinct RNA processing and degradation enzymes. Critical Reviews in Biochemistry and Molecular Biology 2020: 1-30

Hyman, D.M.; Piha-Paul, S.A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G.I.; Juric, D.; Quinn, D.I.; Moreno, V.; Doger, B.; Mayer, I.A.; Boni, V.; Calvo, E.; Loi, S.; Lockhart, A.C.; Erinjeri, J.P.; Scaltriti, M.; Ulaner, G.A.; Patel, J.; Tang, J.; Beer, H.; Selcuklu, S.Duygu.; Hanrahan, A.J.; Bouvier, N.; Melcer, M.; Murali, R.; Schram, A.M.; Smyth, L.M.; Jhaveri, K.; Li, B.T.; Drilon, A.; Harding, J.J.; Iyer, G.; Taylor, B.S.; Berger, M.F.; Cutler, R.E.; Xu, F.; Butturini, A.; Eli, L.D.; Mann, G.; Farrell, C.; Lalani, A.S.; Bryce, R 2018: HER kinase inhibition in patients with HER2- and HER3-mutant cancers. Nature 554(7691): 189-194

Mohammed, T.; Mangeshkar, S.; Desai, A.; Hegde, U. 2021: HER-2 Neu gene: a valuable therapeutic target in metastatic mucoepidermoid carcinoma. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 27(7): 1806-1809

Bewick, M.; Conlon, M.; Gerard, S.; Lee, H.; Parissenti, A.M.; Zhang, L.; Glück, S.; Lafrenie, R.M. 2001: HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support. Bone Marrow Transplantation 27(8): 847-853

Arena, V.; Pennacchia, I.; Vecchio, F.Maria.; Carbone, A. 2013: HER-2 intratumoral heterogeneity. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 26(4): 607-609

Fu, Y.F.; Gui, R.; Liu, J. 2015: HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer. Cancer Gene Therapy 22(3): 145-153

Padayachee, J.; Daniels, A.; Balgobind, A.; Ariatti, M.; Singh, M. 2020: HER-2/neu and MYC gene silencing in breast cancer: therapeutic potential and advancement in nonviral nanocarrier systems. Nanomedicine 15(14): 1437-1452

Thomson, T.A.; Hayes, M.M.; Spinelli, J.J.; Hilland, E.; Sawrenko, C.; Phillips, D.; Dupuis, B.; Parker, R.L. 2001: HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 14(11): 1079-1086

Zhou, B.P.; Liao, Y.; Xia, W.; Zou, Y.; Spohn, B.; Hung, M.C. 2001: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nature Cell Biology 3(11): 973-982

Pavy, J.J.; Descotes, F.; Adessi, G.L. 1993: HER-2/neu oncogene: what does amplification mean?. British Journal of Cancer 68(1): 214-215

Ridolfi, R.L.; Jamehdor, M.R.; Arber, J.M. 2000: HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 13(8): 866-873

Chan, T.; Sami, A.; El-Gayed, A.; Guo, X.; Xiang, J. 2006: HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination. Gene Therapy 13(19): 1391-1402

Khan, A.N.; Yang, W.; Seifalian, A.M.; Winslet, M.C. 2006: HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus. British Journal of Cancer 94(8): 1213-4; Author Reply 1214-5

Watrowski, R.ł; Castillo-Tong, D.C.; Wolf, A.; Schuster, E.; Fischer, M.B.; Speiser, P.; Zeillinger, R. 2015: HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women. Anticancer Research 35(12): 6667-6670

Zhang, X.; Lv, J.; Wu, Y.; Qin, N.; Ma, L.; Li, X.; Nong, J.; Zhang, H.; Zhang, Q.; Yang, X.; Shi, H.; Wang, J.; Zhang, S. 2020: HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib. Frontiers in Oncology 10: 1162

Cagaanan, A.; Stelter, B.; Vu, N.; Rhode, E.N.; Stewart, T.; Hui, P.; Buza, N.; Al-Niaimi, A.; Flynn, C.; Weisman, P.S.; McGregor, S.M. 2022: HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 41(2): 132-141

Haffner, I.; Schierle, K.; Raimúndez, E.; Geier, B.; Maier, D.; Hasenauer, J.; Luber, B.; Walch, A.; Kolbe, K.; Riera Knorrenschild, J.; Kretzschmar, A.; Rau, B.; Fischer von Weikersthal, L.; Ahlborn, M.; Siegler, G.; Fuxius, S.; Decker, T.; Wittekind, C.; Lordick, F. 2021: HER2 Expression, Test Deviations, and their Impact on Survival in Metastatic Gastric Cancer: Results from the Prospective Multicenter VARIANZ Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 39(13): 1468-1478

Satala, C.B.; Jung, I.; Stefan-van Staden, R.I.; Kovacs, Z.; Molnar, C.; Bara, T.; Fulop, Z.Z.; Gurzu, S. 2020: HER2 Heterogeneity in Gastric Cancer: a Comparative Study, Using two Commercial Antibodies. Journal of Oncology 2020: 8860174

Castillon, M.; Bourhis, A.él.; Quintin-Roué, I.; Uguen, A. 2021: HER2 Mutated and Nonmutated Non-small Cell Lung Carcinomas can Harbor Heterogeneous HER2 Gene Amplification and HER2 Protein Expression. Applied Immunohistochemistry and Molecular Morphology: Aimm 29(4): 321-326

Muscatello, L.V.; Oto, E.D.; Dignazzi, M.; Murphy, W.J.; Porcellato, I.; De Maria, R.; Raudsepp, T.; Foschini, M.P.; Sforna, M.; Benazzi, C.; Brunetti, B. 2021: HER2 Overexpression and Amplification in Feline Pulmonary Carcinoma. Veterinary Pathology 58(3): 527-530

Luo, H.; Cui, L.; Shen, K.; Li, R.; Wang, Z.; Xie, Z. 2021: HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer. Cancer Management and Research 13: 3443-3454

He, L.; Araj, E.; Peng, Y. 2021: HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features. Current Oncology 28(3): 1608-1617

Egebjerg, K.; Harwood, C.D.; Woller, N.C.; Kristensen, C.A.; Mau-Sørensen, M. 2021: HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: a Systematic Review and Meta-Analysis. Frontiers in Oncology 11: 693394